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ABSTRACT
The availability of conditional-lethal yeast (Saccharomyces cerevisiae) m utants that are 
defective in the process of pre-m R N A  splicing (precursor R N A  processing; prp) has greatly 
facilitated the characterisation of com ponents of the  splicing machinery. W hen this project was 
initiated nine pip  com plem entation groups had been defined (prp2-prpll), all of which accum ulate 
pre-m R N A  at the expense of m R N A  when incubated at the non-perm issive tem perature. 
Pre-m R N A  splicing is a complex and dynamic process relying on many gene products for its 
com pletion and therefore many m ore com plem entation  groups rem ained to be identified. 
D eterm ination  of a prp phenotype has relied on the direct m easurem ent of protein to R N A  ratios 
and on the N orthern  blot analysis of conditional-lethal m utants incubated at the restrictive 
tem perature. Such analyses are both tim e-consum ing and labour-intensive. In this thesis I present 
the developm ent of a novel screening procedure which positively identifies prp m utants. I have fused 
a yeast intron-containing gene to the lacZ  gene o f E.coli such that only the pre-m R N A  generated 
from this fusion can encode an active /?-galactosidase fusion-protein. This gene-fusion has been 
introduced into a prp2 strain  and the encoded pre-m R N A  has been shown to accum ulate on 
incubation at the non-permissive tem perature. This pre-m R N A  accum ulation results in an increase 
in jS-galactosidase activity. Exploiting this observation a simple p late assay has been developed and 
used to screen a pool of tem perature-sensitive m utants for defects in pre-m R N A  splicing. A  num ber 
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rR N A  : ribosom al R N A
SDS : sodium  dodecyl su lphate
SDM  : site-directed m utagenesis
secs : seconds
snR N A  : small nuclear R N A
snRN P : small nuclear R N P
TCA  : trichloroacetic acid
TEM ED  : N, N, N ',  N ' -tetram ethyl-ethylenediam ine
ts : tem perature-sensitive
Tris : 2-am ino-2-hydroxym ethyl-propane-l, 3-diol
tR N A  : transfer R N A
UTP : uridine 5 ' -triphosphate
U V  : ultra-violet light
V : V olt
v/v : volum e per un it volum e
W : W att
w/o : w ithout
w/v : weight per unit volume
X-gal : 5-bromo-4-chloro-3-indolyl-/?-D-galactoside
/a : micro (ie. x 10~6)
Mg : microgram





In the mid 1970s it was discovered that the coding regions of many eukaryotic genes 
are in terrup ted  by stretches of D N A  which do not encode R N A  found in the m ature transcript 
(see Crick, 1978). It was subsequently found that these intervening sequences (introns; see 
Gilbert, 1978) are removed from a prim ary R N A  transcript by a process now known as 
pre-m R N A  splicing. Introns are divided in to  4 classes based on the m echanism of their removal, 
and the conserved sequence and structural elem ents residing in them. These 4 classes are;
(i) those found in tR N A  genes (Abelson, 1979),
(ii) G roup I introns, first described in Tetrcihymena rR N A  genes but now also found in
many fungal m itochondrial genes, chloroplast genes and in som e bacteriophage T4 genes
(Cech and Bass, 1986),
(iii) G roup II introns, found in fungal m itochondrial and chloroplast genes (Cech and Bass,
1986),
(iv) those found in nuclear protein-encoding genes (G reen, 1986; Padgett et al., 1986). 
Recently a G roup IV in tron has been found in thé U6 snR N A  gene of 
Schizosaccharomyces pom be  (Tani and Ohshim a, 1989).
This thesis is concerned with the removal of introns from protein-encoding genes of 
eukaryotic organisms and therefore this C hapter will introduce relevant aspects o f this process. 
In this thesis Saccharomyces cerevisiae and yeast, and TACTAAC and U A CU A A C, will be used 
interchangeably.
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1.2 INTRONS IN NUCLEAR PROTEIN-ENCODING GENES
In higher eukaryotic organism s protein-encoding genes can contain m ultiple introns 
ranging in size from 31 nucleotides to lOOkb (G reen, 1986; Padgett et al., 1986; Smith et al., 
1989a). This arrangem ent facilitates the  process o f alternative splicing, thereby generating 
diverse com inations of exons (R N A  sequences presen t in the m ature transcript) (see Section
1.11.1). A lternative splicing is extremely im portan t in the control o f gene expression (Leff and 
Rosenfeld, 1986; B reibart et al., 1987; Sm ith et al., 1989a).
In protein-encoding genes of yeast it appears that the presence of introns is the 
exception rather than the rule (Teem et al., 1984). In contrast to mammals the introns present 
in yeast genes fall into a distinct size range of 300-500 nucleotides. T here is usually only one 
intron present in any given gene and it is generally situated at the 5 ' end of the primary 
transcript. To date only one exception to these observations has been found; the M A T a l gene 
contains two small introns of 54 and 52 nucleotides (M iller, 1984), however no biological 
significance for this arrangem ent has yet been observed (K ohrer and Domdey, 1988; N er and 
Smith, 1989).
13 MECHANISM OF PRE-mRNA SPLICING
U nravelling the biochemical m echanism of splicing required the developm ent of an 
efficient in vitro splicing system which could faithfully reproduce the splicing pattern  observed 
in vivo. Early attem pts at such a developm ent relied on systems which coupled transcription and 
splicing in whole cell o r nuclear extracts (W eingartner and Keller, 1981; Kole and W eissman, 
1982; Padgett et al., 1983a); or relied on the addition of exogenous polyadenylated R N A  
precursors to the splicing extract (G oldenberg and Raskas, 1981; H ernandez and Keller, 1983; 
Goldenberg and H auser, 1983). Such strategies either produced splicing of a low efficiency or 
involved m anipulations that were extremely time-consuming.
The biochemical pathway of splicing was eventually dissected utilising H eLa cell nuclear
2
FIGURE 1.1: INTRON STRUCTURE
The conserved sequence elem ents of both  m am m alian and yeast introns are indicated. 
Vertical bars indicate the 5 ' and 3 ' splice sites. The num bers above each nucleotide refers to 
their position with respect to the discussion o f the ir m utational analyses (see Section 1.4). The 
asterisk indicates the branchpoint nucleotide in yeast introns.
FIGURE 1.2: MECHANISM OF SPLICING
The m echanism of nuclear pre-m R N A  splicing in m am m alian and yeast cells.
Figure 1.1
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extracts, which could efficiently and faithfully splice exogenous pre-m R N A  transcripts generated 
in vitro (K rainer et al., 1984; Hardy et al., 1984; R uskin et al., 1984; Grabowski et al., 1984; 
Padgett et al., 1984; Keller, 1984; Konarska et al., 1985; Padgett et al., 1985). These studies led 
to the proposal of a two-step pathway (see Fig. 1.2). A fter a characteristic lag period, usually 
30-45 m inutes, the first chemical m odification to  the pre-m R N A  can be detected. Step 1 of the 
splicing reaction proceeds with the cleavage o f the transcrip t at the 5 ' splice site producing 
exon 1 (E l)  and in tron lariat-exon 2 (IVS-E2) interm ediates. The 5 ' end of the  in tron  is jo ined 
via a 5 ' -2 ' phosphodiester bond to  an A  nucleotide usually situated  18-40 nucleotides upstream  
of the 3 ' splice site. Step 2 involves the cleavage o f the IVS-E2 at the 3 ' splice site and the 
ligation of E l  to E2 to form the m ature  R N A  transcript. The in tron  (IVS) is recovered as a 
lariat structure.
It is not known w hether bond cleavage and form ation at each step in the reaction 
occur concom itantly. There is no net change in the num ber of phosphodiester bonds and 
therefore theoretically these reactions require no phosphate donor i.e. no input of energy. 
Because of this and the sim ilarity to  the excision o f the self-splicing introns o f G roups I and 
II (Cech and Bass, 1986), it is considered that bond breaking and form ation are the result of 
a series of nucleophilic attacks as indicated in Fig. 1.2 and at each step occur concomitantly. 
However splicing in vitro does require ATP and this requirem ent may be for splicing-complex 
assembly and conform ational changes w ithin this assembly (e.g. see Cheng and Abelson, 1987). 
In yeast cell extracts, splicing proceeds by an identical m echanism (Lin et al., 1985).
For the analysis o f splicing in vitro to be of any benefit the sam e mechanism o f splicing 
must take place in vivo and thus the sam e molécules must be identifiable. H eLa cell nuclear 
extracts (but not cytoplasmic extracts) contain a significant num ber of R N A  molecules that 
harbour 2 ' - 5 '  phoshodiester branches (W allace and Edm onds, 1983). The nucleotide at the 
branch site o f these molecules was found to  be nearly always an A, though C and to a lesser 
extent U branched nucleotides were also found. Subsequently the interm ediates of the splicing 
reaction were identified in vivo in m am m alian cells (Zeitlin  and Efstratitiadis, 1984) and in yeast 
cells (Rodriguez et al„ 1984; Domdey et a l ,  1984).
3
The presence of a m 7G (5 ' )p p p (5 ' )N  cap structure  at the 5 ' end o f intron-containing 
transcripts is not required for splicing in m am m alian nuclear extracts, though when analysed in 
vitro its presence does increase both  the efficiency of splicing- complex form ation and fidelity 
of the splicing reaction (K onarska et al., 1984; Patzelt et a l., 1987; Inoue et a!., 1989). In yeast 
extracts the presence of the cap structure  on  the transcript appears to have no effect on 
splicing (Lin et al., 1985). Polyadenylation o r correct 3 ' end form ation o f pre-m R N A  transcripts 
are not required for splicing (K rainer et al., 1984).
Since nuclear pre-m R N A  introns presen t in both m am m alian and yeast transcripts are 
spliced by the sam e m echanism a search was undertaken for conserved sequences w ithin the 
introns of both  species (and indeed in o ther species) (M ount, 1982; Keller and Noon, 1984; 
Teem et al., 1984). This search pointed to  the conservation o f sequences at the 5 ' end, 
branchpoint and 3 ' end* of the introns. To determ ine the im portance of these conserved 
sequences in the process o f pre-m R N A  splicing, num erous experim ents were perform ed 
involving deletion and m utational analysis of these elem ents. The effects of the changes 
introduced have been analysed extensively both in vivo and in vitro, and generally the 
observations made using both approaches have been consistent. However the effects o f the 
m utations appear to be m ore pronounced when analysed in vitro.
1-4 SEQUENCE REQUIREMENTS FOR PRE-mRNA SPLICING
1-4.1 M am m alian Pre-m R N A  Transcripts
Naturally occurring m utations in the 5 ' splice site of globin gene introns not only 
reduce the efficiency of splicing but also activate cryptic 5 ' splice sites in vitro and in vivo 
(Felber et al., 1982; Treism an et al., 1982, 1983; W ieringa et al., 1983; K rainer et al., 1984). 
M utations at G1 or T2 (refer to Fig. 1.1) produce the m ost pronounced effect on splicing 
efficiency, however there are contrasting reports regarding the qualitative effects of such
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m utations. In som e reports 5 ' cleavage is com pletely inhibited (Treism an et al., 1982, 1983; 
W ieringa et al., 1983; G reen et al., 1983) whereas in others the efficiency of step 1 is reduced 
and step 2 is inhibited (Aebi et al., 1986, 1987). M utations in the conserved G T nucleotides not 
only reduce the efficiency of active spliceosom e form ation bu t also cause the accum ulation of 
a complex containing the interm ediates o f the splicing reaction (Lam ond et al., 1987). This 
observation suggests that m utations in the conserved G T  nucleotides cause a block in step 2 of 
the splicing reaction. O ther m utations in the 5 ' splice site region, though exhibiting less o f an 
effect on the efficiency of splicing, lead to the activation of cryptic splice sites (Treism an et al., 
1983) and "exon-skipping" (Aebi et al., 1986). The 5 ' splice site consensus sequence (indicated 
in Fig. 1.1) is the sequence used m ost efficiently in the splicing process (Aebi et al., 1986, 1987; 
Lear et al., 1990). It is considered that this is a consequence of its optim um  com plem entarity 
to the 5 ' end o f the U1 snR N A  (Aebi et al., 1987). However it appears that this 
com plem entarity to  the U1 snR N A  is no t the only determ inant of 5 ' splice site choice. The 
context in which the 5 ' splice site resides appears to influence its relative use (Nelson and 
G reen, 1988). Recently it has been postulated that the sequence at the 5 ' splice site may be 
affected by the length o f the  in tron (Fields, 1990).
The m am m alian branch-acceptor region is not as highly conserved as that for yeast 
transcripts. D eletion of the authentic branchpoint region results in the use of cryptic 
branch-acceptor sites (R eed and M aniatis, 1985), indeed cryptic sites need not exhibit any 
sequence similarity to the branchpoint consensus (Padgett et al., 1985). U tilisation of cryptic 
branchpoints appears to decrease the efficiency of splicing (Padgett- et al., 1985). B ranchpoints 
are usually situated 18-40 nucleotides upstream  of the 3 ' splice site (R uskin et al., 1984; Reed,
1989) and the m inimum distance from the 5 ' .  splice site that allows efficient splicing is —50 
nucleotides (see Smith et al., 1989a). Increasing the distance separating the 3 ' splice site from 
the branchpoint above —70 nucleotides decreases the efficiency of step 2 o f the splicing reaction 
(Reed, 1989). A lthough most branches are form ed at an A  nucleotide any nucleotide can act 
as a branch-acceptor, however G  or U  nucleotides form IVS-E2 molecules incapable of
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undergoing step 2 of the splicing reaction (H ornig et al., 1986). C oupled with the results of 
m utations at positions G1 and T2 o f the 5 ' splice site, these observations suggest that specific 
nucleotides are required on either side of the phosphodiester bond form ed at the branchpoint 
to enable step 2 of the splicing reaction to take place. M utational analysis of sequences 
surrounding the branchpoint have indicated that this region affects the efficiency of branchpoint 
recognition and utilisation (Reed and M aniatis, 1988). Thus the weak consensus derived for the 
branchpoint region is im portant in pre-m R N A  splicing. Some m am m alian branchpoints are 
situated well upstream  of the 3 ' splice site i.e. —100 nucleotides (Reed, 1989; G oux-Pelletan 
et al., 1990). It has been suggested that such sites are utilised in the process of alternative 
splicing (Reed, 1989). Such sites are norm ally followed by an extremely long (Py)n tract, and 
such long tracts do not require an A G  (3 ' cleavage site) in close proximity to  enable efficient 
com pletion of step 1 o f the splicing reaction (Reed, 1989).
T here are two elem ents present at the 3 ' splice site region o f introns which are of 
im portance in the splicing process. The 3 ' cleavage site immediately follows the highly 
conserved A G  dinucleotide which is itself preceded by a (Py)n tract (n> 10) (See Fig. 1.1). 
D eletion o f the (Py)n tract from the first in tron  of the hum an /?-globin gene and the m ajor late 
transcript o f adenovirus 2 com pletely abolishes lariat form ation (Frendewey and Keller, 1985; 
Reed and M aniatis, 1985a; Ruskin and G reen, 1985c) and spliceosom e assembly (Frendewey and 
Keller, 1985; B indereif and G reen, 1986). The efficiency of splicing appears to decrease 
sequentially with the progressive reduction in size of the (Py)n tract, which can also lead to the 
utilisation of cryptic 3 ' splice sites (W ieringa et al., 1984). M utations of the A G  dinucleotide 
can either m oderately inhibit step 1 of splicing (R eed and M aniatis, 1985) o r completely abolish 
it (Aebi et al., 1986). In addition step 2 is com pletely inhibited by m utations in the AG 
dinucleotide, indeed cryptic 3 ' cleavage sites can be activated in reponse to such m utations 
(Aebi et al., 1986). M utations of the A G  dinucleotide inhibit spliceosom e assembly (Lam ond 
et al., 1987). In cw-com petition assays R. R eed was able to define m ore clearly the relationship 
between the (Py)n tract and the A G  cleavage site and concluded that there is a sequence and 
distance requirem ent for efficient com pletion of steps 1 and 2 of splicing (Reed, 1989). From
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this analysis it appears that the (Py)n tract is required prim arily for step 1 and the A G  
dinucleotide is required (though not. essential) for efficient com pletion of step 2. Recently it has 
been observed that the branchpoint is specified by both  its sequence context and by the adjacent 
downstream  (Py)n tract (Sm ith et al., 1989b). Indeed splicing efficiency is greater when the (Py)n 
tract is situated  im m ediately dow nstream  of the branchpoint region (Reed, 1989). Specification 
of the A G  cleavage site, which is norm ally the first A G  dinucleotide downstream  of the 
branchpoint, is proposed to be by a scanning mechanism initiated at the branchpoint region 
(Smith et al., 1989b). It was previously considered that in m am m alian introns the branchpoint 
was determ ined, in part, by its distance from the 3 ' cleavage site, therefore this scanning model 
rationalises the observation that som e branchpoints are located at greater than expected 
distances upstream  of the splice site.
D eletion of in tron  sequences (o ther than the conserved elem ents) appears to have little 
effect on the efficiency of splicing (W ieringa et al., 1984; van Santen and Spritz, 1985). However 
in the case o f alternative splicing, in tron sequences may play a role in splice site selection 
(G oux-Pelletan et al., 1990; Helfm an et al., 1990). Introns below the size of 80 nucleotides are 
spliced inefficiently from their transcripts (W ieringa et al., 1984), however introns of significantly 
sm aller sizes have been identified though this may reflect the splicing process in individual 
organisms (Karn et al., 1983; Kay et al., 1987).
In contrast to non-conserved in tron  sequences, exon sequences do influence the 
efficiency of splicing and indeed the choice o f splice sites (Reed and M aniatis, 1986; Lear et al., 
1990). Both steps of splicing can be detected when as little as 4 nucleotides are present in exon 
2, however the efficiency of splicing increases as the length of exon 2 increases (Turnbull-Ross 
et al., 1988). Indeed exon 2 is not required for step 1 of splicing (Frendewey and Keller, 1985). 
A  transcript containing 20 nucleotides in exon 1 can undergo both steps of splicing (Parent et 
al., 1987).
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1.4.2 Y east Pre-m R N A  Transcripts
It is clear that m utations at m ost positions in the consensus sequences (see Fig. 1.1) 
affect the efficiency of splicing and prim arily they cause an accum ulation of pre-m RN A . 
However they do so to varying degrees and indeed different nucleotide substitutions at the same 
positions can produce varied effects (Jaquier et al., 1985; V ijaraghavan et al., 1986; Fouser and 
Friesen, 1986). In different transcripts there  also appear to be distinct responses to com parable 
m utations (see Newman et al., 1985; V ijaraghavan et al., 1986). The effects of nucleotide 
substitutions and transcript-specific responses appear to be quantitative ra ther than qualitative.
M utations at G1 and T2 of the 5 ' splice site consensus region allow step 1 of the 
splicing reaction to proceed but result in the partial accum ulation of IVS-E2 interm ediate 
molecules which cannot undergo step 2 (Newman et al., 1985; V ijaraghavan et al., 1986; Fouser 
and Friesen, 1986; Siliciano and G uthrie, 1988). This suggests that 5 ' splice site cleavage and 
lariat form ation do not require a G  nucleotide at position 1 but that step 2 does. This is 
consistent with the observations made for sim ilar m utations in m am m alian introns (see Section
1.4.1). This hypothesis is further supported  by the observation that m utations at position G5 
produce aberran t 5 ' cleavage events which result in "dead-end" IVS-E2 molecules. These 
aberrant sites are situated close to the norm al 5 ' cleavage site (~ 5  nucleotides away) and 
cleavage can occur before an A, C o r U  nucleotide which then can form 5 ' -2 ' phosphodiester 
bonds with the norm al branchpoint A  nucleotide (Parker and G uthrie, 1985; Jaquier et al., 1985; 
Vijayraghavan et al., 1986; Fouser and Friesen, 1986). Such molecules are unable to undergo 
step 2 of the splicing reaction. The sites of aberran t 5 ' cleavage (caused by a m utation at G5) 
bear no resem blance to the norm al sites of 5 ' cleavage and it has been suggested that 5 ' splice 
site recognition and cleavage are distinct processes. This is supported by the observation that 
m utations of the yeast U1 snR N A  which are com plem entary to those at position G5 o f the 5 ' 
splice site, not only increase the efficiency of correct 5 ' splice site cleavage (indicating specific 
recognition of this site) but also increased the efficiency of the aberrant 5 ' cleavage event 
(Siliciano and G uthrie, 1988; Seraphin et al., 1988). These results suggest that the two 5 '
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cleavage events i.e. correct and aberrant, arise from the one specific U1 snR N A  to 5 ' splice 
site recognition event, which can then result in one of the  two types of cleavages. They also 
suggest that a specific nucleotide, G5, is involved in the fidelity of 5 ' cleavage. These aberrant 
cleavage events are  therefore no t com parable to  the use of crytic sites observed in m am m alian 
transcripts w here the 5 ' splice sites are probably recognised independently by individual U1 
snRN P particles (C habot and Steitz, 1987b; A ebi et al., 1987; N elson and G reen, 1988; Lear et 
al., 1990). However in the M A T a l transcript, two cryptic 5 ' splice sites located in exon 1 which 
function in vitro and in vivo have been identified, though the biological significance of this 
observation (if any) is unknown (K ohrer and Domdey, 1988).
Consistent w ith the in vivo observations that 5 ' cleavage is com pletely blocked, 
m utations at positions G1 and T2 prevent spliceosom e form ation in vitro (Vijayraghavan et al., 
1986). M utations at T6 appear to have a lim ited affect on the efficiency of splicing (Pikielny 
et al., 1983; Pikielny and Rosbash, 1985; Fouser and Friesen, 1986), however they can be 
"unmasked" by coupling them  with m utations in the U A C U A A C  sequence i.e. the jo in t 
consequence of such double m utants is greater than the sum of their individual effects (Seraphin 
and Rosbash, 1989a). This suggests an in teraction between the 5 ' splice site and the 
U A C U A A C  branchpoint sequence. M utations at position T4 have no m easurable effect on the 
efficiency of splicing though cells harbouring such m utations exhibit reduced rates of growth 
(Siliciano and G uthrie, 1988; Seraphin and Rosbash, 1989a). M utations at this position may 
affect the com m itm ent of pre-m R N A  to splicing and thus explain the reduced growth rate of 
cells harbouring essential genes m utated at this position (see the A ppendix and Legrain and 
Rosbash, 1989).
D eletion of the TA CTA A C sequence results in the com plete inhibition o f splicing in 
vivo (Langford and Gallwitz, 1983; Pikielny and Rosbash, 1985). U tilising the actin gene 
m utations at positions T7 and A8 o f the transcrip t (see Fig. 1.1) appear to  have little effect on 
the efficiency of splicing though an accum ulation of pre-m R N A  and a decrease in the level of 
m RN A  can be observed (Jaquier et al., 1985; Fouser and Friesen, 1986). Conflicting results
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indicate that the sam e m utations at position A8 do have a pronounced effect on the efficiency 
of splicing (Langford and Gallwitz, 1983). Such differences probably reflect the varied 
sensitivities of the assays used. M utations at position A8 on the RP51A  transcrip t produce a 
considerable increase in the level of pre-m RN A . This effect is enhanced by coupling the A8 
m utation w ith a m utation at T6 of the 5 ' splice site (as indicated above) (Seraphin and 
Rosbash, 1989a). M utations at position C9 appear to have a lim ited effect on the efficiency of 
splicing (Langford and Gallwitz, 1983; Jaquier et al., 1985). However contradictory results have 
been obtained indicating that m utations at this position block splicing both  in vivo and in vitro 
as transcripts harbouring T9 m utations fail to  form spliceosomes (Vijayraghavan et al., 1986). 
Differences at position C9 appear to be a consequence of the nature o f the nucleotide 
substitution, with an A  nucleotide resulting in. the com plete inhibition o f splicing and a T 
nucleotide having little o r no effect (Langford and Gallwitz, 1983; Vijayraghavan et al., 1986; 
Fouser and Friesen, 1986; Seraphin and Rosbash, 1989a). M utations at positions T10 and A l l  
produce m odest increases in the levels o f pre-m R N A  (Vijayraghavan et al., 1986; Fouser and 
Friesen, 1986), whereas m utations o f the branchpoint A12 position inhibit splicing to a 
considerable degree (Langford and Gallwitz, 1983). In transcripts harbouring m utations at 
position A12, steps 1 and 2 of splicing can still proceed both in vivo and in vitro but with a 
drastic reduction in efficiency (Jaquier and Rosbash, 1986; Vijayraghavan et al., 1986). All 
nucleotide substitutions tested at position A12 can form 2 ' -5 ' phosphodiester bonds with the 
G1 of the 5 ' splice site (Vijayraghavan et al., 1986; Fouser and Friesen, 1986) and the intron 
lariats generated by the inefficient splicing of transcripts containing these m utations are 
extremely stable in vivo; probably as a consequence o f poor recognition of the branchpoint by 
a "debranching" activity present in the cells (Jaquier and Rosbash, 1986). Because A12 m utations 
can still undergo a low level o f step 2 of splicing whereas G1 m utations can only accomplish 
step 1, it seems likely that the G1 nucleotide is m ore im portant for step 2 of the reaction. 
M utations at position C13 affect step 1 of splicing though not to a great extent (Fouser and 
Friesen, 1986). From  all these observations it would appear that m utations in the U A C U A A C
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sequence prim arily affect step 1 of splicing though m utations at position A12 can also inhibit 
step 2 (Fouser and Friesen, 1986). Actin gene transcripts harbouring m utations at the norm al 
U A CU A A C sequence can activate a cryptic U A C U A A G  sequence located just upstream  of the 
norm al site o f branch form ation (Cellini et al., 1986b; Vijayraghavan et al., 1986). The use of 
this cryptic site is very inefficient and indeed o ther studies have failed to detect its use (Fouser 
and Friesen, 1986).
M utations at positions A14 and G15 (see Fig. 1.1) produce m oderate decreases in the 
efficiency o f step 1 of the splicing reaction, however they drastically inhibit step 2 in vivo 
(Vijayraghavan et al., 1986; Fouser and Friesen, 1986). Production of m R N A  molecules is not 
completely inhibited and 3 ' cleavage takes place at the m utated  site. C onsistent with these 
observations is the finding that transcripts containing m utations at position G15 can undergo 
splicing in vitro albeit at a reduced efficiency and can also form the 40S spliceosom e complex 
as defined by glycerol gradient centrifugation (Vijayraghavan et al., 1986; See Section 1.5). 
Transcripts containing only 29 nucleotides dow nstream  of the branchpoint and missing an AG 
at the 3 ' cleavage site can still undergo step 1 o f the splicing reaction (Rym ond and Rosbash, 
1985). These observations suggest that the A G  dinucleotide is prim arily required for step 2 of 
splicing. It has been found that the first A G  downstream  of the branchpoint is utilised as the 
3 ' cleavage site, however inefficent use of o ther downstream  A G  dinucleotides has also been 
detected (Langford and Gallwitz, 1983; Pikielny et al., 1983). Sequence com parisons o f yeast 
introns have indicated that a pyrimidine nucleotide is preferred at the position preceding A14 
though its im portance in splicing is unknown (Langford and Gallwitz, 1983; Teem et al., 1984).
A lthough large regions of certain introns can be deleted w ithout affecting the efficiency 
of splicing (Gallwitz, 1982; Langford and Gallwitz, 1983; Pikielny et al., 1983) o ther 
non-conserved in tron sequences have been im plicated in the splicing process. M utational analysis 
has indicated that sequences close to the 5 ' splice and U A C U A A C  region influence the the 
efficiency of splicing (Pikielny and Rosbash, 1985). In the CYH2  gene transcript a sequence near 
the 5 ' end of the in tron appears to exhibit a negative effect on splicing and indeed interacts
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(in an undefined m anner) with a com plem entary sequence just upstream  of the branchpoint 
(Newman, 1987; see also Swida et al., 1986).
C om pletion of both  steps o f splicing requires an exon 1 length of a t least 12 
nucleotides though a transcrip t with just 1 nucleotide in exon 1 can undergo step 1 of splicing 
(albeit inefficiently) (D uchene et al., 1988). In the sam e study it has been observed that 
transcripts starting at the G1 o f the in tron  cannot be spliced even though they can form a 40S 
spliceosom e complex. A  transcript containing only 10 nucleotdes in exon 2 undergoes both steps 
of splicing (Rym ond and Rosbash, 1985). Thus exon sequences are required for splicing though 
it may be that they simply act as a support for splicing-complex assembly.
M ost yeast introns are found to be in the size range of 300-500 nucleotides, the largest 
being the in tron of L17a  (513 nts), however the sm allest are the two introns o f the M A T a l 
gene (54 and 52 nts) (Teem  et al., 1984; Leer et al., 1984; M iller, 1984). Increasing the size of 
introns above 551 nucleotides (Klinz and Gallwitz, 1985) o r above 700-800 nucleotides (Swida 
et al., 1986) reduces considerably the efficiency of splicing. This restriction on the size of introns 
may represent the spatial requirem ents o f the yeast splicing machinery and therefore may 
explain the inefficient splicing of M A T a l  transcripts (M iller, 1984). The further an in tron is 
located from the 5 ' cap structure the less efficiently it is spliced from its transcript (Klinz and 
Gallwitz, 1985). Indeed m ost yeast introns are located at the 5 ' end of their respective 
transcripts, usually among the first few nucleotides of the coding sequence (Leer et al., 1984), 
though in at least one case the in tron is placed in the the 5 ' untranslated region (M itra and 
W arner, 1984). This suggests that the introns are m aintained and/or tolerated  at the 5 ' end of 
their transcripts to enable their efficient removal.
The conserved sequences are subject to  certain constraints regarding their spatial 
arrangem ents w ithin introns. The distance separating the 5 ' splice site and the branchpoint is 
of critical im portance in the splicing reaction. Distances below 44 nucleotides reduce the 
efficiency of splicing quite considerably (D uchene et al., 1988; K ohrer and Domdey, 1988). The 
3 ' splice site is usually situated 10-60 nucleotides downstream  of the branchpoint (Teem et al..
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1984; Leer et al., 1984) and the efficiency o f splicing is reduced considerably when this distance 
is increased above 66 nucleotides (Cellini et al., 1986a). T ranscripts with as little as 8 
nucleotides separating the branchpoint from  the 3 ' splice site can still undergo steps 1 and 2 
of the splicing reaction (Langford and Gallwitz, 1984).
1-4.3 Com parison of M am m alian and Y east Sequence R equirem ents
There appears to be a basic difference in the recognition of the branchpoint region in 
mam m alian and yeast introns. M am m alian introns require the presence of a (Py)n tract 
immediately dow nstream  of the branchpoin t region to specify the branchpoint itself (Reed, 1989; 
Smith et al., 1989) whereas in yeast introns the branchpoint is dictated by the presence o f the 
invariant U A C U A A C  sequence (see Vijayraghavan et al., 1986). The fact that m utations in the 
m am m alian branchpoint region affect the efficiency of splicing suggests that this region is 
recognised in some way and is indeed analogous to the U A C U A A C  sequence in yeast (also see 
Section 1.5). The weak conservation of sequences at the m am m alian branchpoin t region (and 
indeed the 5 ' splice site) probably reflects the ability of m am m alian transcripts to be 
alternatively spliced. The strict sequence requirem ent in yeast for the U A C U A A C  region is 
reflected in the fact that m am m alian introns are not spliced in yeast cells (Beggs et al., 1980). 
Conversely the yeast RP51A  transcript is spliced in vitro in H eLa nuclear extracts though a 
cryptic U A C U A A C  sequence is utilised (R uskin et al., 1986). This cryptic branchpoint region 
is situated immediately upstream  of a (Py)n tract and suggests a reason for its use in preference 
to the norm al yeast U A CU A A C sequence (see R eed, 1989). It would appear that in both 
species the 3 ' splice site is determ ined by the branchpoint i.e. the cleavage site is the first A G  
dincleotide downstream  of the branchpoint. Thus the fundam ental processes o f pre-m R N A  
splicing appear to be the same in mammals and yeast although the specification of the 
branchpoint differs with respect to the sequence requirem ents.
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1.5 MAMMALIAN SMALL NUCLEAR RIBONUCLEPROTEIN PARTICLES
1.5.1 Introduction
Small nuclear ribonucleoprotein  particles are a class o f R N A -containing particles 
(snRN P) present in the nucleus of eukaryotic cells (reviewed in Busch et al., 1982; Steitz, 1988). 
Each snRN P particle contains a specific small nuclear R N A  (snRN A ) which is complexed with 
at least 7 polypeptides com m on to all the m ajor snRN Ps (Bringm ann and Luhrm ann, 1986). In 
addition individual snRN Ps can contain proteins which are specific to  them. The m ajor snRN Ps 
are nam ed after their snR N A  com ponent, the m ajor species being U l, U2, U4, U5 and U6. The 
snRNAs are m etabolically stable and range in size from 108-189 nucleotides. They are abundant 
molecules ranging from 10s to 106 copies/cell and with the exception of U 6 possess a 
trim ethylguanosine cap structure (m3G ) at their 5 ' ends.
The study of the structure  and function of these particles has been facilitated by the 
availability of certain antibodies which recognise their com ponents. Sera taken from hum an 
patients suffering from autoim m une diseases such as systemic lupus erythem atosis can contain 
antibodies that recognise all the  snR N P particles (anti-Sm ), U l only (an ti-(U l)- R N P), U 2 only 
(anti-(U 2)-R N P) or U l  and U 2 (an ti-(U l, U 2)-R N P) (Lerner and Steitz, 1979; Lerner et al., 
1980; Lerner et al., 1981). In addition antibodies recognising the trim ethylguanosine moiety of 
the cap structure can precipitate all the m ajor snR N A  species (Bringm ann et al., 1983; Smith 
and Eliceiri, 1983). The U4 and U 6 snRN A s are normally base-paired together and therefore 
exist in a single particle (Bringm ann et al., 1984; H ashim oto and Steitz, 1984). As a consequence 
of this interaction U6 (which does not contain a trim ethylguanosine cap structure) can be co- 
im m unoprecipitated using antibodies that recognise the trim ethylguanosine cap. SnR N A  
structure and snRN P pro tein  content appear to be highly conserved in evolutionary term s, as 
hum an anti-Sm  and an ti-(U l)-R N P  antibodies can precipitate the snRN P particles from a 
num ber of organism s including yeast (Tollervey and M attaj, 1987; Tollervey, 1987; G uthrie  and 
Patterson, 1988).
14
1.5.2 Evidence for the Involvem ent of snR N Ps in Splicing
The first proposals that the  U1 snR N P was involved in splicing were based on the 
observation tha t the 5 ' end of the U1 snR N A  contained regions com plem entary to the 5 ' and 
3 ' splice sites of introns. It was suggested that the U 1 snR N P aligned the splice sites such that 
the introns were excised accurately (L erner et al., 1980; Rogers and W all, 1980). Evidence has 
since accum ulated indicating the involvem ent of the U1 snR N P in the splicing process 
particularly its interaction  at the 5 ' splice site.
Splicing o f pre-m R N A  transcripts in w hole cell extracts is inhibited by both  anti-Sm  
and an ti-(U l)-R N P  antibodies (Padgett et al., 1983b). These two anti-sera also inhibit splicing 
in vivo when assayed in Xenopus laevis oocytes (Bozzoni et al., 1984; Fradin et al., 1984). 
A ddition of oligodeoxynucleotides com plem entary to specific regions o f U  snRN A s to splicing 
extracts, can lead to the selective cleavage o f the partial duplex created; this is caused by a 
RNase H  activity endogenous to the  splicing extracts and will subsequently be referred to as 
RN ase H -directed cleavage. Experim ents utilising this phenom enon are  able to selectively 
degrade U1 snR N A  and show its requirem ent for splicing (K ram er et al., 1984; Black et al., 
1985; Black and Steitz, 1986; Berget and R obberson, 1986). Indeed, selective removal of the first 
8 nucleotides of the U1 snR N A  (the region thought to base-pair with the 5 ' splice site) 
completely abolishes splicing and thus im plicates the U1 snR N A  in a base-pairing interaction 
with the 5 ' splice site (K ram er et al., 1984). Analysis o f protected R N A  fragments after 
im m unoprecipitation with an ti-(U l)-R N P  antibodies and RN ase T1 digestion shows that the U1 
snRN P protects the 5 ' splice site (M ount et al., 1983; C habot and Steitz, 1987b). Direct, genetic 
evidence for this base-pairing interaction was obtained when it was shown that 5 ' splice site 
m utations which inhibit splicing can be suppressed by com plem entary m utations in the U1 
snR N A  (Zhaung and W einer, 1986). However because ano ther m utation at a different position 
in the 5 ' splice site cannot be suppressed in a sim ilar m anner it has been suggested that 
recognition of the 5 ' splice site is dependent on other contributing factors. This analysis 
correlates well with sim ilar experim ents carried out in yeast (Seraphin and Rosbash, 1989a). In
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this respect it has been observed that the binding of the U1 snR N P to the 5 ' splice site 
requires o ther factors (Tatei et al., 1987; Z app  and Berget, 1989). Recently it has been shown 
that the C protein  (which is specific to the  U1 snR N P) is required for the binding of the U1 
snRN P to the 5 ' splice site (H einrichs et al., 1990). The U1 snR N P was shown to bind to 
cryptic 5 ' splice sites even though they w ere no t necessarily utilised as sites of cleavage (Nelson 
and G reen, 1988; Y uo and W einer, 1989b). It seems likely that 5 ' splice site recognition and 
cleavage have different requirem ents though the U1 snR N A  appears to play a role in both. 
Analysis of 5 ' splice sites from a variety o f in trons of evolutionary diverse organism s shows that 
although the geom etry of in teraction is variable, 5 ' cleavage of the pre-m R N A  always occurs 
opposite the junction  between residues 9 and 10 o f the U1 snR N A  (Jacob and G allinaro, 1989). 
This suggests that 5 ' cleavage is determ ined by the in teraction with the U1 snRNP.
F urther evidence for the involvem ent of the U1 snRN P in splicing comes from the 
analysis of splicing complexes. It has been shown that the U1 snR N P is present in the large 
ribonucleoprotein complex (spliceosom e) in which splicing takes place and it is also present in 
o ther complexes related to splicing (see Section 1.5.3) (Grabowski et al., 1985; Frendewey and 
Keller, 1985; B indereif and G reen, 1986, 1987; C habot and Steitz, 1987a; Z illm an et al., 1987, 
1988; R eed et al., 1988; Agris et al., 1989; Tazi et al., 1989; Z app  and Berget, 1989). Indeed in 
com plem entation experim ents using extracts depleted in specific snRN Ps, the U1 snRN P was 
required for step 1 of the splicing reaction (W inkelm ann et al., 1989).
Similar experim ents to those described above have yielded results indicating the 
involvement of the U2 snRN P in splicing. R N ase H -directed cleavage of U2 snR N A  inhibits 
splicing in vitro (Black et al., 1985; K rainer and M aniatis, 1985; Berget and Robberson, 1986; 
Black and Steitz, 1986). Injection of olignucleotides com plem entary to the U2 snR N A  into the 
nuclei o f Xenopus oocytes also inhibit splicing thus providing evidence for the U2 snRN P 
function in splicing in vivo (Pan et al., 1989). Im m unoprecipitation with anti-(U 2)-R N P 
antibodies followed by RN ase T1 digestion reveals an in teraction of the U 2 snRN P with the 
branchpoint region (Black et al., 1985). This interaction is dependent on the presence o f the
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(Py)n tract and to  a lesser extent the A G  dinucleotide present at the 3 ' splice site region of 
m am m alian introns (C habot and Steitz, 1987a). H ybridisation of biotinylated 2 '-O M e  R N A  
oligonucleotides to a region of the U 2 snR N A  postulated to base-pair with the branchpoint 
region com pletely inhibits splicing in vitro by preventing the binding of the U 2 snR N P to the 
pre-m R N A  (Lam ond et al., 1989). This supports the hypothesis that the U 2 snR N A  base-pairs 
with the branchpoint region. D irect genetic evidence for such an in teraction has been obtained 
by showing shown that m utations in the branchpoint region can be suppressed by 
com plem entary m utations in the  U 2 snR N A  (W u and M anley, 1989) and indeed that cryptic 
branchpoints can be recognised m ore efficiently when the U2 snR N A  is altered to  exhibit a 
greater degree o f com plem entarity to  the cryptic site (Zhuang and W einer, 1989). The binding 
of the  U 2 snR N P to the branchpoint region is dependent on the binding o f ano ther factor, U2 
associated factor (U 2A F), to the (Py)n tract (R uskin et al., 1988). However binding of the U2 
snR N P to the branchpoint exhibits a degree of sequence preference (Nelson and G reen, 1989) 
and indeed splicing is m ore efficient when the branchpoint region is com plem entary to  the U2 
snR N A  branchpoint-binding sequence (Z huang et al., 1989). It has been suggested that in 
contrast to yeast, the base-pairing in teraction betw een the m am m alian U 2 snR N P and the 
branchpoint region may be an optional in teraction as som e branchpoints exhibit no 
com plem entarity to the U2 snR N A  branchpoint-binding sequence at all (Zhuang and W einer,
1989). D ifferent dom ains of the U2 snR N A  appear to be required at different stages in splicing. 
Hybridisation of biotinylated 2 ' -OM e R N A  oligonucleotides to the 5 ' end of the U2 snR N A  
allows the U 2 snRN P to bind to the pre-m R N A  but inhibits form ation of an active spliceosome 
(Barabino et al., 1989; Lam ond et al., 1989).
The U2 snRN P has also been identified as a com ponent of a pre-splicing complex 
(Grabowski and Sharp, 1986; Konarska and Sharp, 1986; Lam ond et al., 1987), the spliceosome 
(references just indicated; C habot and Steitz, 1987a; B indereif and G reen, 1987; Lam ond et al., 
1988; R eed et al., 1988; Agris et al., 1989; Z app  and Berget, 1989) and a post-splicing complex 
(Barabino et al., 1989). In com plem entation experim ents utilising extracts devoid of U  snRNPs,
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RN ase H -directed cleavage o f the U 4 and U6 snRN A s inhibits splicing in vitro (Berget 
and R obberson, 1986; Black and Steitz, 1986). The use of 2 ' -O M e R N A  oligonucleotides which 
hybridise to  specific regions o f the U 4 and U 6 snR N A s also inhibits splicing in vitro (Blencowe 
et al., 1989). In com plem entation experim ents a reconsitituted U4/U6 snRN P particle is required 
for splicing in vitro (Pikielny et al., 1989) and W inkelm ann et al., (1989) have dem onstrated the 
requirem ent for the U4/U 6 snR N P in the first step of splicing. F u rther evidence for the 
involvement of the U4/U 6 snR N P in splicing comes from the observation that it is present in 
splicing complexes (K onarska and Sharp, 1986, 1987; B indereif and G reen, 1987; Lam ond et al., 
1987, 1988; Reed et al., 1988; Z illm an et al., 1988).
In RN ase protection  experim ents the 3 ' splice site is protected from digestion by a 
factor that is precipitable w ith anti-Sm  and anti-m 3G  antibodies, and that is also resistant to 
digestion with micrococcal nuclease (C habot et al., 1985). The U5 snR N P is the only m ajor 
snRN P that is resistant to micrococcal nuclease leading to the suggestion that it is associated 
with the 3 ' splice site. This proposal is further supported  by the observation that a protein 
which binds directly to the (Py)n tract, the  intron-binding protein  (IBP), co-purified with the 
U5 snRN P (Tazi et al., 1986; see also G erke and Steitz, 1986). Recently it has been shown that 
the U5 snR N P does interact with the 3 ' splice site region and requires the IBP protein to do 
so (Tazi et al., 1989). Further evidence for the involvement of the U5 snR N P in splicing is 
provided by the observation that it is present in splicing complexes (K onarska and Sharp, 1985; 
Grabowski and Sharp, 1986; B indereif and G reen, 1987; Lam ond et al., 1987, 1988; Reed et al., 
1988; Agris et al., 1989; Zapp and Berget, 1989). In com plem entation studies perform ed in vitro 
the U5 snR N P is required for efficient com pletion o f both steps in splicing, however it appears 
to have a greater influence on step 2 (W inkelm ann et al., 1989).
the U 2 snR N P is required for step 1 o f splicing (W inkelm ann et al., 1989).
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1.5.3 snR N P Proteins
The snR N P particles are the focus of intense biochem ical and genetic analyses. The 
protein constituents of the snRN Ps have been determ ined (Luhrm ann, 1988). Each particle 
contains a group of 7 proteins that is com m on to all the m ajor snRN Ps, these are called B, B ',
D, D ' ,  E, F  and G  (Bringm ann and L uhrm ann, 1986). D ue to the fact that hum an antibodies 
specific for these particles can im m unoprecipitate the analogous snR N P particles from a wide 
variety o f organisms, it is likely that the relevant determ inants (i.e. proteins, R N A  and/or 
protein /R N A  structures) are highly conserved in evolutionary diverse species (Tollervey and 
M attaj, 1987; Palfi et al., 1989). The transcripts encoding the B and B ' proteins appear to  be 
generated by alternative splicing of the sam e pre-m R N A  m olecule (van Dam  et al., 1989) and 
the E  protein  has regions of am ino acid homology to a yeast m itochondrial ribosom al protein 
(Stanford et al., 1988).
The snR N A  m olecules U l, U2, U4, and U5 contain the so-called "domain A" m otif 
which consists of the sequence Pu-A -(U )n- G -Pu (n > 3 ) situated in a single-stranded region 
flanked by double-stranded regions (Busch, 1982). Extensive nuclease digestion of snRN P 
particles results in the protection of the dom ain A  site by a core group of proteins namely D,
E, F  and G (L iautard et al., 1982). These core proteins assemble in the absence of the snR N A  
(Fisher et al., 1985) suggesting that it is this core assembly that recognises the dom ain A  motif. 
This m otif is required for the transport of newly assembled cytoplasmic snR N P particles to the 
nucleus (M attaj and D eR obertis, 1985) and can confer Sm -precipitability on R N A  molecules 
previously unprecipitable, suggesting that the proteins and/or R N A /protein structure  a t this 
region is the Sm -determ inant (M attaj, 1986).
The U l  snRN P has 3 unique protein  constituents (U l-A , 70K and C), U2 has 2 (A ' 
and B"), a portion  of the U5 snRN Ps have at least 7 unique proteins associated with them  
(Bach et al., 1989) one of which is the hum an hom ologue of the yeast PRP8 protein  (Anderson 
et al., 1989). The U6 snRN P may also have a unique protein of MW  50kD associated with it 
at certain developm ental stages in Xenopus laevis (Hamm and M attaj, 1989b). The U l-A  and
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U2-B" proteins share extensive regions of homology (Sillekens et al., 1987) and their modes of 
in teraction with their respective snRN A s appear to  be sim ilar suggesting that they perform  
sim ilar functions (Lutz-R eyerm uth and Keene, 1989). The proteins unique to the U1 snRN P 
appear to be less tightly associated w ith the particle than the com m on proteins (Bach et al.,
1990). However the U1-70K and U l-A  proteins contain a highly conserved RNA-binding 
dom ain (see M attaj, 1989) and when assayed in vitro contact the U1 snR N A  at stem  loops I and 
II respectively (Scerly et al., 1989; Surowy et al., 1989; Query et al., 1989). The U l-C  protein 
does not contain the RN A -binding consensus (Sillekens et al., 1988) and does not appear to 
contact the R N A  (Bach et al., 1990), yet it may poten tia te  the base-pairing in teraction of the 
U1 snR N P w ith the 5 ' splice site (H einrichs et al., 1990).
U1 snR N A  molecules containing m utations in stem  loops I, II, III and dom ain A  
inhibit splicing in vivo when introduced into the nuclei o f Xenopus  oocytes (Hamm et al., 1990; 
see also Y uo and W einer, 1989a). This suggests that specific proteins norm ally associated with 
these regions are required for splicing and/or snRN P assembly and transport. However it could 
also indicate a U1 snR N A  sequence requirem ent for splicing, irrespective of the associated 
factors.
In contrast to the m utations indicated above, U2 snR N A  m olecules harbouring 
deletions of the regions that bind the A ' and B" proteins exhibit no effect on splicing when 
assayed in Xenopus oocytes (H am m  et al., 1989). This suggests that these proteins have little 
or no effect on splicing in vivo.
Very little is known about the function of the o ther snRN P proteins though the B and 
B ' proteins possess an endonucleolytic activity which is inactive in native snR N P particles 
(Temsamani et al., 1989).
The elucidation of the structure/function relationships between snRN P proteins and 
their respective snRNAs has been greatly facilitated by the developm ent of in vitro reconstitution 
techniques for the snRN P particles. Initially this has been developed with the U1 snRN P 
(Ham m  et al., 1987; Patton  et al., 1987; see also Patton  et al., 1989) but has recently been used
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to identify the regions of U6 required for U4 in teraction and spliceosom e assembly (B indereif 
et al., 1990). Indeed reconstitu tion  has been attem pted  for all the m ajor snRN Ps and an active 
U 4/U6 particle has been formed (Pikielny et al., 1989).
1.6 OTHER FACTORS INVOLVED IN MAMMALIAN SPLICING
In com plem entation studies using biochemically fractionated extracts, non-snR N P 
com ponents required for splicing in vitro have been identified (Furneaux et al., 1985; Krainer,
1988). Factors term ed SF4B and SF4A are  required for steps 1 and 2 of splicing respectively 
(K rainer and M aniatis, 1985). In o ther experim ents 6 fractions required for splicing have been 
identified (K ram er et al., 1987). Indeed from these studies fractions SF1 and SF3 along with the 
U2 snRN P are required for the form ation o f a pre-splicing complex (K ram er, 1988). Two non- 
snRN P com ponents which co-purify with de novo  spliceosomes have also been identified 
(Conway et al., 1989). However, due to the different experim ental techniques utilised by 
individual investigators, the relationship of the com ponents required for splicing remains 
unclear. Conditions have recently been defined in which fully operable in vhro-assembled 
spliceosomes have been form ed and this should accelerate the dissection of the functional 
relationships of the constituents o f the spliceosom e (Parent et al., 1989).
A  m onoclonal antibody raised against hnR N P C protein  inhibits step 1 of splicing in 
vitro, however it does not prevent the assembly of the 60S spliceosom e complex (see Section 
1.7) (Choi et al., 1986). Im m unodepletion o f the hnRN P C-type protein  from the splicing 
extracts results in the com plete inhibition of spliceosom e form ation. The hnR N P A  C and D 
proteins appear to bind to the 3 ' splice site region of introns (Swanson and Dreyfus, 1988). 
These observations suggest the involvement of the hnR N P C, A  and D proteins in pre-m R N A  
splicing.
A factor term ed the U2 auxiliary factor (U 2A F) is required for the binding of the U2 
snRNP to the branchpoint region (Ruskin et al., 1988). U 2A F binds to the 3 ' splice site region
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and may be present in the SF2 fraction previously identified by K ram er (K ram er et al., 1987).
Two independent studies have identified a protein  that binds to the (Py)n tract located 
upstream  of the  3 ' splice site (Tazi et al., 1986; G erke and Steitz, 1986). It is likely that the 
differences observed in the M W  (100 and 70kD respectively) of the proteins isolated reflect the 
different isolation procedures used, and thus both  studies have probably identified the same 
protein. This intron-binding protein  (IBP) co-purifies with the U5 snR N P (Tazi et al., 1986) 
and is im m unoprecipitable with anti-Sm  antibodies (G erke and Steitz, 1986). IBP appears to 
bind to  the 3 ' splice site in the absence of ATP and this may constitu te one of the earliest 
events in the assembly of the spliceosom e (Tazi et al., 1989).
Recently a protein, present only in the oocyte stage o f Xenopus  developm ent, has been 
identified (H am m  and M attaj, 1989). This 50kD protein  appears to associate with U6 snRN Ps 
that are  not complexed w ith U4 snRN Ps and may be involved in the transport of the U6 
snRN P to the nucleus rather than in splicing. Factors o ther than the U1 snR N P have been 
im plicated in the recognition of the 5 ' splice site (Tatei et al., 1987; Z app  and Berget, 1989).
1.7 MAMMALIAN SPLICING COMPLEXES
1.7.1 Isolation and Identification
To align the 5 ' and 3 ' splice sites and account for the  involvem ent of the m ajor 
snRN P particles it was postulated that splicing took place in a large ribonucleoprotein complex. 
This was first identified as 60S and SOS complexes in glycerol and sucrose gradient 
sedim entation analysis respectively (Grabowski et al., 1985; Frendewey and Keller, 1985; 
Bindereif and G reen, 1986). These complexes contain the interm ediates of the splicing reaction, 
thereby defining them  as active so-called spliceosomes. Form ation of the active spliceosome 
proceeds in a stepwise m anner requiring all the m ajor U  snRN Ps and ATP (Grabowski et al., 
1985; Frendewey and Keller, 1985; Grabowski and Sharp, 1986; B indereif and G reen, 1986;
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Zillm an et al., 1987). The 5 ' and 3 ' splice site consensus sequences are  also necessary for the 
form ation o f the spliceosome, although transcripts containing deletions or m utations at either 
the 5 ' o r 3 ' splice site can still form sm aller complexes (Grabowski et al., 1985; Frendewey and 
Keller, 1985). Pre-spliceosom e complexes (35-40S) containing snR N P particles have also been 
identified and appear to form in an A TP-independent m anner requiring the presence of the 3 ' 
splice site consensus sequence (Grabow ski et al., 1985; Frendewey and Keller, 1985; B indereif 
and G reen, 1986).
Splicing complexes have been fu rther analysed utilising polyacrylamide gel 
electrophoresis techniques (PA G E). Initially two splicing complexes, arising in a sequential 
m anner, w ere defined (K onarska and Sharp, 1986, 1987). The so-called complex A  requires the 
3 ' splice site region for its form ation and gives rise to complex B which requires the 5 ' splice 
site. In further studies using a different pre-m R N A  transcript as the substrate, 3 complexes were 
resolved which also arise in a sequential m anner. The so-called complex (X gives rise to ¡3 which 
precedes complex y  (Lam ond et al., 1987). Complexes B and y  contain the splicing interm ediates 
and are therefore defined as spliceosomes. Complex B can be resolved into two com ponents (/3 
and y) by this analysis, one of which (complex y) lacks the U 4 snRN P. All the complexes 
contain the U2 snRN P and require ATP for their form ation. The U 4/U6/U5 complex (see 1.7.1) 
joins the forming spliceosom e in the transition  from complex A  to B.
1-7.2 Tem poral O rder of snRN P A ddition in Spliceosom e Assembly
Having observed that active spliceosom e form ation arises in a stepwise m anner, it 
became im portant to  define the stages at which the splicing factors (i.e. snRN Ps and other 
com ponents) jo in  the spliceosome. There has been some controversey about the earliest events 
in spliceosom e assembly. The U 1 snRN P is detected in early splicing complexes (Zillm an et al., 
1987, 1988) and binds to the 5 ' splice site, in an A TP-independent m anner, p rior to the binding 
of the U 2 snR N P (B indereif and G reen, 1987; Tazi et al., 1989). However the U1 snRN P 
rem ains undetected in a num ber o f splicing-complex studies (Grabowski and Sharp, 1986; 
Konarska and Sharp, 1987; Lamond et al., 1987, 1988). These anom alous results are probably
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a consequence of the different experim ental procedures used. The IBP protein  (hence 
im plicating the U5 snRN P, see Section 1.6) binds to the (Py)n tract, located a t the 3 ' splice site 
region, at an early stage in spliceosom al assembly and in the absence of A TP (Tazi et al., 1989). 
It has been suggested that the U1 snR N P and the IBP p ro tein  (U5 snR N P) recognise the 5 ' 
and (Py)n tract respectively and that this constitu tes the earliest event in spliceosom e assembly 
(Tazi et al., 1989). C onsistent with this hypothesis is the observation that the 5 ' and 3 ' splice 
sites collaborate in early complex form ation (Lam ond et al., 1987) and that the U1 snRN P 
appears to  in teract w ith the 3 ' splice site a t early stages o f spliceosom e form ation (Z illm an et 
al., 1987, 1988; see also Tatei et al., 1987).
Pre-splicing complexes containing the U2 snRN P and requiring A TP for their 
form ation have been identified (Grabowski and Sharp, 1986; K onarska and Sharp, 1986, 1987; 
Lam ond et al., 1987, 1988); this suggests that the binding o f the U 2 snR N P is the next step in 
spliceosom e assembly. It has been postulated  that the binding of the U1 snR N P to the 5 ' splice 
site followed by the in teraction of the U2 snR N P at the branchpoint is the preferred  o rder of 
events (B indereif and G reen, 1987). C onsistent with this suggestion is the observation that 
complexes can form on a transcript lacking e ither the 5 ' o r 3 ' splice site consensus sequences 
(Grabowski et al., 1985; Frendewey and Keller, 1985). However in som e cases it has been 
observed that form ation of a stable complex at the 5 ' splice site requires the presence of the 
3 ' splice site sequences (Ruskin and G reen, 1985), the  U1 snRN P, the U2 snR N P and ATP 
(Z app and Berget, 1989). These pre-splicing complexes i.e'. those forming p rio r to the addition 
of the U4/U6/U5 complex, probably correspond to complex A  as defined by PAGE.
The U5 snR N P interacts, in an A TP-dependent m anner, with the U4/U6 snRN P 
particle (Pinto and Black, 1989). This complex then joins the pre-splicing complexes described 
above (Konarska and Sharp, 1987; Lam ond et al., 1988). It has been previously observed, by 
PA G E analysis, that the U 4 snR N P leaves the spliceosom e prior to step 1 of the splicing 
reaction (Lam ond et al., 1988; Pikielny et al., 1989). However recent data, using biotinylated 
2 ' -OM e R N A  oligonucleotides com plem entary to the U 4 snRN A , suggests that although a
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conform ational change is likely to take place, the U 4 snR N P rem ains associated with the 
spliceosom e (Blencowe et al., 1989). The addition o f the U 4/U 5/U 6 complex to  the U1/U 2 
pre-splicing complex probably defines the active spliceosome.
It has been proposed that the U5 snR N P acts a t two stages in splicing i.e. at the initial 
recognition of the 3 ' splice site sequences and at a la ter stage when it is complexed with the 
U4/U6 snR N P particle (Tazi et al., 1989). The U5 snRN P acting at the initial stage may be 
replaced by o ther 3 ' splice site binding factors such as U 2A F and becom e available for the 
form ation of the U4/U 5/U 6 complex. This hypothesis is consistent with the observations of 
W inkelm ann et al., (1989).
Post-splicing complexes containing the excised in tron and the U2, U5 and U6 snRN Ps 
have been observed (K onarska and Sharp, 1987; Z illm an et al., 1988).
1.8 YEAST SMALL NUCLEAR RIBONUCLEOPROTEIN PARTICLES
1,8.1 Introduction
Yeast cells contain at least 23 species of snRN A s which exhibit a varied degree of 
abundance, size and complexity (R iedal et al., 1986; see also Tollervey, 1987). Initial experim ents 
indicated that a large p roportion  of these snR N A  molecules are not required for cell viability 
(reviewed in G uthrie, 1986a, 1986b; Patterson and G uthrie, 1988), indeed a haploid strain  in 
which five snR N A  genes are deleted exhibits growth properties sim ilar to wild-type cells (Parker 
et al., 1988). C ertain yeast snRNAs becom e im m unoprecipitable with anti-Sm  antibodies when 
introduced into Xenopus oocytes, suggesting the evolutionary conservation of the factors that 
recognise the Sm-binding site (R iedal et al., 1987). The yeast hom ologues of the m ajor 
mammalian U l,  U2, U4, U5 and U 6 snR N A  molecules have been identified and their genes 
cloned (Patterson and G uthrie, 1988). Sim ilar to their m am m alian hom ologues the m ajor yeast 
snRNAs posses a trim ethylguanosine cap, contain the highly conserved dom ain A m otif required 
for the binding of the Sm determ inant (see Section 1.5) and share sequence and structural
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hom ologies to their m am m alian counterparts. The U6 snR N A  of yeast, as with its m am m alian 
hom olgue, has a modified cap stru tu re  (distinct from the trim ethylguanosine cap) and does not 
posses the Sm binding site (dom ain A). The m ajor yeast snRN A s are  essential for viability.
In contrast to  their m am m alian counterparts the m ajor yeast snR N A  genes are present 
in single-copy in the genom e and the snR N A  molecules are  found in relatively low abundance 
in the cell (200-500 copies/cell). In addition considerable size variation can exist between the 
yeast snRN A s and their m am m alian counterparts.
1.8.2 Evidence for the Involvement of Y east snRN Ps in Splicing
M icrococcal nuclease treatm ent o f yeast splicing extracts inhibits splicing in vitro 
(Cheng and Abelson, 1986). This suggested that snRN P particles participate in splicing in yeast. 
A nti-m 3G  antibodies which recognise the 5 ' cap structure  of the snR N A s (except U6) are able 
to im m unoprecipitate the splicing interm ediates suggesting the presence of snR N P particles in 
the active spliceosom e (Cheng and Abelson, 1986). Indeed splicing complexes resolved by native 
gel electrophoresis contain the U2, U4, U5 and U6 snR N A s (Pikielny and Rosbash, 1986; 
Pikielny et ai., 1986; Cheng and Abelson, 1987).
The yeast U1 snRN A , at 569 nucleotides, is m ore than 3 times the size of its 
m am m alian counterpart. The 5 ' ends of the yeast and m am m alian U 1 snR N A  are highly 
conserved and it is this region that was postu lated  to base-pair with the 5 ' splice site (K retzner 
et til., 1987). RNase H -directed cleavage of the U1 snR N A  (Legrain et aL, 1988) and in 
particular the 5 ' end of the m olecule (K retzner et al„ 1987) results in the com plete inhibition 
of splicing in vitro. The la tter observation is consistent with the postulated base-pairing 
interaction between U1 snR N A  and the 5 ' splice site. In vivo analysis indicated that m utations 
of the 5 ' splice site, which inhibit splicing, are suppressed by the com plem entary m utation  in 
the U1 snRN A , thus proving the base-pairing in teraction (Seraphin et at., 1988; Siliciano and 
G uthrie, 1988; Seraphin and Rosbash, 1989a). Further evidence for the participation of the U1 
snRN P in splicing comes from the observation that it is present in splicing complexes (K retzner
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et al., 1987; Ruby and Abelson, 1988; Seraphin and Rosbash, 1989b).
The yeast U2 snR N A , at >  1000 nucleotides, is ~ 6  times the length o f it m am m alian 
counterpart (Ares, 1986). R N ase H -directed cleavage of U2 snR N A  results in the inhibition 
of splicing in vitro and suggests the involvem ent o f the U2 snR N A  in splicing (Legrain et al., 
1988; M cPheeters et al., 1989). Strikingly, large in ternal regions of the U2 snR N A  are 
inessential for splicing in vivo (Igel and Ares, 1988) and indeed the hum an and ra t U2 snRNAs 
can functionally replace the yeast U2 snR N A  in yeast extracts (M cPheeters et al., 1989). In 
snRN P reconstitu tion studies it has been shown that only 123 nucleotides present at the 5 ' end 
of the yeast U 2 snR N A  m olecule are required for splicing in vitro (M cPheeters et al., 1989). 
M utations o f the U A C U A A C  sequence which inhibit splicing are suppressed by com plem entary 
m utations in the U2 snR N A  both in vivo (Parker et al., 1987) and in vitro (M cPheeters et al.,
1989), indicating a base-pairing in teraction  betw een the U 2 snR N A  and the branchpoint. The 
U2 snR N A  has been found in splicing complexes, further indicating the participation  of the U2 
snRN P in splicing in yeast (Pikielny et al., 1986; Cheng and Abelson, 1987; Ruby and Abelson,
1988).
The yeast U4 and U6 snRN A s are involved in an extensive base-pairing interaction 
suggesting that they are com ponents of the sam e snR N P particle as observed with their 
mammalian counterparts (Siliciano et al., 1987; Brow and G uthrie, 1988). The U6 snR N A  is the 
m ost highly conserved snR N A  exhibiting 75%  identity between yeast and hum ans (Brow and 
G uthrie, 1988). RNase H -directed cleavage o f the U 6 snR N A  analysed in vitro, results in the 
inhibition of splicing and an accum ulation of early splicing complexes (Fabrizio et al., 1989). 
U nlike the hum an U 2 snRNA, the hum an U6 snR N A  cannot functionally replace the yeast U6 
snR N A  in vitro. This observation is surprising considering the high degree o f sequence and 
structural conservation exhibited by the U 6 snR N A  molecules. The U4 and U6 snRNAs are 
constituen t' o f splicing complexes further indicating the participation of the U4/U6 snRN P 
particle in splicing (Pikielny et al., 1986; Cheng and Abelson, 1987; Ruby and Abelson, 1988).
D epletion of the U5 snRN A , achieved in vivo, leads to the accum ulation of pre-m R N A
27
and the IVS-E2, lariat in term ediate (Patterson and G uthrie, 1987). These observations suggest 
that the U5 snR N P is involved in splicing in yeast and prom pted the proposal that it functioned 
at the two steps in splicing. A  sim ilar proposal has been advocated for the function of the U5 
snRN P in m am m alian splicing (W inkelm ann et al., 1989; see also Tazi et al., 1989). The yeast 
U5 snR N P is also present in splicing complexes (Pikielny et al., 1986; Cheng and Abelson, 
1987; Ruby and Abelson, 1988).
1.8.3 Y east snR N P Proteins
Analysis o f yeast snRN Ps has been hindered by their low abundance. The existence of 
a batch of tem perature-sensitive (fs) m utants defective in precurso r R N A  processing (prp\ see 
Section 1.9) has facilitated the identification o f 2, possibly 3, snR N P proteins. A ntibodies have 
been raised against the protein  products o f the PRP  genes and used to im m unoprecipitate 
snRN P particles and splicing complexes from yeast extracts. Indeed antibodies raised against 
PRP4 and 11 inhibit splicing in vitro suggesting their requirem ent for splicing (Chang et al., 
1988; Banroques and Abelson, 1989), and im m unodepletion of yeast extracts using anti-PR P8 
antibodies abolishes splicing activity indicating its participation in pre-m R N A  splicing (Jackson 
et al., 1987). Using these sort o f approaches, PRP8 has been identified as a com ponent o f the 
U5 snR N P (Lossky et al., 1987; Jackson et al., 1988) and the spliceosom e (W hittaker et al.,
1990); and PRP4 identified as a com ponent of the U4/U 6 snR N P (Petersen-B jorn et al., 1989; 
Banroques and Abelson, 1989). R N ase digestion of the U4/U 6 snR N P followed by 
im m unoprécipitation of the protected ■ R N A  fragments has revealed that PRP4 is primarily 
associated with the 5 ' end of the U 4 snRN A , though there is also a loose association with the 
3 ' end of the U6 snR N A  (Xu et al., 1990). PRP11 may not be a snR N P protein, however it 
is associated with the 40S spliceosom e complex (see Section 1.11) and a putative 30S 
pre-splicing complex (Chang et al., 1988). Im m unofluorescence studies have placed PRP11 at 
the periphery of the nuclear m em brane (Chang et al., 1988).
28
1.9 GENETIC AND BIOCHEMICAL APPROACHES TO THE ISOLATION OF 
FACTORS INVOLVED IN PRE-mRNA SPLICING IN YEAST
The prp m utants com prise a set o f tem perature-sensitive (7s) m utants originally isolated 
from a screen o f 400 ts m utants assayed for defects in m acrom olecular synthesis (H artwell, 
1967). The basis o f this screen was the incorporation  o f 13C-adenine and 3H-lysine into 
D N A /R N A  and protein  respectively, when a ts m utant was incubated at the non-perm issive 
tem perature. M utant cultures which exhibited a protein :R N A  (P/R) ratio  > 4  after 3-6 hours 
incubation at the restrictive tem perature w ere classed as being defective in R N A  metabolism. 
Twenty-three such m utants were later placed into 9 com plem entation groups term ed prp2-prpll 
(previously called m a 2 -m a ll:  N.B. prplO  and p r p l l  are the sam e com plem entation group) 
(Hartwell et a l , 1970). These m utants were subsequently shown to be defective in pre-m R N A  
processing (Rosbash et al., 1981; Teem  and Rosbash, 1983; Lustig et al., 1986) and not in the 
rate of transcription (Kim and W arner, 1983). N orthern  blot analysis of R N A  prepared from 
the prp2-prpll m utant strains incubated at the non-perm issive tem perature, shows that they all 
accum ulate pre-m R N A  (Jackson, 1987). This suggests that the prp2-prp ll m utants are defective 
in pre-m R N A  splicing at the non-perm issive tem perature. Further proof o f the involvement of 
the RP2-PRP11 proteins in splicing has been obtained from the observation that splicing extracts 
made from the prp3, prp4, prp5, prp7, prp8 and p r p ll  m utants cannot form spliceosomes at the 
restrictive tem perature in vitro, suggesting the involvement of the PRP proteins in spliceosom e 
form ation (Lustig et al., 1986). In contrast extracts made from prp2  m utants can form a 40S-like 
spliceosom e at the restrictive tem perature, however this complex cannot undergo step 1 of the 
splicing reaction. The various m utant extracts can com plem ent each o ther at the elevated 
tem perature suggesting that specific com ponents are inactivated in the different extracts and that 
these com ponents are freely exchangeable in vitro.
These results suggest that PR P2 functions before step 1 of the splicing reaction. The 
presence of extra plasm id-borne copies of PRP3 is able to relieve the ts phenotype o f a prp4
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m utant, suggesting tha t PR P3 and PRP4 perform  a sim ilar function (Last et al., 1987). Null 
alleles of PRP4 are not suppressed by the overexpression of PRP3 suggesting that PRP3 and 
PR P4 interact with each other, perhaps in the sam e complex (snR N P particle) (Last and 
W oolford, 1986). PR P6 and PRP9 may function at the com m itm ent stage of a pre-m R N A  
transcript to splicing (Legrain and Rosbash, 1989).
The accum ulation o f pre-m R N A  exhibited by prp  m utants incubated at the 
non-perm issive tem perature  has been utilised as the basis of a screen o f ~  1000 ts m utants for 
defects in splicing (Vijayraghavan and A belson, 1989). R N A  was prepared from these m utants, 
after a 2 hour incubation at the non-perm issive tem perature, and analysed by N orthern  blot 
analysis. Thirty-seven prp  m utants were identified by this screen and they can be placed into 4 
distinct groups based on their N orthern  blo t phenotype. These are; (a) those tha t accum ulate 
pre-m R N A  only; these include new alleleic m utants of the pre-existing prp2, prp3, prp6  and prp9  
m utants, and those placed into new com plem entation groups, prpl9, prp20, prp21, prp23, prp24  
and prp25, (b) those that accum ulate pre-m R N A  and the in tron-lariat, prp22 , (c) those that 
accum ulate the IVS-E2 lariat in term ediate only, p rp !7  and p rp l8 , (d) those that accum ulate the 
in tron lariat only, prp2 and prp27.
Eleven new com plem entation groups have been identified (prp!7-prp27). The fact that 
prp25 and prp26 are not tem perature sensitive suggests that certain m utations reduce the 
efficiency of splicing in vivo ra ther than com pletely inhibiting it. In this respect it has been 
proposed that splicing itself is not the rate-lim iting step in pre-m R N A  processing (Pikielny and 
Rosbash, 1985) and it is therefore conceivable that splicing m utants showing the growth 
phenotype o f prp25 and prp26 can exist.
H eat-inactivated extracts made from a p rp l8  m utant are unable to undergo the second 
step of splicing and accum ulate the 40S spliceosom e (see Section 1.10) containing the splicing 
interm ediates (Vijayraghavan and Abelson, 1990). Spliceosomes isolated from the extracts made 
from a prp l8  m utant can be com plem ented (for step 2) by extracts from o ther prp  m utants, and 
with an extract treated  with micrococcal nuclease. In addition, efficient com plem entation
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requires ATP. These observations suggest respectively that PR P18 is required for step 2 o f the 
splicing reaction, is readily exchangeable in vitro, may not be a snR N P com ponent (though the 
U5 snRN P is resistant to micrococcal nuclease and therefore PRP18 may be a com ponent of 
this snR N P) and that ATP is required for the second step of splicing. Thus PRP18 is necessary 
but riot sufficient for step 2 o f splicing.
A  m ore direct approach to  the isolation of putative splicing factors is the generation 
of extragenic suppressor m utants. The SRN1  m utant suppresses the fs phenotype o f a strain  
harbouring the prp2  and prp6  m utations (Pearson et al., 1982). SRN1  suppresses prpl, 2, 3, 4, 
5, 6 and 8  e ither singly or in pairs, however its function rem ains unknown. The SR N 2  m utatiorr 
suppresses the prp2  m utant phenotype (Last et al., 1987). Its in teraction with prp2 is suggested 
by the fact that SR N 2  does not suppress null alleles o f PRP2. The SPP81 m utant is a cold- 
sensitive suppressor of the ts phenotype of the prp8-l m utan t and based on the predicted 
protein  sequence, the  SPP81 + gene appears to  encode a putative A T P-dependent R N A  helicase 
(D. Jam ieson, pers. comm.). The generation of conditional-lethal suppressors in an alternate 
cold-sensitive, heat-sensitive m anner is a powerful genetic approach to  the isolation of 
interacting factors. The conditional-lethal phenotype o f the m utants makes genetic m anipulation 
easier and facilitates the isolation of the wild-type gene o f interest. The p rp !6  m utan t is a 
trans-acting suppressor of a branchpoint m utation (C outo et al., 1987). The PRP16  gene has 
been cloned and sequenced and it has been proposed that PRP16 is a putative ATP-binding 
protein involved in the fidelity of branchpoint recognition (Burgess et al., 1990).
Biochemical fractionation of yeast splicing extracts has identified 3 fractions (I, II and 
III) that are required for splicing in vitro (Cheng and Abelson, 1986). Fractions I and II together 
can perform  step 1 of the splicing reaction, however fraction III is necessary for step 2. A t least 
2 factors required for splicing which are extrinsic to the spliceosom e were identified; cn and 
bn are required for 3 ' and 5 ' splice site cleavage respectively (Cheng and Abelson, 1987). In 
the presence of ATP fraction I can com plem ent heat-inactivated p rp l8 extracts (Vijayraghavan 
and Abelson, 1990) and indeed cn is present in fraction I, therfore it is possible that cn is
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PRP18 (which is necessary for step 2). A n intrinsic com ponent o f the spliceosome, cIII, is 
required for step 2 of splicing and this has also been identified by biochemical fractionation 
(Cheng and Abelson, 1987).
1.10 YEAST SPLICING COMPLEXES
I.10.1 Isolation and Identification
Splicing complexes in yeast have been distinguished by glycerol gradient centrifugation 
(Brody and Abelson, 1985). A  40S complex has been identified whose efficient form ation 
requires ATP and the presence of the correct 5 ' and branchpoint consensus sequences. The 
presence o f the IVS-E2 lariat and exon 1 splicing interm ediates in this 40S complex defines it 
as the active spliceosome.
Splicing complexes have also been identified by native gel electrophoresis and shown 
to require ATP, the 5 ' splice site and branchpoint consensus sequences for their efficient 
form ation (Pikielny and Rosbash, 1986; Pikielny et al., 1986). Three complexes arising in a 
stepwise m anner have been resolved and these are term ed III-I-II (Pikielny et al., 1986). The 
U2 snR N A  is present in all three complexes, U4 snR N A  in I only and U5 snR N A  in I and
II. Complex II contains the splicing interm ediates and is thus defined as the active spliceosome. 
A  sim ilar approach using a different experim ental procedure also identified a stepwise assembly 
process in spliceosom e form ation (Cheng and Abelson, 1987). In this study the U6 snR N A  is 
present in complexes analogous to complexes I' and II above, indicating the participation o f all 
the m ajor snRN Ps (except U l)  in splicing in yeast. However, U1 snR N A  base-pairs with the 
5 ' splice site early in splicing (Seraphin et al., 1988) and indeed this interaction occurs in the 
absence of ATP and before the binding of the U2 snRN P to the pre-m R N A  (Ruby and 
Abelson, 1988). So-called "commitment" complexes, which form in the absence of ATP, contain 
the U l snRN A , pre-m R N A  and possibly o ther factors (but not the U2 snRN A ) have been 
identified by native gel electrophoresis (Seraphin and Rosbash, 1989b; see also Legrain et al.,
32
1988).
In R N ase H -directed cleavage experim ents the  biochem ical requirem ents for 
spliceosom e form ation appear to parallel the resistance of the 5 ' splice site and branchpoint 
to digestion, indicating that these two sites are bound by factors required for spliceosom e 
form ation (Rym ond and Rosbash, 1986). Protection  at either site requires the presence on the 
pre-m R N A  transcrip t of the o ther consensus sequence and is also dependent on ATP. The 
pattern  of protection of the 5 ' splice site changes as the splicing reaction proceeds, and indeed 
correlates with the change from complex III to I/II (Rym ond and Rosbash, 1986). In addition, 
chemical m odification studies indicate that nucleotides at the 5 ' splice site participate in several 
roles in spliceosom e assembly and splicing (Rym ond and Rosbash, 1988).
1-10.2. Tem poral O rder of snR N P Interaction in Spliceosom e Assembly
It is now apparen t that the tem poral order of events leading to  spliceosom e form ation 
in yeast m irrors closely the assembly of spliceosomes in m am m alian cells. The U1 snR N P binds 
to the pre-m R N A  at the 5 ' splice site (possibly interacting with the 3 ' splice site) in an 
A TP-independent m anner (Ruby and Abelson, 1988). This is followed by the A TP-dependent 
binding of the U2 snRN P at the branchpoint (o ther as of yet unidentified factors may bind to 
the pre-m R N A  prior to this U 2 snRN P interaction, e.g. the yeast equivalent o f U 2A F) (Pikielny 
et al., 1986; Cheng and Abelson, 1987; Ruby and Abelson, 1988). The U5 and U4/U6 snRN Ps 
appear to complex together in an A TP-dependent m anner prior to their com bined association 
with the U1/U 2/ pre-m R N A  complex which leads to the form ation of the spliceosom e (Lossky 
et al., 1988; see also Pinto and Black, 1989). As in m am m alian studies using gel electrophoresis 
techniques the yeast U4 snRN P appears to leave the spliceosome prior to step 1 o f splicing 
(Pikielny et al., 1986; Cheng and Abelson, 1987). However the apparen t exit o f the U4 snRN P 
may only reflect a conform ational change in the U4/U6 interaction which leaves the U 4 snRN P 
less tightly associated with the spliceosome. D ue to this w eakened in teraction the U4 snRN P 
may be displaced from the spliceosom e as a consequence o f the gel electrophoresis conditions
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employed. Post-splicing complexes containing PR P8 (hence the U5 snR N P) have been identified 
by W hittaker et al., (1990).
It has been proposed that the U 4 snR N A  is in fact a negative regulator of a catalytic 
U 6 snR N A  function (Brow and G uthrie, 1989). Unwinding o f the U4/U6 base-pairing 
in teraction (analogous to the conform ational change observed in native gel electrophoresis) may 
unm ask the highly conserved U 6 sequence proposed to act catalytically in the splicing process. 
This putative catalytic function of the U 6 snR N A  is based on the observation that the IJ6 
snR N A  gene of Schizosaccharomyces pom be  contains a pre-m RN A -type in tron in the highly 
conserved region of the U 6 snR N A  (Tani and Ohshim a, 1989). Insertion o f the in tron at this 
site is postu lated  to have occurred as a consequence of a m ishap during a splicing reaction. This 
would therefore place the highly conserved region of the U6 snR N A  at a site o f catalytic activity 
in the spliceosom e (Brow and G uthrie, 1989). It is also interesting to no te  that the U2 snR N A  
which itse lf may reside near a catalytic centre in the spliceosom e (due to its in teraction with 
the branchpoint region) has a poten tia l base-pairing in teraction with the U 6 snR N A  
(M cPheeters et al., 1989).
1.11 PRE-mRNA SPLICING AND THE CONTROL OF GENE EXPRESSION
1.11.1 A lternative Splicing
A lternative splicing o f pre-m R N A  transcripts has emerged as an im portant device for 
regulating gene expression. An extensive discussion of this topic is beyond the scope o f this 
in troduction and the reader is referred to  the com prehensive review o f Smith et al., 1989a.
There are several ways in which alternative splicing can generate different transcripts. 
These modes of alternative splicing can be classified into 5 groups; (i) transcripts in which an 
in tron has been retained or removed, (ii) transcripts in which alternative 5 ' and 3 ' splice sites 
are  utilised, (iii) transcripts which e ither in itiate at or are polyadenylated at different p rom oter 
and/or polyadenylation sites respectively (this can lead to the exclusion/inclusion of exons from
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the 5 ' and 3 ' ends of the transcripts), (iv) transcripts which can contain exons that are removed 
in a mutally exclusive m anner and (v) transcripts w here individual exons can be included or 
excluded independently of o ther sequences.
There are a num ber of ways in w hich alternative splicing can affect gene expression. 
D ifferent (though sim ilar) proteins encoded by alternatively spliced transcripts can be m em brane 
bound or secreted from the cell, e.g. the im m unoglobulin pro te in  (Ig/xm) proceeds from being 
in m em brane-associated form  to being in a secreted form  (Ig/us) as a result o f alternative 
splicing of the 3 ' end exons residing in the transcrip t that encodes it. A lternative splicing, 
causing early term ination o f translation, can erase the function o f a protein , e.g. the Sex-lethal 
protein  of Drosophila. P rotein  function itself may be m odulated by the inclusion or exclusion 
of certain exons, e.g. the tyroponin-T  protein , and indeed this can also lead to the production 
of proteins with different functions, e.g. calcitonin and calcitonin gene-related peptide (CG RP). 
A lternative splicing which creates heterogeneity  in the 5 ' and 3 ' untranslated  regions may affect 
translational efficiency and/or R N A  stability.
Various determ inants appear to  be involved in splice site selection. The in teraction of 
these determ inants is no t at all clear and is the object o f intense study. I will briefly dut-line 
the determ inants im plicated so far w ithout discussing the mechanisms proposed to account for 
their involvement. W hat is clear is that transcripts may have different determ inants which 
regulate their alternative splicing patterns.
(i) Some introns contain branchpoints fu rther upstream  (—lOOnts) than would normally be 
expected. It has been proposed that the long (Py)n tracts found adjacent to these branchpoints 
are im portant in branchpoint recognition and may be an im portan t feature of transcripts that 
are alternatively spliced (Reed, 1989; G oux-Pelletan et al., 1990). The branchpoint itself can 
determ ine 5 ' splice site utilisation (Noble et al., 1988, 1989).
(ii) D ifferential recognition of introns by distinctive forms of snRN Ps (some of which are known 
to be developm entally regulated) has been postulated as an im portant factor in alternative 
splicing (see Lund and D ahlberg, 1987; Lund et al., 1987). Indeed com plem entarity of the 5 ' 
splice site with the U1 snR N A  may increase the use of that site (Lear et al., 1990). It is also
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known that increased com plem entarity betw een the branchpoint region and the U 2 snR N A  is 
im portant for splicing efficiency (Z huang et al., 1989).
(iii) In tron size appears to be im portan t in splice site selection (Fu and Manley, 1987; see also 
Reed and M aniatis, 1986).
(iv) Exon sequences can also influence the choice of splice sites (R eed and M aniatis, 1986; Tsai 
et al., 1989; Nagoshi and Baker, 1990) and indeed it has been suggested that the "definition" 
of the exons can determ ine splice site selection (R obberson et al., 1990).
(v) R N A  secondary or indeed tertiary structure  may influence splice site choice (Khoury et al., 
1979; Solnick, 1985; E peron  et al., 1986; Chebli et al., 1989).
(vi) Introns may contain sequences (outw ith the consensus sequences) that influence the 
selection of splice sites (Helfm an et al., 1990).
(vii) Tranx-acting factors are involved in both  determ ining (Nagoshi and Baker, 1990) and 
inhibiting (Inoue et al., 1990) splice site utilisation.
(viii) The "first come first served" principle has been postulated based on the observations that 
some introns can be removed co-transcriptionally, suggesting that it is the transcriptional order 
of appearence of an intron that determ ines its removal (Beyer and Osheim, 1988).
Probably the m ost exciting discovery so far is that sexual differentiation in Drosophila 
melanogaster is regulated by a cascade o f alternative splicing events. The epistatic hierarchy of 
genes involved in this cascade is well established (reviewed in Smith et al., 1989). The Sex-lethal 
gene (Sxl) activates transformer (tra) which in conjunction with transformer-2 (tra-2) then acts 
to establish the female mode of expression o f the double-sex gene (dsx). Sxl, tra and dsx are all 
regulated at the level of splicing. Each gene can produce two transcripts which are either male 
or female-specific, though for Sxl and tra the male-specific transcripts are non-functional. The 
female-specific transcript of Sxl encodes a protein  which has an RNA-binding consensus (Bell 
et al., 1988) and this binds to the male-specific 3 ' splice site of the tra transcript (Inoue et al.,
1990). Thus Sxl inhibits the utilisation of the male-specific 3 ' splice site and so tra only 
generates female-specific transcripts. Sxl is thought to regulate its own female-specific expression
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in a sim ilar m anner. In contrast, the choice of the female-specific splice site  in the dsx transcript 
appears to be determ ined in a positive m anner i.e. trans-acting factors increase its use, ra ther 
than inhibit the use of the male-specific sites (Nagoshi and Baker, 1990).
The failure to mimic the in vivo pa ttern  o f splicing in vitro (and so identify factors 
involved in alternative splicing) has revealed the advantages provided by the genetic system 
available in Drosophila. It seems likely tha t studies utilising Drosophila may provide m ore 
examples of systems controlled by a cascade of alternative splicing events.
1.11.2 Introns: Effects on G ene Expression
Early experim ents utilising viral recom binants indicated that introns are required for 
the production of stable cytoplasmic R N A  (G russ et al., 1979; H am er and Leder, 1979) and the 
efficient expression of the gene encoding the chicken ovalbum in protein  (W ickens et al., 1980). 
However, introns are not required for the expression of o ther viral genes (G hosh et al., 1981; 
Carlock and Jones, 1981; Treism an et al., 1981). R ecent data from a num ber of studies involving 
a variety of genes, have indicated that introns are necessary for efficient gene expression and 
indeed can increase expression several hundred-fold. The genes studied includea the m ouse 
ribosom al gene RPL32  (Chung and Perry, 1989), a /?-globin gene analysed in SV40 recom binants 
(Buchm an and Berg, 1988), the hum an proliferating cell nuclear antigen gene (P C N A ) (O ttavio 
et al., 1990) and the alcohol dehydrogenase-1 gene (Adhl )  of maize cells (Callis et al., 1987).
This in tron-dependent effect on gene expression does not appear to be a consequence 
of differences in the levels o r rates of transcription between intron-containing (IV S (+ )) and 
intron-less (IVS(-)) genes (W ickens et al., 1980). Results obtained from nuclear run-off 
experim ents are consistent with this view (H uang and G orm an, 1990). In the study of H uang 
and G orm an, steady-state levels of to tal nuclear R N A  transcribed from an IV S (+ ) and IVS(-) 
gene, and the rate of decay of both types of R N A  generated, is similar. This suggests that the 
intron effect on splicing is not at the level of transcription and/or R N A  stability. A lthough the
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steady-state levels of nuclear IV S (+ ) and IVS(-) R N A  are similar, polyadenylated nuclear R N A  
consists o f (in this study) seven times m ore IV S (+ ) R N A  This d istribution  of polyadenylated 
R N A  is m irrored in the cytoplasm i.e. there  is 7-fold m ore m R N A  (poly A + )  derived from 
the IV S (+ ) gene in the cytoplasm than m R N A  (poly A + )  derived from the IVS(-) gene. This 
suggests that the rates of transport o f the two R N A  species are similar. Thus it has been 
postulated that there is a selective transition  o f IV S (+ ) transcripts from the total nuclear R N A  
pool into a steady-state population  of polyadenylated RN A , and that this accounts for the 
increased expression of the IV S (+ ) genes. It has been suggested that genes which do not require 
an in tron for efficient expression may have strong signals for, and/or alternative m ethods of, 3 ' 
end processing.
How m ight the presence o f an in tron  increase the efficiency of polyadenylation? It has 
been suggested that the in tron  sequesters snR N P particles (and/or o ther factors) which may be 
involved in splicing and 3 ' processing (H uang and G orm an, 1990). There is som e evidence to 
support such a proposition. In vitro com plem entation studies of 3 ' end processing is inhibited 
by treatm en t o f the extract with micrococcal nuclease and w ith an anti-Sm  antibody (H ashim oto 
and Steitz, 1986; G ilm artin et al., 1988). These observations suggest that snRN Ps are involved 
in 3 ' end processing. In cross-linking studies the hnR N P C protein  (thought to be involved in 
splicing) is found to be associated with the polyadenylation signal sequence (M oore et al., 1988). 
Two o ther proteins, one of which possesses an Sm -epitope, are also found to be in direct 
contact with the polyadenylation site.
Pre-m R N A  splicing appears to take place on the nuclear matrix (Ciejeck et al., 1982), 
indeed pre-m R N A  transcripts and the splicing interm ediates are found associated with it (Zeitlin 
et al., 1987). In a recent study the pre-m R N A  of the acetylcholine receptor gene has been 
localised to  specific regions of the nuclear m em brane which is in contrast to the random  
distribution of the actin gene pre-m R N A  (Berm an et al., 1990). It has been proposed that the 
nuclear m em brane regulates the export of certain R N A  molecules and it conceivable that 
transcripts may be spliced at specific regions on the nuclear m em brane as a means of controlling 
their expression.
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Introns can contain elem ents involved in the contro l of transcrip tion  (A ronow  et al., 
1989 and references th e re in ) .'T h e  m ouse ribosom al protein  gene RPL32  (Chung and Perry,
1989) and Lhe hum an adenosine deam inase gene (ADA)  (A ronow  et al., 1989), both contain 
transcriptional activators in their first introns. Indeed it is interesting to no te  that increases in 
gene expression appear to  be greater when an in tron is placed at the 5 ' end o f a transcript 
(Callis et al., 1987). This effect need not necessarily be a result of in tron sequences involved in 
transcriptional control. It could be related  to the early sequestration  o f factors required for 
splicing and/or 3 ' processing (see above). Introns can produce negative effects on gene 
expression. The presence o f intron-4 in the transcrip t o f the hum an PCNA  gene reduces the 
level of m R N A  and indeed is required  for the correct regulation of gene expression (O ttavio 
et al., 1990). It is possible that the removal of intron-4 of PCNA  is regulated, indeed the RPL32  
transcript o f yeast can regulate the splicing o f its own transcript (Dabeva et al., 1986). Recently 
a prom oter for antisense R N A  was identified in the yeast actin gene intron, though the function 
of the antisense transcript is unknown (Thom pson-Jager and Domdey, 1990).
1.12 INTRONS AND EVOLUTION
There are two main theories advocated to account for the presence o f introns in genes. 
The first suggests that introns were presen t in the original nucleic acid molecules that 
constituted the so-called "RNA world" (G ilbert, 1986). This idea is an extension of the theory 
that introns pre-dated the divergence of prokaryotic and eukaryotic organisms (D oolittle, 1978; 
Darnell, 1978). In this scenario introns were subsequently lost from prokaryotic genes as a 
consequence of the high selective pressure to minimise the size of the genom e to enable rapid 
D N A  replication. In contrast, in trons were m aintained in eukaryotic genes because they 
facilitated diversity and rapid evolution and enabled the contro l of gene expression. The second 
theory suggests that introns were inserted into the genes of eukaryotes after the divergence from 
prokaryotes (Crick, 1978; Orgel and Crick, 1980).
There is now a considerable am ount of evidence supporting the form er theory. Introns
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have been observed in prokaryotic organism s (Schmidt, 1985) and studies of chloroplast and 
nuclear genes has indicated that introns w ere present before the divergence of prokaryotes and 
eukaryotes (Shih et al., 1988). If introns w ere present in ancestoral genes then the variability 
in in tron  content exhibited by functionally sim ilar genes in different species, should be 
explainable by the specific loss of introns, and indeed this phenom enon has been docum ented 
(Perler et al., 1980). However there  is also evidence to suggest that introns were inserted into 
eukaryotic genes after the divergence of eukaryotes from prokaryotes (Sogin, et al., 1986; Dibb 
and Newman, 1989; Tani and Ohshim a, 1989). G roup  I introns can insert into specific regions 
of D N A  (reviewed by D ujon, 1989; Lambowitz, 1989) and indeed G roup II introns (and some 
G roup I introns) may insert into D N A  via an R N A  interm ediate (W oodson and Cech, 1989; 
M ori and Scmelzer, 1990; A ugustin et al., 1990). The relationship o f the G roup  I and II introns 
to m obile genetic elem ents is an interesting one (see Scazzocchio, 1989) and there are reports 
o f pre-m RN A -type introns possessing sequence homology to  transposons (Tournier-Lasserve,
1989). These observations suggest that present day genom es are in flux, subject to intron 
deletion and insertion.
It has been postulated that R N A  was the first replicator m olecule in pre-biotic 
evolution and in the absence of proteins was both an inform ational and functional m olecule 
(Sharp, 1985; G ilbert, 1986; Lam ond and Gibson, 1990). It was hypothesised that introns could 
recom bine into o ther R N A  molecules and in the process "carry" exon sequences with them. This 
recom bination event would increase the diversity o f molecules by generating novel com binations 
of exons. The discovery that G roup I and II introns could self-splice and re- integrate into o ther 
R N A  molecules leant great weight to this hypothesis (Cech and Bass, 1986; W oodson and Cech, 
1989; A ugustin et al., 1990; M ori and Schmelzer, 1990). The mechanism by which G roup I, II 
and pre-m RN A -type introns are removed is fundam entally sim ilar (Sharp et al., 1985; Cech and 
Bass, 1986) and thus it is thought that pre-m R N A  type introns arose from the ancestoral 
self-splicing introns. Based on this possible connection it is proposed that the catalytic activity 
involved in pre-m R N A  splicing resides with the snR N A  com ponents of the spliceosom e (Brow 
and G uthrie, 1989). The identification of o ther catalytic functions of RNA, e.g. from an R N A
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polymerase to  a sequence-specific R N A  endonuclease, has supported  the argum ents for its role 
in the earliest stages of pre-biotic evolution (reviewed by Lam ond and G ibson, 1990). Indeed 
G roup I self-splicing introns can specifically bind L-arginine, suggesting their involvem ent in 
the creation of the translational apparatus (Hicke et al., 1989).
W hat would be the selective pressure for the reten tion  of introns? As previously 
indicated (see Section 1.11) introns can contain transcriptional regulatory elem ents and be 
involved in o ther m ethods o f regulating gene expression e.g. alternative splicing. Indeed 
pre-m R N A  splicing may be linked to o ther R N A  processing events such as polyadenylation and 
transport. Introns themselves can encode proteins (D ujon, 1989). A nother postulated pressure 
for the reten tion  of introns is that o f the  process known as "exon-shuffling" (G ilbert, 1978). 
N on-hom ologous recom bination w ithin introns may serve to generate coding sequence diversity 
during evolution. In this scenario exon sequences< correspond to functional dom ains of proteins 
(Blake, 1978), thus "exon-shuffling" leads to the reassortm ent of protein  dom ains (G ilbert, 1985). 
Indeed genes made up of exons that encode specific protein  dom ains found in o ther genes have 
been identified (Sudhof et al., 1985a, 1985b). It has been proposed that "exon-shuffling" only 
became prevalent after the divergence of eukaryotes and prokaryotes (Patthy, 1987).
1-13 THIS THESIS
In this thesis I present the following;
(i) the creation of a num ber of plasmid constructs which enabled the developm ent o f a
novel screening procedure for conditional-lethal prp  m utants in Saccharomyces cerevisiae,
(ii) the developm ent of a colony screening m ethod which positively identifies prp m utants,
(iii) the isolation and initial characterisation of tem perature-sensitive prp m utants.
In addition I include an A ppendix section which briefly describes a set o f experim ents 





2.1.1 Suppliers of Laboratory Reagents
R estriction  enzymes and o ther D N A  modifying enzymes:
Am ersham  International, Bethesda R esearch Laboratories, B oehringer M annheim , New England 
Biolabs and Pharmacia.
Radiochemicals:
A m ersham  International.
Deoxynucleotides, dideoxynucleotides and ribonucleotides:
Pharmacia.
Acrylamide and N N ’-m ethylene bisacrylamide:
BD H  Chemicals, "Electran" grade.






Standard laboratory reagents (analytical grade o r better):
BDH, Fisons, Sigma, B io-Rad and Serva.
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2.1.2 G row th M edia
Unless otherw ise stated all quantities given are for 1 litre volumes. These solutions 
were autoclaved (see Section 2.2.1.2) and stored at room  tem perature. A m ino acids were filter
sterilised (see Section 2.2.1.2) and along w ith antibiotics were stored as concentrated  solutions
and added after autoclaving the media. V itam in-free Casamino acids (Difco) and adenine
sulphate were added p rior to sterilisation. W hen Casam ino acids were used, trytophan was added
after autoclaving and cooling the media. Selective growth for U/UO-containing plasmids still
occurs in the presence o f vitam in-free Casam ino acids.
2.1.2.1 Bacterial M edia
Luria Broth (LB): lOg bacto-tryptone (Difco), 5g yeast extract (Difco), lOg NaCl, pH  to
7.2 with NaO H .
Luria agar (LB-agar): LB plus 15g agar (Difco).
LB-ampicillin: LB plus O.lmg/ml ampicillin.
LB-amp agar: LB-agar plus O.lmg/ml ampicillin.
BBL agar: lOg trypticase (B altim ore Biological L aboratories), 5g NaCl, lOg agar
(Difco).
BBL top agar: as for BBL agar except 6.5g agar (Difco).
M9 salts x4: 28g N a2H P 0 4, 12g K H 2P 0 4, 2g NaCl, 4g N H 4C1.
M9 m edium  (400ml): 100ml M9 x 4, 0.4ml 1M M g S 0 4, 0.8g glucose, am ino acids and/or
other requirem ents to  20/ag/ml.
M9 agar (400ml): M9 m edium  plus 300ml w ater agar (Difco).
2.1.2.2 Y east Media
YPDA: lOg bacto yeast extract (Difco), 20g bacto-peptone (Difco), 20g glucose,
20mg adenine sulphate.
Y PD A  agar: . Y PD A  plus 20g agar (Difco).
YM G/Cas: 6.7g yeast nitrogen base w/o am ino acids (Difco), 20mg adenine
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YM G/Cas agar: 
YMM:
YM M  agar: 
YM R/Cas: 
Y M R/G al/Cas agar: 
YM R/G/Cas: 
Sporulation agar:
sulphate, 20g glucose, lGg vitam in-free Casam ino acids (Difco) and 
20mg tryptophan.
Y M G/Cas plus 20g agar.
6.7g yeast nitrogen base w/o am ino acids (Difco), 2,0g glucose, 20mg 
relevent am ino acid or base.
YM M  plus 20g agar (Difco).
YM G/Cas except 20g raffinose instead of glucose.
M R/Cas plus 20g galactose and 20g agar (Difco).
Y M R/Cas plus 500mg glucose.
10g Potassium  acetate, lg  bacto yeast extract (Difco), 0.5g glucose, 20g 
agar (Difco), 20mg each relevant am ino acid and/or adenine sulphate.
2.1.3 Bacterial Strains
All strains of E.coli used in this work are indicated in Table 2.1.
2.1.4 Yeast Strains
All strains of Saccharomyces cerevisiae used in this w ork are indicated in Table 2.2.
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A (lac,pro), supE, thi~, m u tL , 
F'(proAB, lacl, lacZhM IS).
F", hsdS20  (r 'B , m"B), recA13, 
ara-14, proA2, lacYl, galK2, 
rpsL20 (Sm r), xyl-5, mtl-1, supE44.
L(lac, pro), codA, codB, 
trmB, argF, F'(traD36, pro AB, 
lacF , lacZ hM lS).
Reference






M essing et al.,
(1983)
NM522 hsdt\5, (lac, pro),
F '(IacP, lacZhM IS, pro+ ).
N. Murray, 
(this dept.)












M ATa, his3-h200, Iys2-801, ade2-101, K. Struhl.
t ip i-Ai, ura3-52. (Harvard)
MATa, as for K Y I 17.
MATa tys2, Ieu2, his3-bd, ura3-52. S. Jackson, 
(this lab.)




MATa Ieu2-3 and 112, his3-Kl, 
trpl-289, ura3-52.
W ellcome.
MATa Ieu2, adel-100, ura3-52. Legrain and
Rosbash (1989).
M ATa, prpl-1, leu2-3 and 112, D. Jam ieson.













MATO, p tp l-1 , Ieu2-3 and 112, 
his.i-hJ, trpl-289, ura3-52, ural.
M ATa, prp2-l, ade, ura3-52.
MATCH, prp2-l, leu2, lys2, his, 
ade, tyrl, ura3-52.
as for SPJ2.53.
M ATa, prp3-l, leu2, fys2, his, 
ura3-52.
MATa, as for SPJ3.33.
M ATa, prp4-l, leu2, ura3-52.
MATa prp4-l, leu2, tys2, his7, 
ade, ura3-52.
MATa P>p5-1, Ieu2, his, ura3-52. 
MATa prp5-l, ade, trp, arg.
MATa, prp5-l, tys2, his7, adel, 




















M ATa, prp6-l, lys2, his, ade, 
ura3-52.
MATCH, prp6-l, fys2, his, ura3-52.
MATOC, prp7-l, Ieu2, Iys2, his.
M ATa, prp7-l, fys2, his7, adel, 
ade2, tyrl, ural.
MATCL, prp7, leu, adel +1-2, ura.
M ATa, prp7-l, lys2, his7, adel, 
ade2, tyrl, ural, mal, gal.
M ATa, prp8-l, leu2, his3, ura3-52.
MATCH, prp8-l, leu2, ade, ura3-52.
MATCH, prp8-l, leu2, his3 and 7, 
ade, ura3-52.
M ATa, prp9-l, lys2, his7, adel, 














J. W arner. 
(New Y ork)
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M ATa, p r p l l - ì ,  leu2, his4-512, 
tyrl, ura3-52.
MATCH, p i p i l -1, leu2, his4-512, 
ade, tyrl, ura3-52.
M ATa, p rp l 7, lys2-801, his3-1^200, 
ade2-101, ura3-52.
MATOt, as for 60-2a.
M ATa, p rp l8, his3-0,200, ade2-101, 
tyrl, ura3-52.
MATO, p rp l8, Iys2-801, his3-h200, 
ade2-l 01, ura3-52.
M ATa, p r p l9, leu2, Iys2-801, 
his3-k200, ade2-101, ura3-52.
M A T a , as for 10A-6B.













4C M ATa, prp21, as for 20-6D.
2A M ATa, prp21 , as for 60-2a.
9-6C M A T  a, prp22, as for 20-6D.
9-4A MATOC, prp22, as for 60-2a.
29-5B M ATa, prp23, as for 27-5C.
29-6A M ATa, prp23, tys2-801, his3-k200,
ade2-101, tyrl, ura3-52.
40-5C M ATa, prp24, as for 60-2a.
35-3a M ATa, prp24, as for 60-2a, (ura3?).
23-2C-1C M ATa, prp25, as for 27-5C.
23-2C-1A M ATa, prp25, as for 60-2a.
D-5A-3A M ATa, prp26, as for 27-5C.
40-la  M ATa, prp27, as for 60-2a.
20-6A MATa, as for 20-6D.
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35-3b MATa, prp27, as for 60-2a.
DJY63 M ATa, SPP81 -3, leu2, his3, 
ura3-52.
D. Jam ieson, 
(this lab.)
DJY65 M ATa, prp8-l, SPP81-3, leu2,
2.1.5 G eneral Plasmids and Bacteriophage Vectors
Plasmids used for the isolation of gene-specific D N A  fragm ents (utilised as 
radioactively labelled probes in N orthern  b lo t analysis) and as general vectors in cloning 
procedures are described in Table 2.3 and in Fig. 2.1. All D N A  fragments used as probes were 
gel purified (see Section 22.5.1) and radiolabelled as described in Section 2.2.5.10.
2.1.6 Synthetic Oligodeoxynucleotides
Table 2.4 provides the sequences o f the oligodeoxynucleotides used in prim er extension 
studies (see Section 2.2.8.5 and C hapter 4.1.1). All oligodeoxynucleotides were synthesised and 
H PLC  purified by the Oswel D N A  Service based in the departm ent of Chemistry at the 
University of Edinburgh (including those oligodeoxynucleotides described in C hapter 3). All Tm 
values were calculated by the "Wallace rule" i.e. Tm =  4 (G + C  content) +  2 (A + T  content); 
(Suggs et a I., 1981). The concentration of the oligodeoxynucleotide-containing solution was 
determ ined using the following formula: 0.2/umoles of a 20mer produces an O.D. 260nm o f 20 
units and is equivalent to lm g of D N A  (Oswel D N A  Service). Oligodeoxynucleotide integrity 
was checked by phosphorylating the 5 ' end with [y-32P]rATP (employing T4 polynucleotide 
kinase; see Section 2.2.5.12), and analysed by polyacrylamide gel electrophoresis (see Section
2.2.5.12). By com paring the sizes and patterns of radioactive signal with the M13 universal 
sequencing prim er (17mer), those oligonucleotides that were of the wrong size and/or weakly 
labelled were quickly detected and discarded (results not presented).
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E.coli M 13-bacteriophage based 





pSPT19 E.coli plasmids containing a
m ultiple cloning site, used as a 
host vector for the lacZ gene.
Pharm acia
(U.K.)
pYA301 A  1038bp BamHUBgWl fragm ent
from this plasmid, containing 
E l ,  IVS-1 and part o f E2 of the 
actin gene, was used as a probe 




pBRCYH-3 A  2kb E coR I fragment of Y EpCYH-1 
containing 5 ' flanking sequences,
E l ,  IVS-1 and part of E2 of the 
CYH2 gene was clonedinto pBR322. 
This fragm ent is present in 3 copies 
(hence 3) and was used as a probe in 
N orthern  blots.
M ade by 
G. Anderson, 
(this lab.)
pU C -G PM  pUC19 based vector containing the M. W hite.
yeast phosphoglycerate m utase gene (L. G ilm ore’s
(G PM ), which was removed as a 1.3 kb lab. Dept.
H indlll/Sa ll fragm ent and used of Biochem.
as a probe in N orthern  blots. Edinburgh.
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FIGURE 2.1: GENERAL PLASMID AND PHAGE VECTORS
The plasmids and phage used in general cloning experim ents, and those used for the 
isolation of specific gene fragments, are indicated along with their sizes and relevant restriction 
sites. The plasmids are not drawn to scale.
BamHl = B EcoR I = E  Sspl = Ssp
BglU =  Bg H ind lll = H  SalI =  S
F i g u r e  2.1
MCS






B —  1 .038kb —  Bgl




E -  2kb ^ E E E









TABLE 2 4  SYNTHETIC OLIGODEOXYNUCLEOTIDES
Nam e O ligodeoxynucleotide Sequence and D escription
083C 5 ' -C T G C A A G G C G A T T A A G T T G G -3 ' 20mer, Tm =  60°C
This oligodeoxynucleotide is com plem entary to the lacZ  transcript, 47 bases 
dow nstream  of the B a m H l site presen t at the 5 ' end of the coding sequence (see 
C hapter 3.3.1). Thus in all M A T a l  fusion constructs described in C hapter 3 this 
oligodeoxynucleotide was able to differentiate between the pre-m R N A  and m RN A  
generated from each plasmid (it should be noted  that there is no endogenous lacZ  gene 
in any of the yeast strains tested). Using this oligodeoxynucleotide the sizes of prim er 
extension products generated from the pre- and m R N A  encoded by pJBM -4 are 381nts 
and 322nts respectively. The IVS-E2 lariat in term ediate gives rise to a prim er extension 
product of 155nts.
JM O -PG K  5 ' -G G G T G G T G T T C C A A A A C G -3 ' 18mer, Tm =  5 6 °C  
(050B)
This oligodeoxynucleotide was com plem entary to  the m R N A  sequence located 200 
nucleotides downstream  of the transcrip tion start site o f the intronless yeast gene 
phosphoglycerate kinase (PGK), (H itzem an, 1982). It was used as a control for changes 
in R N A  levels such that any detectable increases in pre-m R N A  could be distinguished 
from changes in R N A  not subject to splicing.
JM ACT1 5 ' -TC A A TA A C C A A A G C A G C A A C -3' 20mer, Tm =  56°C
(203D)
This oligodeoxynucleotide is com plem entary to the E2 region of the  actin m R N A  that 
is 2bp downstream  of the 3 ' splice site (Ng and Abelson, 1980). Thus it will detect pre- 
and m R N A  and the IVS-E2 lariat interm ediate. The sizes of the D N A  species generated 
by prim er extension using this oligodeoxynucleotide are 462nts, 153nts and 65nts 
respectively.
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JM ACT2 5 ' -G A A A T C T C T C G A G C A A T T G G -3 ' 20mer, Tm =  58 °C
(204D)
This is com plem entary to the actin transcrip t 54bp downstream  of the 5 ' splice site 
and 186bp upstream  of the TA C TA A C  box. It therefore detects the IVS-E2. lariat 
in term ediate and/or the IVS lariat product (it cannot distinguish betw een them  as 
both produce extension products of 74nts), and pre-m R N A  (205nts extension product).
JM C Y H 2A  5 ' -TTA C C G A TA C G A C C TTTA C C -3' 20mer, Tm =  58 °C
(205A)
This is com plem entary to the E2 region of the ribosom al protein  gene CYH2  transcript 
which is 2bp downstream  of the 3 ' splice site and thus binds to pre- and m RNA, and 
IVS-E2 lariat interm ediate (K aufer et al., 1983). This gene has at least 3 
transcription start sites and this is reflected in the sizes o f the prim er extension 
products: pre-m R N A , 616, 612 and 606nts; m RNA, 106, 102 and 96nts; IVS-E2 lariat, 
66nts.
JM CYH2B 5 ' -A T A T T G G TTG C A C A A C A C TA -3' 20mer, Tm =  54 °C
(206D)
This is com plem entary to the region of the CYH2  in tron that is 75nts downstream  of 
the 5 ' splice site and 385nts upstream  of the TA CTA A C box. It has the same 
recognition pattern  as JM A CT2 and produces prim er extension products of lengths 160, 
156 and 150nts for pre-m R N A  and 75nts for IVS-E2 lariat and/or IVS lariat product.
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2.2 M E TH O D S
2.2.1 G eneral G uidelines
2.2.1.1 Centrifugation
Unless indicated all procedures w ere perform ed at room  tem perature. Centrifugation 
of volumes greater than 50ml was achieved using a Sorvall GS-3 ro to r at 4,100g (5,000rpm); 
volumes betw een 50 and 1.5ml were centrifuged in either a Sorvall SS34 or HB4 ro to r at 
16,000g (11,500 and 10,000rpm respectively), or in a IEC CEN TR A -4X  bench-top centrifuge 
(with swing ou t ro tor) at 5000rpm; and volum es less than or equal to  1.5ml in a 
m icrocentrifuge at 17,500g (12,000rpm).
2.2.1.2 Sterilization of Solutions
W hen necessary solutions were sterilized prior to use by placing them in an autoclave 
(120°C, 15psi), for 20 m inutes. C onstituents of solutions which could not be treated  in this 
m anner e.g. SDS, tryptophan, DTT, /?-m ercaptoethanol and antibiotics etc., were added after 
this process. Such solutions were sterilized by passage through a disposable acrodisc filter- 
sterilizing assembly (0.45/um pore-size; G elm an Sciences).
2.2.1.3 D eionisation o f Solutions
Solutions such as formamide, acrylamide and glyoxal were deionised by mixing with 
0.1-0.2 volumes of analytical grade mixed-bed resin (20-50 mesh, Bio-Rad Laboratories), for 30 
minutes. The resin was then removed by filtration through W hatm an N o .l filter paper. Glyoxal 
was stored in tightly sealed eppendorf tubes, in 100/xl aliquots, at -70°C. Acrylamide and 
formamide were stored at 4 °C
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2.2.1.4 A utoradiography
[32P]-labelled nucleic acids were detected  by exposure to preflashed X-ray film (Cronex) 
a t -70 °C  in the presence of a calcium -tungstate intensifying screen (Am ersham  Review 23, 
Laskey, R. A.).
[35S]-labelled D N A  fragments w ere detected by exposure to unflashed X-ray film 
(Cronex) at room  tem perature  w ithout an intensifying screen.
2.2.1.5 Photography
Photographs of agarose gels containing nucleic acids stained with lq-g/ml ethidium  
brom ide were obtained by visualising the nucleic acid with a short-wave length UV (254nm) 
. transillum inator, and then exposing the gel to Polaroid 667 professional film.
2.2.2 Bacteria and Phage: G eneral M icrobiological M ethods
2.2.2.1 Propagation and Storage
E.coli cells were grown at 37°C. Liquid cultures were shaken continuously, and growth 
was m onitored by determ ination  of the cell density, m easured at O.D. 550nm. E.coli strains 
HB101 and DH5 were propagated on LB-agar whereas JM101, NM 522 and BMH71-18 m utL  
w ere m aintained on M 9-agar to select for the F ' episome. Transform ed E.coli strains were 
grown on LB-amp to select for the plasm id of interest. Perm anent E.coli stocks (85% (v/v) 
stationary culture grown in the relevant m edium ) were stored at -70°C  in 15 %  (v/v) glycerol.
2.2.22 P ieparation  of C om petent Cells
A  1%  (v/v) inoculum  of a stationary culture in 100ml LB, was shaken vigorously until
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it reached an O.D. 550nm of roughly 0.5. A fter chilling on ice for 10 m inutes the cells were 
sedim ented (4,100g, 5 m inutes a t 4 °C ), resuspended in 50% (original volum e) cold 75mM CaCl2 
and incubated on ice for 20 m inutes. The cells were re-sedim ented (4,100g, 5 m inutes a t 4°C , 
resuspended in 4%  (original volum e) cold TFBII (lOmM M OPS pH6.8, lOmM RbCl, 75mM 
CaCl2 15% (v/v) glycerol) and incubated on  ice for 20 m inutes. They were then  aliquoted 
(600/xl) into eppendorf tubes and e ither used im m ediately o r snap frozen in liquid nitrogen and 
stored at -70 °C.
2.2.23 Transform ation
To a glass test-tube containing 200/xl o f com petent cells, roughly 50ng of plasmid DNA 
(in a volum e not exceeding 100/xl) was added and thoroughly mixed. A fter leaving on ice for 
20 m inutes the mixture was incubated at 4 2 °C  for 2.5 m inutes (with occasional mixing), and 
then replaced on ice for a further 5 m inutes. It was then transferred to an eppendorf tube 
containing 1ml of LB and incubated on a ro tating wheel at 37°C  for 40-60 m inutes. A liquots 
of cells were then spread onto  L-amp plates to select for cells containing the plasmid.
2.2.2.4 Isolation of M13 Plaques
Single-stranded or R F  M13 D N A  was introduced into E.coli strains as described in 
Section 2.2.2.3. During the transform ation procedure BBL top agar was melted, aliquoted 
(3.5ml) into small 5ml glass test-tubes and incubated at 42°C  for 5 m inutes followed by the 
addition of 30/xl X-gal (20mg/ml) and 20/xl IPTG  (24mg/ml). A liquots o f the transform ed cells 
(2-100/ri) were then mixed with 200-300,0,1 plating cells (JM101 or NM 522), which could be 
stationary or freshly grown cultures (O D  550nm of 0.2-0.5). A fter this, these cells were added 
to the test-tubes containing the BBL top agar, X-gal and IPTG, mixed and poured over the 
surface of a BBL plate. T he top agar was allowed to set and then the plates were incubated 
overnight at 37 °C.
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2.2.3 Y east: G eneral M icrobiological and G enetic M ethods
2.2.3.1 Propagation and Storage
p tp  strains were grown at 23 °C  while wild-type strains were propagated at 3 0 °C. Liquid 
cultures were continuously shaken and cell density was determ ined by m easuring the O.D. 
600n(Il. U ntransform ed strains were grown on  Y PD A , whereas selective growth for strains 
harbouring plasmids containing the URA3 gene was achieved by growth on YM G/Cas. Strain 
genotypes were determ ined by screening for growth on YM M  m edium  supplem ented with the 
relevant am ino acids and bases. All plates were stored at 4°C . Perm anent yeast stocks were 
m aintained at -70°C; 75% (v/v) yeast stationary culture grown in the relevant medium added 
to 25% (v/v) glycerol. In o rder to recover a higher percentage of viable yeast cells from the 
frozen stocks, 4ml o f stationary culture was sedim ented and resuspended in 0.75ml of YPDA 
or YM G/Cas and this was added to  the glycerol.
2.2.3.2 G eneration  o f D iploid Strains
Cells of opposite m ating type w ere mixed in 30/u.l o f dH 20  on the relevant medium 
and incubated at 23 °C  or 3 0 °C  for 2-3 days (during which tim e m ating took place). Cells from 
the m ixture were then spread onto  YM M  plates supplem ented with those am ino acids and bases 
which allowed growth of the diploid strain  only. If required, single colonies were isolated by 
streaking the cells.
2.2.3.3 Sporulation and Spore Recovery
D iploid cells were mixed in 30/xl of dH 20  on sporulation plates and incubated at 23 °C  
or 30°C  for 3-7 days. They were then suspended in 90/xl o f Spore buffer (1.2M sorbitol, lOmM 
EDTA, lOOmM citric acid) until the solution was slightly turbid, and 10/xl of /?-G lucuronidase
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(Boehringer M annheim ) was added to digest the asci walls. T he suspension was gently mixed 
and left a t room  tem perature^ for 30-45 m inutes. A n aliquot of this m ixture was spread onto 
Y PD A  plates and the Singer m icro-m anipulator was used to isolate single asci and to dissect 
them  into individual spores. These plates w ere incubated at 23 °C  or 3 0 °C  until individual 
spores had germ inated and grown.
2 .23 .4  M ating-Type Analysis
The m ating-type of relevant strains was determ ined by mixing them  on Y PD A  with 
those of known mating-type. These were left to incubate at the relevant tem perature  for 2-3 
days, during which time m ating did or did no t occur. The cells were then replica-plated onto 
YM M  supiem ented with those am ino acids and bases which allowed growth of the diploid cells 
only, and incubated at the relevant tem peratu re  for 3-7 days.
2.2.3.5 C om plem entation Analysis
To determ ine w hether different ts m utants harboured rs m utations in the same 
com plem entation group, ts strains of opposite  m ating type were suspended in dH 20  and mixed 
on Y PD A  plates. They were left to incubate a t 23 °C  for 2-3 days, during which tim e mating 
took place. These were then replica-plated and incubated at 23°C  and 36°C  for 3-10 days. If 
the crosses generated diploids which failed to  grow at 36 °C, this indicated that the parent 
strains contained conditional lethal m utations in the sam e com plem entation group. The plates 
w ere incubated for at least 10 days to detect any possible growth at 36 °C.
2.2.3.6 Transform ation
The lithium  acetate m ethod of transform ation was used to introduce plasmid D N A  
into the appropriate yeast strains (Ito et al., 1983). A 1% (v/v) inoculum of a stationary culture
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"TE" buffer lOmM Tris.HCl pH8
Im M  EDTA
'T E 'q -i buffer lOmM Tris.HCl pH8 
O.lmM ED TA
5 X "P" buffer 1% (w/v) BSA
1% (w/v) Polyvinylpyrrolidone (PVP) 
1% (w/v) Ficoll 
250mM Tris.HCl pH7.5 
0.5% sodium pyrophosphate 
5% SDS




was added to  50ml Y PD A  and grown until an  O.D. 600nm of roughly 0.4 had been attained. 
The cells were harvested in 50ml falcon tubes (5 m inutes, IEC CEN TR A -4X  bench-top 
centrifuge, swing-out ro to r at 4,500rpm) and resuspended in 10ml sterile dH 20  or TE. The cells 
were re-sedim ented and resuspended in 5ml sterile dH 20  or TE. A fter this 208/u.l o f 2.5M 
lithium  acetate (final concentration roughly 0.1M) was added and the tubes were incubated at 
the relevant tem perature  w ith gentle mixing for 1 hour. A liquots o f these cells (200/u.l) were 
transferred to eppendorf tubes and incubated with 1-lQug of D N A  (in a volum e of 100/ul) at 
the appropria te  tem perature  for 30 m inutes (no shaking required). Following this incubation, 
0.7ml of 50% PEG-4,000 (final concentration  35% ) was added, mixed and the suspension left 
to incubate for a further hour. A fter heat-shocking for 5 m inutes at 42°C  the cells were 
harvested (17,500g, 5 m inutes), washed in dH 20 ,  re-sedim ented (17,500g, 5 m inutes) and finally 
resuspended in 100/xl dH 20 .  The cells were then spread on to  medium  selecting for cells that 
had retained the introduced D N A
2.23.1 U V  M utagenesis and Isolation of ts Colonies
DBY745 and DBY746 transform ed with pJBM -4 were grown to stationary phase in 
20ml YM G/Cas. The cells were harvested (4,500rpm, IEC C EN TRA -4X  bench-top centrifuge, 
swing out ro tor, 7 m inutes), washed in 20ml sterile dH 20 ,  sedim ented (as before), resuspended 
in 20ml sterile dH 20  and aliquoted into two sterile glass petri-dishes. All m anipulations from 
this point were carried out either in the dark or with the cells shielded from light. The cell 
suspension was exposed to U V  light (lids off; 10 ergs/mm2/sec. from a height o f 32cm) for the 
required tim e to induce 80% -90%  killing (see C hapter 5.1), then dispensed into universal bottles 
w rapped in tin-foil. The cells were sedim ented by centrifugation (4,500, IEC Centra-4X  
bench-top centrifuge, swing-out ro to r for 5 m inutes), resuspended in 20ml YM G/Cas and 
aliquoted (200/ul) into eppendorf tubes. The eppendorf tubes were placed into polystyrene trays 
which could be covered and taped onto  a ro tor. In this way the small aliquot volum e used could 
be kept in the dark and still allow constant mixing to produce better aeration. A fter 3-5 days
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incubation at 23 ° C each aliquot was diluted (usually 10-4), spread onto  YM G/Cas agar and 
incubated at 23 °C  for 3-5 days. The colonies which grew were replica-plated onto  YM G/Cas 
agar (incubated at 23°C  and YM G/Cas agar containing 0.001% Phloxine B (incubated at 
3 6 °C). Phloxine B is a non-specific red-coloured dye which is thought to bind to intra-cellular 
factors. The rationale for its use is that in rs m utants the cell wall usually becomes "leaky” 
relatively quickly (because the cells are  dying); thus Phloxine B penetrates these cells and as 
a consequence ts colonies exhibit a deep red colour. In contrast, wild-type colonies display a 
pink colour and against this background ts colonies are  easier to detect. Protracted  storage of 
cells on media containing this dye is not advisable as it results in cell death. This dye is used 
extensively w ith Schizosaccharomyces pom be  (Fantes, P., pers. comm.). In Saccharomyces 
cerevisiae the am ount of dye required for efficient detection o f ts m utants may be lower than 
indicated as even wild-type colonies appeared pink; however 0.001% Phloxine B produced an 
acceptable com parison. Those colonies which appeared ts in this assay were isolated and re­
screened for the ts phenotype on YM G/Cas agar. Colonies which still exhibited the Cphenotvpe 
were classed as rs m utants and assayed for poten tia l prp  defects as described in C hapter 4.
2.2.3.8 U V  M utagenesis: Survival Curve
A liquots of cells were removed at 30sec intervals during exposure to U V  light (see 
Section 2.23.1), diluted (if necessary), spread on the relevant medium and incubated in the dark 
for 3-5 days. The num ber of colonies présent at each tim e-point was counted and com pared to 
a sam ple (from the same culture) which had not been subjected to U V  light. In this way the 
percentage of cells which survived a specific exposure tim e was determ ined.
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2.2.4 G eneral Nucleic Acid M ethods
2.2..4.1 Storage
D ouble-stranded D N A  was stored  at 4 °C  in dH 20  or TE, single-stranded M13 D N A  
was stored  a t -20 °C  in TE0.1 and R N A  was stored  in RN ase-free dH 2Q at -70 °C.
2.2.4.2 Q uan tita tion  o f Nucleic Acid
The concentration of a nucleic acid solu tion was determ ined by obtaining the O.D. 
260nm reading (using a quartz cuvette in a LKB Biochrom  U ltraspec II spectrophotom eter), 
and estim ating the concentration based on the assum ption that a 5Qu,g/ml solution of 
double-stranded nucleic acid and 40/xg/ml solution of single-stranded nucleic acid has an O.D. 
260nm of 1. A lternatively the concentration o f double-stranded D N A  was estim ated by viewing 
the D N A  in an agarose gel stained with ethidium  brom ide and com paring it with a known 
standard.
2.2.4.3 Precipitation W ith E thanol
Nucleic acids were precipitated from  aqueous solutions by the addition of 0.1 volum e 
3M sodium  acetate pH5.5 and 2 or 2.5 volumes ethanol (previously incubated at -20°C for 
D N A  and R N A  samples respectively. The mixed samples were then placed on ice for roughly 
15 m inutes and sedim ented by centrifugation in a microfuge or Sorvall SS34 or HB4 ro to r (see 
Section 2.2.1.1). The samples were then washed by resuspension in an equal volum e of 66% 
(v/v) ethanol (if RNA, D E P-treated  dH 20  was added to the ethanol; see Section 2.2.8.1), 
re-sedim ented, dried in a vacuum desiccator and finally dissolved in the appropria te  solvent.
2.2.4.4 Extraction W ith Phenol/Chloroform
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’TE" buffer lOmM Tris.HCl pH 8
Im M  ED TA
T E "0 1  buffer lOmM Tris.HCl pH8 
O.lmM ED TA
5 X "P” buffer 1% (w/v) BSA
1% (w/v) Polyvinylpyrrolidone (PVP) 
1% (w/v) Ficoll 
250mM Tris.HCl pH7.5 
0.5% sodium pyrophosphate 
5% SDS




Nucleic acid solutions were deprotein ised by vortexing vigorously and sequentially in 
an equal volum e of phenol, phenol/chloroform  and chloroform . The aqueous phase was 
separated and recovered each tim e by centrifugation in a microfuge (12,000g5 5 m inutes) or a 
Sorvall SS34 ro to r (4,100g, 7 m inutes), usually a t 4 °C  A fter the final step the nucleic acid was 
precipitated as indicated in Section 2.Z.4.3, which essentially removed any residual phenol. The 
phenol used in these procedures was equilibrated w ith either TE  (double-stranded DN A ), TE0.1 
(single-stranded M13 DN A ) o r D EP treated  ddH 20  (RNA). The chloroform  used was 24 parts 
chloroform  to 1 part iso-amylalcohol.
2.2.5 D N A  M ethods
2.2.5.1 Plasmid D N A  Isolation: Small Scale P reparations
The procedure used was based on the m ethod of Birnboim  and Doly (1979). LB-amp 
(5mls) was inoculated with a single transform ed bacterial colony and incubated (with vigorous 
shaking) overnight a t 37 °C  An aliquot o f the culture (1.5mls) was harvested (17,500g, 5 
m inutes) and the rest stored at 4°C . The cell pellet was suspended in 100/j,1 of ice-cold solution 
I (50mM glucose, lOmM EDTA, 25mM Tris.H Cl pH8; containing freshly added lysozyme to a 
final concentration of 4mg/ml) and incubated on ice for 30 minutes. A fter this 7200/̂ .1 of freshly 
prepared solution II (0.2N N aO H , 1% SDS) was added and the contents o f the tubes gently 
mixed by inversion. Following a 5 m inute incubation on ice, 150/xl of ice-cold solution III 
(potassium  acetate pH4.8; see below) was added, mixed and re-incubated on ice for 60 minutes. 
The cell debris was sedim ented by centrifugation (17,500g, 5 m inutes, 4 °C  , the supernate 
recovered, phenol/chloroform  extracted (see Section 2.2.4.4) and ethanol precipitated (see 
Section 2.2.4.3). The precipitated nucleic acid was resuspended in 25/xl of the  desired buffer 
containing 20/xg/ml RN ase and 3-5/xl aliquots were used in restriction enzyme analysis.
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added to 60ml of 5M potassium  acetate. The resulting solu tion  was 5M  w ith respect to acetate 
and 3M with respect to potassium.
2.25.2 Plasmid D N A  Isolation: M idi-Preparations
In essence this m ethod was a scaled-up version of that outlined in Section 2.2.5.I. It 
should be noted that only the final ethanol precipitation  step in this protocol involves a 66% 
(v/v) e thanol wash. A  single transform ed bacterial colony was inoculated into 40mls LB-amp and 
incubated (with vigorous shaking) overnight at 37 °C  The culture was harvested (IEC 
C EN TRA -4X  bench-top centrifuge, 4,500rpm for 7 m inutes), suspended in 2mls solution I (see 
Section 2.2.5.1) and placed on ice for 30 m inutes. A fter briefly vortexing, 4mls of solution II 
(see Section 2.2.5.1) was added, followed by fu rther vigorous vortexing and incubation on ice 
(5 m inutes). A fter this, 3ml o f 3M sodium  acetate pH5.5 was added and the were samples mixed 
by inversion and then incubated on ice for 30-60 m inutes. Cell debris was sedim ented by 
centrifugation (16,000g, 10-20 m inutes, 4 °C  and 16mls of cold ethanol was added to the 
recovered supernate, followed by incubation on ice for 15 m inutes. The nucleic acid was 
sedim ented by centrifugation (16,000g, 20 m inutes, 4 °C  , dried (vacuum desiccator), suspended 
in 2mls of buffer B (0.1M sodium acetate pH5.5, Im M  EDTA, 0.1%  SDS, 40mM Tris.HCl 
pH8), phenol/chloroform  extracted and ethanol precipitated. The nucleic acid was once again 
sedim ented by centrifugation (16,000g, 15 m inutes) and dried and re-dissolved in 400/jlI T E  to 
which 20/u.ul 4M NaCl and 1ml ethanol was added. A fter e thanol precipitation, centrifugation 
(17,500g, 20 m inutes, 4 °C  and drying, the pellet was re-dissolved in 200ul TE  (containing 
0. l̂ Lg/jU-l RN ase) and incubated at 37°C  for 1 hour. Digestion of the R N A  was followed by 
addition of 20/u.l 4M NaCl, phenol/chloroform  extraction and ethanol precipitation. A fter 
sedim enting the nucleic acid (17,500g, 15 m inutes), the pellet was finally washed with 66% (v/v) 
ethanol, dried (vacuum desiccator) and dissolved in 200^1 TE. This procedure normally yielded 
20-4Qu.g of plasmid D N A
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2.2.5.3 Plasmid D N A  Isolation: Large Scale P reparation
Cells from a 500ml culture (1%  (v/v) inoculum ) incubated overnight, were harvested 
by centrifugation (4,100g, 15 m inutes) and suspended in 6ml of sucrose mix (25% sucrose, 
50mM  Tris.HCl pH8, 40mM ED TA ) containing 0.66mg/ml RNase. Lysozyme (lOmgs; dissolved 
in 1ml sucrose mix) and 1ml 0.5M E D T A  were added and the cells gently mixed for 20 m inutes 
a t room  tem perature. Following this 14ml o f triton  mix (0.1% triton  X-100, 62.5mM EDTA, 
50mM  Tris.HCl pH8) was added and the samples incubated on ice with occasional mixing for 
20 m inutes. Cell debris was sedim ented by centrifugation (39,000g, 45 m inutes) allowing recovery 
of the supernate. Closed circular plasm id D N A  was purified by CsCl equilibrium -gradient 
centrifugation as described by M aniatis et al., 1982. CsCl (0.95g) and 0.1ml ethidium  brom ide 
(5mg/ml) were added to  every 1ml o f the supernate  and the solution transferred into a 1.6 x 
7.6cm polyallom er tube (Beckman). This was then sealed and centrifuged in a Sorvall O TD  50B 
ultracentrifuge using a Sorvall Ti50 ro to r a t 45,000rpm for at least 2 days at roughly 20°C  . 
The tube was then viewed using U V  light and the plasmid D N A  (lower of the two bands) 
recovered through the side using a 2 1 #  gauge hypoderm ic needle and syringe. E thidium  brom ide 
was removed by several extractions of the D N A  with butanol (equilibrated with CsCl saturated 
TE). The CsCl was rem oved by dialysis against four changes o f 2 litres of TE  at 4 °C  The 
isolated D N A -containing solution was then ethanol precipitated, washed with 66% (v/v) ethanol 
and dried (vacuum desiccator). Following this, it was dissolved in TE, phenol/chloroform  
extracted and ethanol precipitated again. A fter washing the pelleted nucleic acid with 66% (v/v) 
ethanol, it was dried (vacuumm desiccator) and re-dissolved in 50Qul-lml of TE.
2.2.5.4 P reparation  of M13 R F  DNA
A single M13 plaque plus 5/al of a stationary E.coli culture (JM101 or NM522) was 
inoculated into 2.5ml of LB and incubated at 3 7 °C  with vigorous shaking for 6 hours. This 
culture was then stored overnight at 4 °C  The next day it was added to a freshly grown JM101
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or NM522 culture (500ml; O.D. 550nm of 0.3-0.4) and incubated at 37 C for 4-4.5 hours. A fter 
this the protocol for isolation of plasmid D N A  (see Section 2.2.5.3) was followed.
2.2.5.5 R estriction Enzyme Digestion of D N A
D N A  was incubated w ith the relevant enzyme(s) in a buffer and at a tem peratu re  indicated 
by the m anufacturer. The duration  of incubation, the num ber of enzyme units used and the total 
reaction volum e was dependent on the am ount o f D N A  to be restricted. N orm ally 1-5/r.g of 
D N A  was restricted with 2-10 units o f restriction enzyme, in 20/ccl for 1-4 hours. To avoid 
glycerol inhibition of enzyme digestion, the enzyme volum e used never exceeded 0.1 volum e of 
the to tal reaction.
2.2.5.6 Agarose G el E lectrophoresis
In order to separate restricted D N A  fragments and visualise nucleic acids, D N A  and 
R N A  were electrophoresed through horizontal agarose gels containing and subm erged in TA E 
buffer (40mM Tris-acetate, 2mM ED TA ). L inear D N A  molecules in the size ranges of 7 to 
0.5kb and 4 to  0.2kb were separated using 0.8%  and 1.5% (w/v) gels respectively. Submerged 
20 x 20cm gels were used for all large scale isolations of restricted D N A  fragments whereas 
the 14 x 11cm gel kits supplied by B R L were utilised for all o ther purposes. To prevent 
light-induced nicking o f D N A  the large gels were electrophoresed at 10 V/cm in the absence 
of ethidium  brom ide and subsequently stained (0.1/u.g/ml ethidium  brom ide) in the dark. The 
small gels were electrophoresed at 5-10 V/cm in the presence of 0.1/xg/ml ethidium  brom ide. 
The nucleic acid contained in these gels was observed using a short wave length U V  
transillum inator and photographed as indicated in Section 2.2.I.5.
2.2.5.7 Isolation of R estricted D N A  Fragm ents
Relevant restriction fragments w ere cut from agarose gels as thin slices and when
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necessary covered with Saran wrap and tin-foil and stored at 4 °C  The D N A  was extracted from 
these slices in two ways;
(a) the Schleicher and Schuell B iotrap:-
The procedure followed is detailed in the booklet accompanying this apparatus. Briefly, the gel 
slice was placed in an electrophoresis cham ber containing TA E and a current (10 V/cm) was 
passed through it. In the  course of electrophoresis (2-4 hours) the D N A  migrated into a 
collecting cham ber and was there retained by binding specifically to a m em brane. Reversal o f 
the current for 30secs eluted the D N A  from the re ten tion  m em brane (w ithout the exit o f the 
D N A  from the collecting cham ber) and allowed its isolation in a relatively small volum e 
(200-500/xl). The D N A  was then phenol/chloroform  extracted and ethanol precipitated (see 
Sections 2.2.4.4 and 2.2.4.3). This procedure consistently produced >75%  recovery o f the 
isolated fragm ent (as judged by its intensity in ethidium  stained gels).
(b) BIO101 Inc. G eneclean Kit
This com m ercial m ethod is based on the the ground glass procedure as described by Vogelstein 
and G illespie (1979). The agarose gel m atrix of the gel slice is dissolved by incubation in 
sodium iodide. D N A  fragments in the resulting solution are free to adhere to an added silica 
matrix and can be sedim ented out o f the solu tion  by centrifugation (17000g, 30secs). The D N A  
fragments can then be eluted from the silica into dH 20  by heating the m ixture at 45-55 °C  for 
a few m inutes. A  m ore detailed protocol is specified in the BIO101 Inc. G eneclean kit. This 
procedure is very fast (taking only 20 m inutes) and produces efficient fragm ent recovery.
2.2.5.8 Ligation of D N A
Linearised vector (final concentration of 10ng/pl) and insert D N A  bearing 
com plem entary cohesive ends were mixed in a m olar ratio  of 1 : 1 in a to tal reaction volume 
of 20/xl containing 4/xl 5 X ligation buffer (330mM Tris.HCl pH7.5, 50mM  MgCl2, 250mM
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NaCl, 50mM DTT, 3mM rA TP) and 5 units o f T4 D N A  ligase. This was incubated at 15 °C  for 
12-16 hours and if necessary the ligase was then inactivated by incubation at 6 5 °C  for 10-15 
minutes.
2.2.5.9 Filling in D N A  Term ini W ith Recessed 3 ' Ends
Term ini with recessed 3 ' ends w ere rendered "blunt" ended by incubation of 1-5/xg of 
D N A  in a 20/ul reaction volum e containing 2/xl X 10 nick translation buffer (0.5M Tris.HCl. 
pH7.5, 0.1M M gCl2, Im M  DTT, 500/ig/ml BSA), O.lmM dNTPs and 2. units o f the Klenow 
fragm ent of the E.coli D N A  polym erase I at room  tem perature  for 30 m inutes. The reaction was 
stopped by incubation at 65 °C  for 10-15 minutes.
2.2.5.10 Labelling DNA by the R andom  Prim ing M ethod
The random  prim ing procedure was essentially perform ed as described by Feinberg and 
Vogelstein (1984). The reaction was assem bled by the addition of each constituent in the stated 
order; dH 20  to a final volum e of 50/xl, 10/xl 5 X OLB (1M H EPES pH6.6, 25mM MgCl2, 
50mM 2-m ercaptoethanol, 250mM Tris.HCl. pH8, O.lmM dNTPs, 7.5mg/ml random  
hexadeoxyribonucleotides), BSA to a final concentration of 0.4mg/ml, 50-100ng of heat-denatured 
D N A  (see below), 3/ul o f [a-32P]-dCTP (3000 Ci/mmol, 10/uCi//ul); and 4 units o f the Klenow 
fragm ent of the D N A  polymerase I o f E.coli. The reaction was incubated at room  tem perature 
for 5-6 hours and then the D N A  was heat-denatured and added to the hybridisation reaction.
G el-purified D N A  fragments and radioactively labelled probe were heat-denatured by 
incubation at 100°C  in a boiling w ater-bath for 5 minutes.
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2.2.5.11 M easurem ent of Radioactivity Incorporated  into DNA
The efficiency of incorporation of radiolabel into D N A  (see Section 2.2.5.10) was 
estim ated by m easuring acid-precipitable counts. A  1/xl aliquot o f the labelling reaction (see 
Section 2.2.5.10) was added to an eppendorf tube containing 45/^1 TE  and 1/u.l 2mg/ml tRNA, 
after which 13/u.l o f 50%  (w/v) TCA  was added and the m ixture incubated on ice for 20-30 
minutes. Precipitated D N A  was collected by vacuum  filtration onto  a W hatm an G F/C glass fibre 
disc (pre-wet w ith 10% (w/v) TCA), then washed with 10ml ice-cold 10% (w/v) TCA  and 10ml 
ice-cold ethanol. As a control 1/ul o f the  labelling reaction was spotted  directly onto  a G F/C  
disc. The am ount o f radioactivity present on each disc was determ ined by scintillation-counting 
and the percentage incorporation of radioactive label was estim ated by com paring the two 
samples.
2.2.5.12 5 ' End Labelling o f Oligodeoxynucleotides
Oligodeoxynucleotides were radioactively labelled by the addition of a radioactive 
phosphate moiety to the 5 ' hydroxyl group present on these molecules. The reaction was carried 
ou t in a 30jul total volum e containing 20/xCi [y-32P]rA TP (3000 Ci/mmol, 10/uCi/ul), 0.1M 
Tris.HCl. pH8, 5mM  DTT, lOmM MgCl2, 20pmol oligonucleotide and 5 units T4 polynucleotide 
kinase. The reaction was incubated at 37 °C  for 1 hour. The oligodeoxynucleotide is in excess 
in this reaction as the am ount of [y-32P]rA TP used is roughly 6.7pmol (10/uCi =  3.35pmol 
rATP). The integrity of the labelled oligodeoxynucleotide was determ ined by PAGE. Briefly, 0.25 
volum e of sequencing load buffer (see Section 2.2.13) was added to  an aliquot of the labelled 
oligodeoxynucleotide, boiled for 5 m inutes, loaded onto  a 20% polyacrylamide gel (see below) 
and eletcrophoresed at 33W for 2-4 hours. O ne of the glass plates was removed and the gel and 
o ther glass plate covered in Saran wrap and exposed to X-ray film (20% gels cannot be 
transferred to filter paper). In this way the size of the oligodeoxynucleotide and its ability to 
be phosphorylated were determ ined.
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The polyacrylamide gel was m ade thus: a 40%  stock acrylamide solu tion was made by 
adding lOg of bis-acrylamide to 190g of acrylamide. U rea (240g) was then added (final 
concentration 7.8M) and the consituents w ere dissolved in dH 20  to a final volum e of 500ml. 
This solution was deionised (see Section 2.2.1.3) and stored at 4°C . For a 20% gel, 25ml of this 
solution was added to 20ml of an 8M urea solution  and 5ml of 10 X TBE. Polym erisation and 
pouring of such gels is detailed in Section 2.2.7.4.
2.2.5.13 Purification o f Labelled O ligodeoxynucleotide
W hen necessary the labelled oligodeoxynucleotide was separated from the 
unincorporated  label by gel exclusion chrom atography. The labelled oligodeoxynucleotide (see 
Section 2.2.5.12) was brought to a volum e o f 1ml with elu tion buffer (lOmM sodium phosphate 
pH7), added to a pre-equilibrated Sephadex G-25 N A P-10 colum n (Pharm acia ¡column volume 
l.Smls) and eluted in the second 1.5mls aliquot washed through the column.
2.2.5.14 Colony Blotting arid H ybridisation
Colony screening was essentially perform ed as described by M aniatis et al., (1982). 
Transform ed E.coli colonies were arranged in a grid pattern  on LB-amp plates and incubated 
overnight at 37 °C. A  Hybond-N nylon m em brane (Am ersham ) was placed on top  of the 
colonies, m arked to indicate its o rien tation  and left at room  tem perature for 2-3 minutes. The 
m em brane was then removed and placed (colony side up) onto  filter paper soaked in Southern 
D enaturation  buffer (1.5M NaCl, 0.5M N aO H ) for three m inutes, then onto  fresh paper soaked 
in the same buffer for a further three m inutes. Excess buffer was then removed by blotting on 
filter paper and the m em brane soaked twice (colony side up; 5 m inute durations) on filter paper 
saturated  with N eutralisation buffer (0.5M Tris.HCl pH7.5, 1.5M NaCl). The m em brane was
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then briefly washed in 2 X SSC, dried at room  tem perature, covered in Saran wrap and the 
D N A  cross-linked to the m em brane by placing it (colony side down.) on a short-wave length U V  
transillum inator for 5 m inutes. The m em brane was then placed in a plastic bag containing
10-25mls of pre-hybridisation solution (2 X SSC, 10 X D enhard t’s solution, O.lmg/ml 
heat-denatured salm on sperm  D N A ), sealed, placed in ano ther bag (which was then sealed) and 
incubated at 65 °C  (with constant agitation) for 3-4 hours. The pre-hybridisation solution was 
then poured off and replaced with 10-25mls hybridisation solution (pre-hybridisation solution 
minus the salm on sperm  DNA). H eat-denatured  probe was added to the bag, which was 
re-sealed and incubated at 65 °C  with constant agitation for 12-16 hours. A fter this the 
m em brane was recovered from the bag and non-specifically bound probe removed by two 
sequential 10 m inute washes in 500ml o f 2 X  SSC at room  tem perature, followed by two 30 
m inute washes in 500ml of 2 X SSC, 0.5%  SDS at 65°C . If required a further two 10 m inute 
washes in 500ml of 0.1% SSC at room  tem peratu re  were perform ed. Excess SSC was removed 
by blotting the m em brane on filter paper, which was then covered with Saran wrap and exposed 
to X-ray film (see Section 2.2.1.4).
2.2.5.15 M13 Plaque H ybridisation Using D N A  Fragm ent Probes
The procedure followed was as described by M ason and Williams, (1985). BBL top agar 
plates harbouring M13 plaques were incubated at 4 °C  for >30 m inutes which helped to reduce 
the am ount of top agar tha t stuck to the  m em brane when the plaques were lifted. A  
nitrocellulose m em brane was placed over the plaques, m arked and orientated, and left at room  
tem perature for 5 m inutes to allow adsorption of the plaques to the m em brane. The m em brane 
was then baked at 80°C  in a vacuum oven for 2-4 hours. No denaturation/neutralisation  steps 
were required as M13 contains a single-stranded D N A  genome; presum ably the baking step 
denatures the protein coat to enable the probe to hybridise to the D N A  A fter baking, the 
m em brane was briefly soaked in SET buffer (3M NaCl, 0.4M Tris.HCl pH7.5, 20mM ED TA ) 
making sure both  sides of the m em brane were wet, blotted on to  filter paper to remove excess
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buffer and sealed in a plastic bag containing lOmls o f pre-hybridisation solution (5ml 
form am ide, 2ml 5 X "P" buffer, 2.5ml 4M  NaCl, 0.1ml 10mg/ml heat-denatured  salm on sperm 
DNA). 'Phis was incubated with constant agitation at 4 2 °C  for 2-3 hours. The pre-hybridisation 
solution was replaced with 10ml hybridisation solution (pre-hybridisation solution minus the 
salm on sperm ), the probe (heat-denatured) was added and the bag was incubated at 42 °C  with 
constant agitation for 12-16 hours. It should be noted that during the pre- and hybridisation 
steps the m em brane was sealed w ithin two bags (m inim um ). Rem oval of non-specifically bound 
probe and exposure to X-ray film was as described in Section 2.2.5.14.
2.2.5.16 Plaque H ybridisation Using Oligodeoxynucleotide Probes
The procedure followed was a m odification o f that described by Z oller and Smith, 1984 
and relates only to site-directed m utagenesis. M13 plaques adsorbed to a Hybond-N nylon 
m em brane (see Section 2.2.5.15) were then placed (plaque side up) on filter paper soaked in 
Southern D énaturation  buffer (1.5M NaCl, 0.5M N aO H ) for 7 minutes. This process was 
repeated on freshly soaked paper. Excess buffer was removed by blotting on filter paper, then 
the m em brane was twice soaked on filter paper saturated  with N eutralisation buffer (0.5M 
Tris.HCl pH7.5, 1.5M NaCl: plaque side up; 3 m inute durations) and briefly washed in 2 X 
SSC. A fter drying (37°C, 15 m inutes), the  m em brane was covered with Saran wrap and the 
D N A  cross-linked to it by exposure to short wave-length U V  light (plaque side down) for 5 
minutes. The m em brane was then placed in a plastic tray containing 25ml of pre-hybridisation 
solution (6 X SSC, 5 X D enhard t’s solution, 0.5% SDS, 0.1mg/ml heat-denatured salm on sperm  
DNA) and incubated with constant agitation at 65 °C  for at least 1 hour. If m ore than one 
m em brane was pre-hybridised then 25ml of pre-hybridisation solution/m em brane was added. The 
m em brane was then placed in a plastic bag and 10ml of hybridisation solution added (6 X SSC, 
5 X D enhard t’s solution). The labelled oligodeoxynucleotide was separated from unincorporated 
label as described in Section 2.2.5.13 and added straight to the bag containing the m em brane 
and hybridisation solution. If m ore than one m em brane was used they were placed in separate
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bags and each received 20pm ol of radioactively labelled probe (see Section 2.2.5.12) and 10ml 
hybridisation solution. The m em brane was then incubated with constant agitation at room  
tem perature  for at least 4 hours. A fter recovery the m em brane was washed three times in 100ml 
of 6 X SSC at room  tem perature  (3 m inute durations) and excess buffer was removed by 
blotting on filter paper. The m em brane was then covered with Saran wrap and exposed to X-ray 
film. Subsequent washes were carried ou t in 6 X  SSC at increasing tem perature (see C hapter 
3.3.3.1).
It should be noted that after pre-hybridisation the m em brane was never allowed to dry 
completely; blotting on filter paper was used only as a means to rem ove excess liquid. Dry 
m em branes bind oligonucleotides irreversibly and make it im possible to differentially remove 
mism atched hybrids by increasing the wash tem perature  (see C hapter 3.3.3.1 for a fuller 
description o f the wash process).
2.2.6 Site-D irected M utagenesis
2.2.6.1 5 ' Phosphorylation of M utagenic Oligodeoxynucleotides
Stock solutions of phosphorylated oligodeoxynucleotides were prepared in the following 
m anner: in a reaction volum e of 30| a1, 200pmol of oligonucleotide was added to 0.1M Tris.HCl 
pH8, lOmM MgCl^, 5mM DTT, Im M  rA TP and 5 units T4 polynucleotide kinase. This was 
incubated at 37 °C  for 1 hour. If required the T4 polynucleotide kinase was inactivated by 
incubation at 65 °C  for 10-15 minutes.
2.2.6.2 A nnealing Conditions
Efficient recovery of M13 phage harbouring site-directed m utations relies on the 
specific hybridisation of the m utagenic oligodeoxynucleotide to the D N A  sequence to be 
m utated. The num ber of m utants recovered will increase with the num ber of oligonucleotide
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molecules that hybridise to the sequence of interest. However if you present a vast excess of 
oligodeoxynucleotide m olecules (relative to  the sequence of interest), non-specific hybridisation 
will reduce the efficiency o f m utant recovery. A nother reason for such a reduction  is non­
specific hybridisation which is a result o f com plem entarity betw een the m utagenic 
oligodeoxynucleotide and o ther sequences distinct from the one to  be m utated. It is therefore 
im portant to obtain hybridisation tha t is specific to  the sequence to be m utated. Non-specific 
hybridisation can be reduced not only by m aking sure that the oligodeoxynucleotide : tem plate 
ratio is correct but also by increasing the stringency of the annealing reaction (i.e. by increasing 
the tem perature); as the  annealing tem peratu re  increases only those molecules with the highest 
degree of com plem entarity will rem ain hybridised to their com plem entary sequence. Therefore 
both the ratio o f oligodeoxynucleotide molecules to tem plate molecules and the tem perature 
at which they are annealed are controllable variables that can alter the pattern  of hybridisation.
By using the m utagenic oligodeoxynucleotides as sequencing prim ers it was possible 
to determ ine w hether they annealed at the correct place. Correctly annealed 
oligodeoxynucleotides produced the same sequencing pattern  as the M13 universal prim er: of 
course the M13 prim er initiated polym erisation 5 ' to the oligodeoxynucleotide and therefore 
contained sequences not detected by the oligodeoxynucleotide. Oligodeoxynucleotides annealing 
at various regions of the tem plate D N A  produced sm eared sequencing patterns, representing 
the m ultiple sizes of term inated fragments. In this way the tem perature of annealing and the 
oligodeoxynucleotide : tem plate ratio were assayed.
Norm al sequencing reactions were perform ed (see Section 2.2.7.3) except that only the 
(A) sequencing solution was used (i.e. A -tracking), therefore ingredients in the m ethod were 
reduced accordingly. Tem plate D N A  (0.125pmol; 1/xl of norm al tem plate preparation) was mixed 
with 10 X, 25 X and 50 X excess of oligodeoxynucleotide (l/ig  solution containing 1.25, 3.125 
and 6.25pmol respectively and the o ther ingredients of the annealing mix (AM) see Section
2.2.12) and each was incubated at 55 °C, 70 °C  and 85 °C  for 15 minutes. The samples were then 
briefly spun (5 secs; 17,500g) and incubated at room  tem perature for 15 minutes. A fter this 
annealing reaction, 2.9q.1 of a solution containing 0.4/xl of [0r-35S]-dATP (400 Ci/mmol) and
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2.5/xl of sequencing solution (A) was added and mixed. To this 0.5 units o f D N A  polymerase 
I o f E.coli was added (Klenow fragm en t in a volum e o f 2/3 made by making a 1 in 4 dilution 
of stock Klenow in cold lOmM Tris.HCl pH7.5). The samples were mixed and incubated at 
room  tem perature  for 20 m inutes, followed by the addition of 2.5/3 of Chase Mix (Im M  dNTPs) 
and further incubation a t room  tem perature  for 20 m inutes. Sequencing load buffer (4/3) was 
then added and the samples were incubated at 100°C  for 5 m inutes and fractionated by 
polyacrylamide gel electrophoresis (see Section 2.2.7.4). Fixing of the gel and its subsequent 
exposure to X-ray film were as described in Section 2.2.1 A.
2.2.63 Site-D irected M utagenesis: A nnealing and Extension
In a to tal volum e of 10/3, tem plate D N A  (0.5pmol; 4/3 of norm al tem plate 
preparation) was incubated with the m utagenic oligodeoxynucleotide and 1/3 10 X buffer A  
(0.2M Tris.HCl pH7.5, 0.1M MgCl2, 0.5M NaCl, lOmM DTT) at a tem perature and ratio 
previously determ ined (see Section 2.2.6.2). A nnealing continued at the relevant tem perature 
for 15 m inutes and the samples were then centrifuged (17,500g, lOsecs), mixed and incubated 
at room  tem perature  for another 15 m inutes. A fter this annealing reaction, 10/3 of E/L mix (1/3 
10 X buffer B {0.2M Tris.HCl pH7.5, 0.1M MgCl2, 0.1M DTT}, 0.8mM dNTPs, Im M  rATP, 
3 units T4 ligase, 2 units Klenow) was added and the mixture was incubated at 16°C  for 12-16 
hours.
2.2.6.4 T ransform ation
A n aliquot o f the E/L mix (5/3) was transform ed into the E.coli strain BM H71-18 
m utL  (see Section 2.1.3) and 2-5/3 aliquots of the transform ation mix were plated along with 
200/3 of JM101 plating cells, 30/3 X-gal (20mg/ml), 20/3 IPTG (24mg/ml) and 3.5ml BBL top 
agar (see Section 2.2.23). The BMH71-18 m utL  strain is defective in mismatch repair 
(K ram er et al., 1984) and therefore the D N A  heteroduplex introduced i.e. the duplex
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containing the mismatch, is unlikely to be corrected to the wild-type sequence. Thus the 
specific m utation  is "fixed" in BM H71-18 m ittL . However, it is possible that spontaneous 
m utations may arise in o ther regions and rem ain uncorrected. M13 plaques arise by continuous 
infection of E.coli cells and if an excess o f JM101 plating cells (repair proficient) is added it is 
likely that they will be infected in preference to the  relatively small am ount of BM H71-18 
m utL  cells present. As a consequence, spontaneous m utations that arise later in the plaque 
life-cycle (i.e after the first round of infection) probably do so in JM101 and therefore 
have m ore chance of being corrected to wild-type. It was hoped that the frequency of 
spontaneous m utations would be m inim ised using this approach.
D etection  of plaques containing m utant phage is described in C hapter 3.3.3.1 and. 
Section 2.2.5.16.
2.2.7 D N A  Sequencing
2.2.7.1 Preparation  of Tem plate D N A
A 1% (v/v) inoculum  from a fresh stationary culture of E.coli strains JM101 or 
NM522 was grown at 37°C in  LB until an O D  550nm of 0.2-0.3 was obtained. The cells were 
then aliquoted (1.5ml) into 5ml glass bottles, to which single M13 plaques were added. The 
bottles Were incubated at 37 °C  with vigorous shaking for 4-4.5 hours and then the cultures 
transferred to eppendorf tubes. The cells were sedim ented by centrifugation (2 x 17,500g, 5 
m inutes each tim e), the supernate was recovered and 150/xl o f a solution containing 2.5M 
NaCl and 20% (w/v) polyethylene glycol M W  6,000 (PE G ) was added. A fter a 20 m inute 
incubation at room  tem perature, precipitated phage were pelleted by centrifugation (17,500g, 
10 m inutes) and the supernate discarded. The tubes were then briefly respun and all traces of 
liquid removed. The phage pellet was then dissolved in lOQul TE0.1, to which 50/i\ of phenol 
(equilibrated with TE0.1) was added. The samples were then vortexed (10 secs), 
incubated at room  tem perature (5 m inutes), re-vortexed (10 secs) and then the phases
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separated by centrifugation (17,500g, 5 m inutes). A fter recovery of the aqueous phase, 
lOjtxl o f 3M sodium  acetate and 250/ul of e thanol were added, followed by incubation at 
-20°C  for 15 minutes. P recipitated D N A  was then pelleted by centrifugation (17,500g, 30 
m inutes), washed with 66%  (v/v) ethanol, re-spun (17,500g, 10 m inutes), dried (vacuum 
desiccator) and resuspended in 25/ul TE0.1. The concentration of D N A  in the final sam ple 
was roughly 0.125pmol//ul,
22.1 .2  Sequencing Solutions
A nnealing Mix (AM ) was m ade by mixing heptadecam er sequencing prim er 
(2.5/ig, New England Biolabs), 10 X  TM  buffer (0.1M Tris.H Cl pH7.5, 0.1M M gCl2) and 
dH sO in the ratio  2:3:7.
Sequencing solutions G, C and T  were made by mixing dG, dC and dT (see Table 2.5) 
with an equal volum e of ddG, ddC and ddT (see Table 2.6) respectively. Sequencing solution 
A  was made by mixing two volumes of dA  with one volum e of ddA. All solutions were stored 
at -70 C.
2 2 .1 3  Sequencing Reactions
Tem plate D N A  (0.5pmol =  4/ul o f tem plate preparation) was mixed with 4/u.l of 
AM  in an eppendorf tube, the cap was tightly sealed and then the tube placed in a water 
bath pre-heated to 70°C. The samples were allowed to cool in the w ater-bath for 15 
minutes, centrifuged briefly (17,500g, 10 secs), mixed again and incubated at room
tem perature for a further 15 minutes. D uring these incubation periods, 2.5/xl of the sequencing 
solutions A, G, C and T  were aliquoted into 4 eppendorf tubes m arked "A", "G", "C" and 
" T  respectively. A fter incubation, 1.5/ul o f [Of-35S]-dATP (400Ci/mmol) and 2 units of E.coli 
D N A  polymerase I (Klenow fragm ent) were mixed with the annealed tem plate. A liquots 
of this mixture (2.5/a.l) were then allocated to  the 4 separate tubes containing either A, G, C
78
or T  sequencing solutions, mixed and incubated at room  tem perature  for 20 m inutes. 
Chase Mix (Im M  dNTPs) was then added (2.5jul), followed by incubation at room  tem perature 
for 20 m inutes. A fter this, 4/a.l of sequencing load buffer (3ml deionised form am ide, 300/u.l of 
3%  (w/v) xylene cyanol, 300ul of 3%  (w/v) brom ophenol blue, 12^1 of 0.5M ED TA ) was added 
and the samples were incubated at 100 °C  for 5 m inutes and then fractionated on a 6%  
polyacrylamide gel (see Section 2.2.7.4
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TA BLE 2.5 C O M PO SITIO N  O F  dNTP SO LU TIO N S
(all volum es in /xl)
dN TP Solutions
Stock Solutions dA dG dC dT
lOmM dG TP 10 10 10
lOmM dCTP 10 10 10




TE0.1 570 570 570 570
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TA BLE 2.6 C O M PO SITIO N  O F  ddNTP SO LU TIO N S
(ail volum es in ¡jl1)
ddNTP Solutions




lOmM ddTTP - - - 10
TE0.1 198 198 194 190
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2.2.7.4 Sequencing Gels
Sequencing gels (6%  (w/v) polyacrylamide, 7.8M urea) were prepared as follows: 
3g bis-acrylamide, 57g acrylamide and 470g o f urea were dissolved in 600ml of dH 20 .  The 
volum e was brought to 900ml with dH 20 ,  deionised and stored at 4 ° C  W hen required 45ml 
o f this stock plus 5ml 10 X TBE (0.89M Tris.borate, 0.89M boric acid, 20mM
ED TA ) was added to a 50ml conical flask, to which 400/ul 10% (w/v) APS and 40^1 TEM ED  
w ere then added. The contents w ere mixed and poured betw een two (42 X  23cm) glass plates 
which were separated  along their 42cm edges by 0.5 X 42cm strips of 0.4mm m odellers 
plasticard, and sealed along th ree edges w ith PVC tape. A  shark-too th  comb was inserted 
(straight side placed into the polyacrylamide) in between the two plates and polym erisation 
of the gel was allowed to proceed overnight. A fter this the sealing tape along the bottom  
of the plates and the shark-too th  comb were rem oved and the comb replaced with its 
teeth touching the the top of the gel. This was then assem bled into a vertical 
electrophoresis apparatus containing 1 X TBE. Prior to loading the gel was electrophoresed 
at 33 W atts for 30 m inutes to warm it to its operational tem perature. The
sample-wells were flushed ou t with TB E using a pasteur p ipette  and heat-denatured  samples 
were then loaded using a draw n-out capillary tube. E lectrophoresis was perform ed at 33 watts 
(27-48 V/cm) for 2-4 hours. Following this the gel plates were separated and the plate 
attached to the gel was placed horizontally into two litres of "fix" (10% (v/v) acetic acid, 10% 
(v/v) m ethanol) for 15 minutes. A fter rem oving the plate from the "fix" the gel was transferred 
to blotting paper, covered with Saran wrap and dried in a vacuum gel drier at 80 °C  for 2 
hours. The Saran wrap was then removed and the gel exposed to X-ray film (see Section 
2.2.1.4).
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2.2.8 R N A  M ethods
2.2.8.1 Protection  of R N A  from RNases
To preclude R N ase contam ination  o f R N A  samples, all glassware was baked at 
250°C  overnight and all m aterials were m anipulated with gloved hands. Solutions used in 
experim ents involving R N A  were rendered RN ase-free by mixing with 0.1%  (v/v)
diethylpyrocarbonate (D EP) for 1-2 hours at room  tem perature, followed by autoclaving 
(see Section 2.2.1.2). Solutions containing E D T A  or Tris were not treated  with D EP 
because it reacts chemically with the am ino groups o f these com pounds. Instead, these 
solutions were prepared in R N ase-free glassware w ith D EP treated, autoclaved dH 20 .
2.2.8.2 Extraction of R N A  from Yeast
Y east cultures (200ml) were grown at 23 °C  until the O D  600nm was between 0.2 
and 0.7. A t this stage (if required) the culture was split and one half heat-shocked thus: an 
equal volum e of pre-incubated m edium  (49°C ) was added (final tem perature, 3 6 °C) and 
incubated with vigorous shaking at 3 6 °C  for the required time. The o th e r half o f the culture 
was treated in a sim ilar m anner except that the medium  was pre-incubated at 23 °C  (final 
tem perature, 23 °C).
All of the following steps were perform ed at 4 °C  or on ice. The cultures were 
then added to an equal volum e of ice/water, sedim ented by centrifugation (4,100g, 7 
m inutes), resuspended in 9ml ice-cold TN E  (50mM Tris.H Cl pH7.5, lOOmM NaCl, 5mM 
ED TA ) and transferred to a 15ml Corex tube. The cells were sedim ented by centrifugation 
(4,100g, 7 m inutes), resuspended in 1ml TN E and 30mg of acid-washed glass beads were 
added (see below). The cells were fractured by vortexing vigorously for 1 m inute; 4ml TNE, 
0.2ml 20% SDS and 4ml phenol (equilibrated with D EP treated dH 20 )  were added rapidly, 
followed by further vortexing for 1.5 m inutes. A fter centrifugation (4,100g, 5 m inutes)
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the aqueous phase was recovered, extracted with phenol/chloroform  (1:1) and 
chloroform , and then the R N A  was precip itated  with ethanol (see Section 2.2.4.3). The 
integrity of the R N A  was determ ined by electrophoresing sam ples in agarose 
gels containing ethidium  brom ide (see Section 2.2.5.6).
Acid-washed glass beads were prepared  by heating lOg glass beads (approxim ately 
100 mesh, BD H ) with 100m) 1M HC1 to 100 °C  for 20 m inutes. The beads were then washed 
sequentially w ith 1 litre  dH 20 ,  300ml of both  1M and 0.1M Tris.H Cl pH7.5 and then 2 litres 
of dH 20 .  They were then dried at 65 °C  (overnight) and baked at 250 °C  (overnight).
2.2.8.3 R N A  A garose G el E lectrophoresis
H orizontal slab gel electrophoresis o f R N A  was perform ed in subm erged 
20 X 20cm, 1.5% (w/v) agarose gels containing lOmM sodium  phosphate pH 7 (the
electrophoresis buffer was also lOmM sodium  phosphate). Before loading, the R N A  samples 
and the D N A  m arkers were denatured by incubation at 50 °C  for 1 hour with 4 volumes 
glyoxal mix (25% (v/v) glyoxal, 62.5% (v/v) deionised form am ide, 12.5mM sodium  phosphate 
pH7). This procedure is a m odification o f that described by M cM aster and Carm ichael, (1977). 
Samples were electrophoresed at lOV/cm.
2.2.8.4 N orthern  B lotting and Hybridisation
Following electrophoretic separation of RN A , the gel was assembled into a 
capillary blot. A  glass p late was placed over a reservoir containing approxim ately 1 litre of 1 
X SSC. Two sheets of W hatm an 3MM filter paper (pre-soaked in 1 X SSC) were then placed 
on top of the plate with their ends subm erged in the reservoir. The gel was placed on top 
of the paper (sample-wells facing down) and PV C tape placed all around to inhibit buffer 
transfer that would bypass the gel and m em brane. O n top of this were placed sequentially; 
pre-soaked m em brane (G enescreen, see below), 3 double sheets o f W hatm an 3MM paper
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(soaked in 1 X SSC), 3 double sheets o f W hatm an 3M M  paper (dry), a 10-15cm stack of 
paper towels and a 500g weight. D uring blo t assembly, care was taken to  rem ove air bubbles 
present between the w etted paper, the gel and m em brane, and the m em brane/paper 
interfaces. A fter leaving for roughly 16 hours the m em brane was removed, washed briefly 
in 1 X SSC, dried at 37 °C  for 15 m inutes and then baked at 80 °C  for 2 hours in a vacuum, 
oven. Pre-hybridisation and hybridisation were perform ed as described in Section 2.2.5.15, 
except tha t a Hybaid hybridisation oven, employing bottles instead of plastic bags, was 
used (see Hybaid hybridisation oven m anual for instructions). W ashes and exposure to X-ray 
film were as described in Section 2.2.5.14.
Prior to being placed in the  blot, G enescreen m em branes were soaked in dH 2C> (2 
m inutes) and 1 X  SSC (30 m inutes).
2.2.8.5 Prim er Extension
The procedure followed was a m odification of that described by Domdey et al.,
(1984) and also detailed in the G IB C O  BRL catalogue. End-labelling ( 5 ')  o f the 
oligodeoxynucleotide was as described in Section 2.2.5.12, except that 7pmol of 
oligodeoxynucleotide was used. The radioactively labelled oligodeoxynucleotide 
(0.667pmol) was annealed to 30-100/ag to tal RN A , at a tem perature  equal to Tm - 5 °C  for 
15-30 m inutes. This reaction was carried ou t in a 30/xl to tal volum e containing 50mM 
Tris.HCl pH7.5, 75mM KC1 and 3mM M gCl2. The samples were then incubated on ice for 
5 m inutes after which 19/al o f a so lu tion containing 50mM  Tris.HCl pH7.5, 75mM KC1, 
5mM M gCl2, 25mM DTT, 1.25mM dNTPs and 0.25mg/ml BSA (high grade) was added. 
Following this, 100-200 units (1-2/u.l) o f M oloney M urine Leukem ia Virus Reverse 
T ranscriptase were added and the samples were mixed and incubated at 37 °C  for 1 hour. To 
each sam ple 12.5/ul of 0.5M N aO H  were then added, followed by incubation at 100 °C  for 3 
m inutes and im m ediate incubation on ice (5 m inutes). A fter briefly centrifuging the 
samples (17,500g, 10 secs), 12.5/xl of 0.5M HC1 and 12.5/xl of Tris.HCl pH7.5 were added and
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the D N A  was ethanol precipitated (see Section 2.2.4.3). A fter centrifugation (17,500g, 
30 m inutes) the D N A  pellet was washed w ith 66%  (v/v) ethanol, dried (vacuum desiccator) 
and suspended in 3/a1 dH ?0/3/xl 2 X urea load buffer (10M urea, 1 X  TBE, 0.2%  xylene 
cyanol and brom ophenol blue). P rio r to  electrophoresis through a 6%  (w/v) polyacrylamide 
gel (see Section 2.2.7.4), the sam ples were incubated at 100 °C  for 4 m inutes and 
briefly centrifuged (17,500g, lOsecs). Following electrophoresis the glass plates were 
removed, the gel was transferred to filter paper (no gel "fixing" is required for nucleic acid 
labelled with [32P]; see Section 2.2.7.4), covered with Saran wrap and exposed to X-ray film 
(see Section 2.2.1.4).
2.2.9 ff-Galactosidase Assays
2.2.9.1 Induction of the G AL1  P rom oter
Y east strains harbouring plasmids with the G AL1  prom oter, were grown in 
Y M R/G/Cas at 23 °C  until an O D  600nm of 0.1-0.4 was attained. The cultures were then split 
and one half heat-shocked thus: an equal volum e of pre-incubated YM R/Cas (49°C) was 
added (final tem perature 36 °C) and the cu lture  incubated with vigorous shaking at 36 °C. The 
o ther half o f the culture was treated in a sim ilar m anner except that the YM R/Cas was 
pre-incubated at 23 °C  (final tem perature  23 °C). If induction of the prom oter was to occur 
at 30°C  then the cultures were grown at 30°C  and the YM R/Cas pre-incubated at 30°C . 
Fifteen m inutes after the addition of YM R/Cas, galactose (to a final concentration of 2% ) 
was added and this point was regarded as time-zero. T hereafter aliquots of the 
cultures were removed at hourly intervals and assayed for /3-galactosidase activity.
induction of cultures from which R N A  was extracted was perform ed thus: yeast cells 
were grown in 6 x 100ml of Y M R/G /Cas at 2 3 °C  to an OD 600nm of 0.1-0.4. The cultures 
were not split, and 6 x 100ml of pre-incubated YM R/Cas (49 °C  or 23 °C) was added. The
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cultures were then incubated at the relevant tem pera tu re  (36 °C  or 23 °C). Fifteen m inutes 
after the addition of YM R/Cas, galactose (2%  final concentration; tim e-point zero) was added 
and therafter one of the  6 cultures was rem oved at hourly intervals. The protocol for R N A  
preparation was followed prior to the cells being resuspended in 1ml T N E  (see Section 2.2.8.2); 
a t this stage they w ere resuspended in 2ml ethanol (-20 °C ) and stored at -20 °C  overnight (for 
at least 4 days R N A  did not degrade under these conditions). The next day the cells 
were sedim ented by centrifugation (4,100g, 5 m inutes, 4 °C ), washed with 2ml ice-cold 
TNE, re-sedim ented (4,100g, 5 m inutes, 4 °C ) and resuspended in lm l TN E. The norm al 
protocol for R N A  preparation  was then  continued.
2 .2 .9 2  /?-Galactosidase Assays
The procedure used was a m odification of that described by Legrain and Rosbash, 
1989. C ulture samples (0.25-2ml) to be assayed (see Section 2.2.9.1) were immediately 
sedim ented by centrifugation (4,100g, 7 m inutes), suspended in 200pl 50mM potassium 
phosphate pH 7 and incubated at 2 8 °C  for 5 m inutes. A fter . this 200/xl Z  buffer 
(60mM di-sodium  hydrogen orthophosphate , 40mM sodium  di-hydrogen orthophosphate , lOmM 
KC1, ImM  magnesium sulphate, 50mM /?-m ercaptoethanol, 0.025% (w/v) SDS: pH7) and 2.5^1 
chloroform  were added, then the samples were vortexed (lOsecs) and re-incubated at 2 8 °C  
for 5 m inutes. Following this, 200/jlI of 4mg/ml O N PG  (dissolved in 0.1M potassium  phosphate 
pH7) was added and the samples were mixed and then incubated at 2 8 °C. The reaction 
was stopped by addition of 250jul o f 1M sodium  carbonate, the cell debris sedim ented by 
centrifugation (4,100g, 7 m inutes) and the /?-galactosidase activity quantified by measuring 
the O D  420nm of the supernate. The units of /3-galactosidase activity were calculated using
the form ula given by M iller, 1972 (see below).
U nits =  OD 420nm x 1000
t x OD 600nm x v
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O D  420nm reflects the  hydrolysis of O N PG  by /3-galactosidase
O D  600nm reflects the cell density of the culture just before the  assay
t is the tim e o f the reaction in m inutes
v is the volum e of culture used in the assay, in ml
This form ula is no t a m easure of the  specific activity of /J-galactosidase, which is 
normally defined as /3-galactosidase units/m g o f protein. However, these units are proportional 
to the increase in o-n itrophenol per m inute per yeast cell and, as it is assum ed that the 
protein  content of an exponentially growing cu lture  is p roportional to its cell density (i.e. 
its cell num ber), it is adequate for the purposes for which it was used. It should be noted 
that the spectrophotom eter used was calibrated for both  O D  420nm and 600nm, and all 
m easurem ents were made w ithin the linear range of the m achine’s capabilities.
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CHAPTER 3
CONSTRUCTION OF PLASMIDS USED IN MUTANT SCREENING AND ANALYSIS OF
PRE-mRNA COMMITMENT TO SPLICING
3.1 INTRODUCTION
This chapter describes the  rationale  for, and construction of, those plasmids required 
in setting up a prp  m utant screen. In the  course o f these constructions it becam e apparen t that 
two further plasmid constructs would allow a study o f the com m itm ent of pre-m R N A  to 
splicing. This chapter describes the construction of all the plasmids, as they were derived from 
the same "parent" clone and m ade by a sim ilar m ethod. However the rationale for the 
construction o f those plasmids involved in the study of pre-m R N A  com m itm ent is dealt with 
in the Appendix.
3.2 RATIONALE FOR CONSTRUCTION OF THE SCREENING PLASMIDS
The prim ary objective of this thesis was to develop a novel m ethod of screening fs 
yeast m utants for defects in pre-m R N A  processing at the restrictive tem perature. The vast 
majority of prp m utants accum ulate pre-m R N A  with concom itant loss of m R N A  and this is 
probably indicative of defects in splicing (for further discussion see Section 1.9). Large scale 
screening o f is m utants for such defects has relied exclusively on N orthern  blot analysis to 
detect pre-m R N A  accum ulation. Prp m utants are thought to account for approxim ately 5% 
of all rs m utants (Hartw ell et al., 1970; Vijayraghavan et al., 1989) If a bank of prp  m utants is 
desired, then such an approach is both tim e consum ing and labour intensive, requiring RN A  
preparations from many ts m utants grown at the  non-perm issive and permissive tem peratures 
(Vijayraghavan et al., 1989; W arner, 1989; Hartw ell, 1967). A t the time o f establishing a new 
m ethod the only prp  m utants in existence were prp2-prp ll, which all accum ulate p re -m R N A  It
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was considered that any screen should rely on this com m on property, and if it was to  be fast 
it had to obviate the need for extensive N orthern  blot analysis. The basic aim  was therefore to 
m easure pre-m R N A  accum ulation by ano ther procedure. The approach taken was to try to 
detect any increase in pre-m R N A  indirectly, by m easurem ent of an assayable protein  which was 
encoded by the pre-m R N A  only. Exploiting the appropriate  protein , a sim ple p late assay was 
to be developed to allow large scale screening. This screen therefore relied on th ree im portant 
criteria :
(a) that only the pre-m R N A  could encode the assayable protein
(b) that pre-m R N A  would be transported  from the nucleus to the cytoplasm w here it would 
be translated
(c) tha t pre-m R N A  accum ulation would result in an increase in the assayable protein 
activity.
The rest of this chapter is concerned w ith the creation of suitable gene constructs that 
e ither accom odate criterion (a) above o r are variations on a sim ilar them e. The rem aining 
points are addressed in C hapter 4 and the Appendix.
T here is no known yeast gene in which only the pre-m R N A  can encode an assayable 
protein  (criterion (a) above), therefore direct assay of m utagenised cells was not possible. In 
order to use the approach outlined above a novel gene was required i.e. one that had an O R F  
through its pre-m R N A  that encodes assayable activity, yet when spliced had none (i.e. the 
screening gene). Such a gene was to be in troduced into yeast using a suitable plasmid vector 
(i.e. the screening construct).
This novel gene was created by fusing part of a yeast in tron-containing gene to the 5 ' 
end of the lacZ  gene of E.coli, thereby encoding a potential /?-galactosidase fusion protein 
which initiates translation  in exon 1 of the yeast gene. As it was a norm al yeast gene it had 
the advantage that it possessed all the essential sequence elem ents required for accurate splicing, 
and the use of lacZ  allowed both the biochem ical analysis of cell extracts and the developm ent 
of a colourm etric colony assay. The M A T a l  gene of yeast was utilised because it contained a
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small IVS-1 (54 nucleotides) rendering it easily am enable to  genetic m anipulation  (cloning and 
SDM ), and its transcrip t was inefficiently spliced and therefore m ore sensitive to subtle changes 
in splicing efficiency. In this way it was hoped to isolate splicing m utants with relatively weak 
phenotypes. M ore im portantly it had an O R F  occurring through E1-IVS1-E2 allowing expression 
o f a fusion p ro tein  when fused in-fram e with lacZ. However to satisfy the criterion  required of 
the screening gene (criterion (a) above), the  in tron had first to be modified such that, following 
splicing, the now intron-less M A T a l  region was out-of-fram e with the lacZ  O R F  and could not 
encode an active 0-galaci.osidase fusion protein.
To confirm  that unspliced transcrip t encoded the active fusion protein  a stop codon 
was engineered into the O R F  o f the intron. The resulting construct was called pJBM-4/s. A 
/J-galactosidase fusion protein  should not be encoded by the M A T a l -lacZ  gene fusion present 
in pJBM-4/s.
In screening ts m utants for a prp  phenotype it was envisaged that /?-galactosidase 
activity would be m easured from yeast strains incubated at the permissive and non-perm issive 
tem peratures. Thus it had to be ascertained that any increase in /?-galactosidase activity exhibited 
at the non-perm issive tem perature  was no t due to, for example, increased rates o f transcription 
and/or translation, but due solely to changes in the post-transcriptional processing of 
pre-m RN A . Consequently an intron-less M A T a l-la cZ  gene fusion was engineered which encoded 
an active jS-galactosidase fusion protein. This gene fusion could be used to  m onitor the effects 
o f tem perature on aspects of gene expression o ther than pre-m R N A  processing.
O ther yeast genes were considered, notably actin, but construction of an O R F  in 
alternative introns would have been very tim e-consum ing because m ost introns are long (300-500 
nucleotides) and contain m ultiple stop codons in all reading frames.
33  PLASMID CONSTRUCTION
A  D N A  fragm ent encoding exon 1, in tron 1 and part o f exon 2 of the M A T a l gene 
was sub-cloned into M 13mp9, and SDM  was perform ed on the cloned fragm ent to produce
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various changes. All M 13mp9 clones were plaque-purified th ree times (and sequenced each 
tim e), p rior to isolation of the altered M A T a l  sequence as a B am YW E coK l fragment. In a 
tri-m olecular reaction the M A T a l  and lacZ  genes were ligated into a yeast shu ttle  vector, 
pBM272ARI, perm itting generation of a fusion transcript initiating in, and under the control 
of, the G AL1  prom oter. All plasm id and R F  phage constructs were verified by restriction 
enzyme analysis, confirm ing the presence o f individual fragm ents in single copy (results not 
presented; see Fig. 3.4).
3.3.1 Paren t Plasmids
3.3.1.1 pBEMAT'/S
Plasmid pBEM AT/S (a gift from H. D om dey ; see Fig. 3.1) is the plasmid pSP64 
carrying a modified M A T a l  gene in which in tron  1 has been m utated by a three base-pair 
substitu tion to produce a Sm a l  site just upstream  of the TA CTA A C box. This also fortuitously 
changes the only stop codon in the frame that allows translational read-through of the intron. 
W hen com pared to the norm al sequence these m utations do not appear to  affect the splicing 
efficiency of the in tron  either in vitro or in vivo (K ohrer and Domdey, 1988). Thus for our 
purposes this gene is wild-type and will be referred to as such in this thesis.
3.3.1.2 pD EV 19
This plasmid was a gift from M. W inther, W ellcome Biotechnology Ltd. London, and 
contains the coding sequence of the lacZ  gene of E.coli. A t the translation initiation site o f this 
lacZ  sequence is an E coR I restriction site which is cleaved after the G nucleotide of the 
initiating ATG. The en tire lacZ  coding sequence (minus the initiating A TG ) can be isolated as 
a 3.128kb £coR I/5a/I fragment. A t least the first 27 am ino acids of /J-galactosidase are not
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required for activity (Casadaban et al., 1980) therefore the absence of the initiating A TG  does 
not affect activity as long as translation is initiated  at an upstream , in-fram e A T G  (i.e. in a 
gene fusion construct) o r a t an A TG  w ithin the first 27 am ino acids of lacZ  (of which there 
are normally none; see above paper). Thus in any fusion construct utilising this E coR l/Sa ll lacZ  
fragment, translation  should in itiate at the first A T G  5 ' to lacZ  (if such an A TG  is supplied 
as part o f the am ino term inal gene fusion). W ithin the space o f eight codons downstream  of 
the lacZ  £ co R I site described above there are  S m a l  and B a m H l sites presen t (in that order). 
Thus Sm al/Sa ll and B am H l/Sa ll lacZ  restriction  fragments will also encode active 
/?-galactosidase proteins, subject to the sam e constraints as outlined for the £coRI/8V?/I fragment 
described above. However, the lacZ  gene on pD EV 19 has an 8bp Clal linker inserted a t the 
Sm al site which unfortuneately introduces an in-fram e A TG  between the E co R l and B am H l 
sites. Thus E coR l/Sa ll lacZ  fragments from pD EV 19 contain an in-fram e A TG  at the 5 ' o f the 
lacZ  coding sequence, whereas B am H l/Sa ll fragm ents do not. The presence of this in-frame 
A TG  raises the possibility of in ternal initiation o f translation, producing /?-galactosidase activity 
from both a pre-m R N A  and m R N A  transcrip t (i.e. activity which is independent of w hether 
sequences upstream , in this case the M A T a l  in tron, are spliced o r unspliced). Such activity 
would not satisfy criterion (a); see Section 3.2 above. pD EV 19 was used as a source of the  lacZ  
gene.
3.3.1.3 pSFlacZ
The B am H l/Sall lacZ  fragm ent o f pD EV 19 was cloned into pSPT19, thus elim inating 
the internal A TG  present between the £ co R I and B a m H l sites of the lacZ  coding sequence 
(see above) and facilitating the removal o f lacZ  as an E coR l/Sa ll fragment. In this construct the 
E coR l/B am H l region o f the lacZ  fragm ent isolated is entirely pSPT19 poly-linker sequence, 
but still produces an in-fram e fusion w ithout elim inating /?-galactosidase activity. This plasmid 
was used as a source of the lacZ  gene, and to distinguish this from that of pD EV 19 it is term ed
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the p lacZ  fragm ent. The difference betw een lacZ  (pD EV 19) and p lacZ  was verified by restriction 
enzyme analysis (results no t presented). The final yeast expression plasmids containing the placZ  
fragm ent are pJBM-5, pJBM -4, pJBM -4/s and pJB M -l^T he plasmids pJBM-1 and 2 contain the 
lacZ  fragm ent from pDEV19.
33.1.4 pBM272ARI
This plasmid is a derivative of pBM125 (a gift from R. Davies). It is a centrom eric 
yeast shu ttle  vector containing the G AL1/10  p rom oter region. Cloning into the B a m H l  site of 
this vector puts the coding sequence of in terest under the contro l o f the G AL1  p rom oter with 
translation initiating at the first A TG  o f the  insert (in ou r case this was presen t on the M A T a l  
com ponent of the fusion with lacZ). The £ co R I site was removed to allow the creation o f the 
final constructs (see Fig. 3.1).
3.3.2 Steps in plasmid construction
All D N A  fragments used in cloning experim ents were individually gel purified (see 
C hapter 2.2.5.7), including the plasmid vector pBM272ARI when cut with B am H l/Sall.
The source of the M A T a l  gene for all constructs was pBEM AT/S. The 256bp 
H indlll/Sspl fragment containing E l ,  IVS-1 and 54 nucleotides of E2 was sub-cloned into 
M13mp9 cut with H ind lll and Sm a l  (see Fig. 3.1). This fragment should have disrupted the 
reading frame of the lacZ  gene present in M 13mp9; however the colourm etric test used to 
determ ine if the insertion was successful produced only blue plaques, indicating failure to 
sub-clone. The presence of this fragm ent in M 13mp9 was established by plaque hybridisation 
using the 256bp fragm ent as a probe (results not presented). The reason for the failure of this 
fragment to elim inate /?-galactosidase activity in M13mp9 is unknown. Internal initiation of 
translation using the M A T a l  A TG  (present in E l) , or its use on a transcript originating within
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FIGURE 3.1: CONSTRUCTION OF PLASMIDS pJBM-1 TO pJBM-5
A  flow diagram is depicted showing the plasmids and gene fragm ents used 
generation of the final yeast centromeric. expression vectors (see Section 3.3).
Bam W l =  B, £ co R I =  E, H ind lll = H , Sail = S, Sspl =  Ssp
F i g u r e  3.1
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the H indlll/Ssp l cloned fragm ent are distinct possibilities, because the M A T a l A TG  is in frame 
with the M 13mp9 lacZ  gene. W hen cloned in the opposite orien tation  into M 13m pl8, this 
fragm ent did elim inate /3-galactosidase activity. Sequencing in both orien tations showed M A T a l 
to be correct (see Fig. 3.4, only one o rien ta tion  presented) i.e. it was wild-type. A  series of 
m utations was then introduced into this gene (see section 3.3.3). Each m utated sequence was 
then isolated as a 232bp BamYiHEco'Rl fragm ent from its respective M13 R F  clone and ligated 
along with the EcoTH/Sall lacZ  or p lacZ  coding sequence into pBM272ARI cut with B am H l and 
Sail. Thus a series of constructs was created that contain wild-type and m utant versions o f a 
region of the M A T a l gene fused to the lacZ  gene and expressed under the control of the G AL1  
prom oter. The m utations varied the /Tgalactosidase activity profile o f the final plasmids as 
discussed in the next section.
3.3.3 Site-D irected M utagenesis
3.3.3.1 M utant Phage D etection
A  simplified screen for detection  of plaques containing m utant phage was utilised. 
Phage containing specifically induced m utations are normally detected by hybridisation of the 
radioactively labelled m utating oligodeoxynucleotide to plaques immobilised on nylon 
membranes. By gradually increasing the wash tem perature  m utant plaques may be differentiated 
from those containing the parental phage (see below). This process involves autoradiography 
o f the m em branes after each washing stage and depending on the strength of the radioactive 
signal can extend over a period of days (due to prolonged exposure intervals).
Single-stranded M13 DNA, and M13 D N A  containing the sequence to be m utated, 
were spotted on to  a control m em brane (CM) at various dilutions. The m utating 
oligodeoxynucleotide was then hybridised to it in the same m anner as the plaques to  be 
screened (m utant screen) i.e. at room  tem perature  for 3-4 hours (see C hapter 2.2.5.16). Both 
types of m em brane (the CM and the m utan t screen m em brane, MSM) were then washed in 6
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X SSC at room  tem perature (3 x 100ml, 3 m inutes each). The m utant screen m em branes were 
then wrapped in cling film and stored at -20°C. The contro l m em brane was washed at increasing 
tem peratures (2 x 100ml, 3 m inutes each: usually only two points) until about 5 °C  below its 
calculated Tm, after which 2-3 °C  increm ents were used. A fter each wash it was m onitered with 
a Geiger counter for loss o f radioactivity. In all cases the m utating oligodeoxynucleotide came 
off the unm utated  M13 insert close to  its calculated Tm. The tem peratu re  at which the 
oligodeoxynucleotide came off was determ ined and the m utan t screen m em branes w ere then 
washed at 2 -4°C  above this. Only those plaques which harboured phage containing the m utated 
sequence that was com plem entary to the m utating oligodeoxynucleotide rem ained radioactively 
labelled. The m em branes w ere then exposed to X-ray film overnight (see chapter 2.2.1.4 and 
Fig. 3.2). By avoiding autoradiographic exposure after each wash, the tim e spent determ ining 
the tem perature  at. which the m utan t screen m em branes had to be washed was reduced 
considerably.
33.3.2 Changes to M A T a l R egion in M 13mp9
Tables 3.1 and 3.2 contain details o f the oligodeoxynucleotides and tem plates used in 
the derivation of the various m utant constructs. Figures 3.3A and 3.4 show the M A T a l-1 
translational reading frame and the m utated M A T a l sequences respectively. Figure 3.3B shows 
the expected /J-galactosidase activity profile o f the m utant constructs, indicates the positions Of 
internal A TG  codons that could theoretically allow internal initiation o f translation (see below) 
and shows the position of the engineered stop codons in the introns. It was assumed that the 
changes in the am ino acid sequence caused by e ither splicing and/or specific m utations would 
have no effect on the /J-galactosidase activity of the fusion. Each m utation  introduced into the 
cloned M A T a l fragm ent (see below) is described individually. The starting point is the wild-type 
M A T a l region cloned into M13mp9. The B am H l/E co R l fragment isolated from this source is 
referred to as M A T al-1  and the final construct is pJBM-1. This construct encodes 
jS-galactosidase fusions from both pre-m R N A  and m RN A  transcripts.
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M utation 1:
M utation 2 :
M utation  3 :
a single base-pair substitu tion  (A > T ) was introduced to create the  stop 
codon T A G  in the in tron  reading frame. The pre-m R N A  from the final 
construct should no t produce an active fusion due to  the block in 
translation. As a result o f splicing this stop codon was not present on 
the mRNA. and therefore it could encode /?-galactosidase activity. The 
result, was creation  o f the Bam W H EcoKl M A T a l- lls  fragm ent and 
the final construct, pJB M -l/s, was used in studies o f pre-m RN A  
com m itm ent to splicing (see Appendix).
the M A T al-1  region had to be altered because the in tron contained 
a m ultiple o f 3 nucleotides such that E l  and E2 were in the same 
translational phase in bo th  spliced and unspliced RN A . It was 
required that splicing produce a m R N A  which could not encode an 
active /?-galactosidase fusion. To fulfill this specification the in tron 
was lengthened by 5 bases into E2 which was reciprocally reduced. This 
m eant that the in tron  was no longer a m ultiple of three and its 
removal caused a change in the reading fram e with the result that an 
active fusion was encoded by unspliced but not spliced transcript. 
This increase in the length of the in tron was achieved by m utating the 
3 ' splice site and producing a new one 5 bases into E2. In the 
resulting M A T a l-2  fragm ent the length and reading frame of the 
pre-m R N A  rem ained unaltered.
an A T G > A T C  m utation was introduced just downsteam  of the new 
3 ' splice site. This removed an in-fram e in itiation codon which could 
possibly lead to in ternal in itiation of translation on the m R N A  (and 
pre-m R N A ) encoded by the M A T a l-2  m utan t fragm ent causing 
background problem s in the screening procedure. The M A T al-3  
m utant fragm ent was thus produced.
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M utation 4:
M utation  5:
M utation 6:
M utation 7 :
an ou t of fram e A TG , prior to  the intron, which in M A T a l-2  and 
M A T a l-3  spliced back into fram e with no intervening stop codons, 
was m utated  to  A CG . This resulted in the M A T a l-4  screening 
fragm ent which was used in the final screening construct pJBM-4.
using SSM 139-4 (see Table 3.2) as the tem plate, a stop codon 
was in troduced in to  the in tron  (see M A T a l- l/s  above). The resulting 
sequence, M A T a l-4  Is, should not produce /?-galactosidase from any 
encoded R N A  in the final construct.
the in tron  of the  M A T a l-4  fragm ent was com pletely removed to give 
M ATal-4hdnt. This was equivalent to an accurately spliced transcript 
from construct pJBM -4 which should not encode /?-galactosidase 
activity.
using SSM139-4Aint as the tem plate, the first nucleotide of the new 
E2 was deleted to generate an intronless in-fram e Bam H U EcoRl 
M A T a l-5  fragm ent. A n in-fram e /?-galactosidase fusion would be 
produced from the final construct pJBM-5. This is the control for 
changes in the rates of R N A  processing events o ther than those 
associated with p re -m R N A
The /?-galactosidase activity profile expected of the final constructs, pJBM-1 to pJBM-5, 
is given in Fig. 3.3B and in the summary below.
3.4 SU M M A R Y
To develop a new screening procedure for the identification of conditional lethal prp 
m utants a series of novel gene fusions had to be created. P art o f the M A T a l gene o f yeast was 
fused to the IcicZ gene of E.coli and placed into a yeast expression vector under the control of 
the G AL1  prom oter. By introducing specific m utations into the M A T a l  region, fusion proteins 
were produced which were expected to encode 3-galactosidase activity as indicated below. Three 
of these final constructs (m arked * below) were used to ascertain w hether the proposed screen 
was viable (see C hapter 4), whilst all 6 were used in the study of pre-m R N A  com m itm ent to 
splicing (see Appendix).
/?-galactosidase activity
plasmid pre-m R N A m RN A
pJBM -5 (*) +
pJBM-1 + +
pJB M -l/s +
pJBM -2 +
pJBM -4 (*) +
pJBM-4/s (*)
/s plasmids have a stop codon in the in tron reading frame.
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F IG U R E  3.2: W ASH IN G  P R O C E D U R E  F O R  T H E  D E T E C T IO N  O F  M U T A N T  P H A G E
The hybridisation and washing procedures utilised in this sim plified screening 
procedure, designed to detect m utant phage-containing plaques, are described in Section 3.3.3.1. 
Single-stranded M13 D N A  (insert-containing and insert-m inus) was spotted  on to  the control 
m em brane (CM) at varying concentrations (0.25/xg, 0.5/xg, lp,g, 2/xg). The D N A  was fixed to the 
mem brane and a radioactively labelled oligodeoxynucleotide was hybridised to the  D N A  The 
CM was then washed in 6 X SSC at increasing tem peratures and m onitored after each wash by 
a Geiger counter. A fter washing m ost of the radioactivity off the CM, the tem perature  was 
raised 2-3 °C  and the m utant screen m em brane (MSM) was washed at this increased 
tem perature. This figure shows the results norm ally obtained using this procedure.
The M13 insert-containing D N A  is identified on the CM by its ability to hybridise with 
the oligodeoxynucleotide (see the heavy radioactive signal on the CM and note  that this 
decreases along the m em brane due to the reduced D N A  concentrations of the individual spots). 
The insert-m inus M13 D N A  (spotted just below the insert-containing M13 DN A ) fails to 
hybridise with the oligodeoxynucleotide and therefore produces only a non-specific background 
signal.
FIG. 3.2
•  • CM
FIGURE 3.3A: THE MATal SEQUENCE AND READING FRAME
The M A T a l (M A T a l-1 ; see Fig. 3.1) sequence from pBEM ATa/S is given from the 
B am H l (B) to Sspl (Ssp) sites. N ucleotides which have been m utated in the generation of the 
o ther M A T al sequences (see Table 3.2) are indicated in bold-type. Exon and in tron sequences 
are in capital and lower case letters respectively. The translational reading fram e o f the 
M A T al-lacZ  fusion is indicated by the vertical lines above and between the nucleotides. The 
internal A TG  codons (see Section 3.3.3.2) are underlined, though the A TG  codon present at 
the 5 ' end of the lacZ  E coR l/Sa ll fragment (see Sections 3.3.1.2 and 3.3.1.3) is not shown.
FIGURE 3.3B: THE EXPECTED (J-GALACTOSIDASE ENCODING ABILITIES OF 
THE MATal-lacZ TRANSCRIPTS OF pJBM-1 TO pJBM-5
The transcripts encoded by the various M A T a l -lacZ  fusions are shown. The positions 
of the internal A U G  codons and stop codons (within the in tron) are indicated by an A  and S 
respectively. The expected /?-galactosidase coding ability of the transcripts are represented by 
the (+ )  and (-) signs, where (+ )  indicates that they have the potential to encode an active ¡3- 
galactosidase fusion protein.
FIGURE 3.3C: A FLOW DIAGRAM OF THE STEPS INVOLVED AND THE
OLIGONUCLEOTIDES USED IN THE CREATION OF THE VARIOUS 
MATal CONSTRUCTS OBTAINED BY SDM
Figure 3.3C shows the derivation of the various M A T al sequences created by successive 
mutageneses of various single-stranded (SS) M13 tem plates which contain the specified M A T al 
sequences. The starting tem plate is SSJM139-1, which gives rise to the M A Tal-1  fragment (see 
Table 3.2). All m utant templates were derived from the SS M13 tem plate immediately prior to 
them in this flow diagram (as indicated by the arrows). Below each SS tem plate e.g. SSJM139- 
1, is the name of the final yeast centrom eric expression vector in which the specific M A T al 
sequences reside e.g. pJBM-1, and also w hether these plasmids contain the lacZ  or placZ  
fragments (see Section 3.3.1.4, p94).
The changes to the 3’ splice site made by M utation 2 are also indicated. Intron and 
exon sequences are in lower and upper case letters respectively.
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F IG U R E  33C
Oligo. 562A, M utation 1
SSJM 139-1 >  SSJM139-l/s
(pJBM-1; lacZ) Introduction of a stop codon (pJBM-l/spfacZ)
into the intron reading frame.
-  Oligo. 023A, M utation 2. Moves the 3’ splice site present in SSJM139-1 
downstream by 5 bases (see Figs. 3.3A and 3.4)
Y
SSJM139-2 5’- cttcagTTTATA -3’ SSJM139-1
(pJBM-2; lacZ) 5’- cttcct t t ta gA -3’ SSJM139-2
— Oligo. 353A, M utation 3. An A TG  >  ATC change just downstream of the 




-  Oligo. 414A, M utation 4. An ATG >  ACG change 34 bases upstream of 
the 5’ splice site present in SSJM 139-3 which changes a possible internal 
initiation codon.
^ /  Oligo. 562A, M utation 5
SSJM139-4 ------------------------------------------------------------------------- >  SSJM139-4/s
(pJBM-4; placZ) Introduction of a stop codon (pJBM-4/s^/acZ)
into the intron reading frame.
— Oligo. 563A, M utation 6. Deletion of the intron present in SSJM139-4 
V
SSM139-4Ä int
— Oligo. 767A, M utation 7. Deletion of the 1st base of the old exon 2 
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SSM139-1 - - MAT a 1 -1 ------------- pJBM-1
SSM139-1 1 SSM139-1/s MAT a 1 -1/s
•
pJBM-1/s
SSM139-1 2 SSM139-2 MATal-2 pJBM-2
j
SSM139-2 3 SSM139-3 _ I
SSM139-3 4 SSM139-4 MATal-4 pJBM-4
SSM139-4 5 SSM139-4/s MATal-4/s pJBM-4/s
SSM139-4 6 SSM139-4Aint - -
SSM139-4Aint 7 SSM139-5 Matal-5 pJBM-5
FIGURE 3.4: GENERATION OF THE VARIOUS MUTANT MATal SEQUENCES
The m utated M A T a l  sequences produced by site-directed m utagenesis were generated 
in a stepwise m anner (see Section 3.3.3.2). The steps involved and the nucleotide changes made 
are shown in this figure; the num bered arrows correspond to the m utations described in Section 
3.3.3.2. The m utated nucleotides (i.e. those changed from the original M A T al-1  sequence) are 
indicated by the horizontal bar lines positioned on either side o f them. Exon and in tron 
sequences are given in capital and lower case letters respectively. The reading frames of the 
various M A T al-lacZ  fusions are shown by the faint horizontal lines separating the nucleotides.
FIG. 3.4
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FEASIBILITY AND DEVELOPMENT OF THE SCREENING PROCEDURE
4.1 THE FEASIBILITY OF A prp MUTANT SCREEN
U sing the plasmids pJBM -5, -4 and -4/s, the feasibility of detecting prp  m utants by 
means o f a postulated increase in their /?-galactosidase activity a t the non-perm issive 
tem perature  was examined. There were a num ber of questions concerning this proposition  that 
needed to be addressed.
(a) Was the fusion-transcript generated  from the screening construct p.TBM-4 spliced at
the new 3 ' splice site under all conditions (see C hapter 33.3 .2  and com pare pJBM-1 
with pJBM -4)?
(b) D id pre-m RN A , generated from  pJBM -4, accum ulate in a prp  strain when splicing was
inhibited i.e. after incubation at the non-perm issive tem perature?
(c) W ere increases in /3-galactosidase activity caused by pre-m R N A  accum ulation rather
than by increases in the rates of o ther R N A  processing events e.g. transcription, R N A  
transport and/or translation?
Experim ents to  resolve these questions were perform ed at the permissive and 
non-permissive tem peratures because the screen involved the incubation of strains under these 
conditions. In addition it had to be ascertained w hether the wild-type strain utilised in making 
rs m utants com plied with a certain condition relevant to the feasibility of the screen; it should 
not accum ulate pre-m R N A  (hence /?-galactosidase) at the non-perm issive tem perature  above that 
already present a t the permissive tem perature.
To address the questions above, a series of experim ents was perform ed scrutinising both
100
the fusion transcript and /3-galactosidase activity profiles em anating from  pJBM -4 (the screening 
construct). /?-galactosidase activities only w ere assayed for the control constructs pJBM -5 and 
pJBM-4/s.
4.1.1 Prim er Extension Analysis o f the M A T a l-la cZ  Fusion-Transcript from pJBM -4 in
W ild-Type and yrp Strains
The R N A  profile o f the  fusion-transcript generated from pJBM-4 was investigated by 
prim er extension analysis using an oligodeoxynucleotide com plem entary to  the 5 ' end of the 
lacZ  coding sequence (see C hapter 2.1.6 and Table 2.4). The wild-type strain, DBY745, was 
com pared to  a prp2  m utant, DJY36, at the  permissive (23 °C ) and non-perm issive (36 °C) 
tem peratures (see Fig. 4.1). Splicing of the  wild-type M A T a l  transcript is norm ally inefficient 
(M iller, 1984; N er and Smith, 1989), producing a ratio  of roughly 20% pre-m R N A  : 80% 
m R N A  D ensitom etric scanning of prim er-extended products from DBY745 (pJBM -4) indicated 
that the pJBM -4 fusion-transcript was spliced at roughly 72% -77%  efficiency at the permissive 
tem perature (results not presented). Taking into- consideration the probable differences in 
splicing efficiency of unrelated  strains, this figure suggests that splicing of the pJBM -4 transcript 
is norm al and that changing the position o f the 3 ' splice site had little  or no effect on splicing 
efficiency (see Fig. 4.1 A)
The first A G  downstream  of the TA CTA A C box is used as the 3 ' splice site in yeast 
(Fouser and Friesen, 1987) and this A G  is norm ally preceded by a pyrim idine nucleotide. W hen 
this pyrimidine is altered to a purine the use of cryptic 3 ' splice sites (at very low efficiency) 
has been detected (Langford and Gallwitz, 1983). The next A G  downstream  of the new 3 ' 
splice site (on the M A T a l-4 part o f the fusion-transcript generated from pJBM -4), which would 
allow splicing back into frame and therefore enable the m R N A  to encode /?-galactosidase 
activity, was preceded by a purine nucleotide. It seem ed likely that the new 3 ' splice site (which 
was preceded by a pyrimidine nucleotide) would be selected in preference to all o ther potential 
sites. D eletion analysis has shown that for efficient splicing there is both a m inimum and a
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maximum distance requirem ent between the TA CTA A C box and the 3 ' splice site (roughly 
8-66nts) (Langford and Gallwitz, 1983; Cellini et al„ 1986a). It should be noted that M A T a l 
IVS-1 has only 10 nucleotides separating the TA CTA A C box from the 3 ' splice site, and this 
may be one reason for its inefficient splicing. The new 3 ' splice site of pJBM-4 was the first 
A G  dow nstream  o f the TA CTA A C box, and increased the distance from the branch point by 
only 5 bases; thus it was considered that this would have little (if any) effect on the choice of 
the 3 ' splice site. C om parison of the sizes of the m ajor prim er extension products indicated 
that the new 3 ' splice site was the only one utilised efficiently (see Fig. 3.4 and 4.1).
Thus in both  a wild-type (DBY745) and a prp2  (DJY36) strain incubated at 23 °C  
the p.JBM-4 fusion-transcript is spliced at the  new 3 ' splice site with sim ilar efficiency to that 
seen for the norm al M A T a l IVS-1 (see Fig. 4.1 A  and C). It is also apparen t from Fig. 4 .IB  that 
in DBY745 incubated at 36 °C , the fusion-transcript was spliced at the new 3 ' splice site and 
there was no accum ulation of pre-m R N A  above that exhibited on incubation at 23 °C. Indeed 
splicing appears to  be m ore efficient at 36 °C  in DBY745 i.e. the ratio  of pre-m R N A  : m R N A  
decreases. D ensitom etric scanning of the prim er-extended products generated from the 
fusion-transcript encoded by pJBM -4 indicates that the fusion-transcript is spliced with roughly 
85% efficiency when cultures of DBY745 (pJBM -4) are incubated at 36°C  (results not 
presented).
W hen analysed in a prp2 m utant at the non-perm issive tem peratu re  (36°C, pJBM -4 
fusion-transcript pre-m R N A  accum ulated (relative to its m R N A  and in ternal PG K  control), 
indicating that the in tron from this fusion is not removed when splicing is inhibited (see Fig. 
4 .ID ). Thus it can be concluded that the screening construct pJBM -4 behaves as proposed i.e. 
the pre-m R N A  of the fusion-transcript is spliced at the new 3 ' splice site with wild-type 
efficiency when cultures are incubated at 23 °C , and accum ulates when splicing is inhibited i.e. 
when prp  m utant cultures are incubated at 36°C .
An oligodeoxynucleotide (JM O -PG K ) com plem entary to a region of the intron-less 
phosphoglycerate kinase (PGK) transcript (see C hapter 2.1.6 and Table 2.4) was used as an 
internal control to allow m onitoring of relative R N A  levels in each prim er extension reaction.
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FIGURE 4.1: PRIMER EXTENSION ANALYSIS OF THE MATal-4 FUSION
TRANSCRIPT IN WILD-TYPE AND prp2 STRAINS
All prim er extension analyses (see C hapter 2.2.8.5) described in this figure, utilised the 
oligodeoxynucleotides 083C (which hybridises to the 5 ' end of the lacZ  region of the M ATcil- 
lacZ  fusion transcript), and JM O -PG K  (which hybridises to the intron-less PG K  transcript: see 
Chapter 2.1.6 and Table 2.4). The sizes of the prim er-extended species produced by the 
hybridisation of the oligodeoxynucleotides to specific RN A s are given below.
083C - pre-m R N A  - 381nts
m R N A  - 322nts
IVS-E2 - 155nts (083C does not hybridise to the IVS RN A )
JM O -PG K  - m R N A  - 200nts
The prim er extension product of JM O -PG K  is denoted as PGK. All o ther species 
indicated arise from 083C and therefore represent the M A T al-4 -lacZ  fusion transcrip t molecules 
generated from pJBM-4. The identification of the IVS-E2 in term ediate (of M A T al-4 -lacZ ) is 
made on the basis tnat the presum ed prim er extension product is the correct size and is absent 
in the analysis of a prp2  strain incubated at 36°C  only (see Fig. 4.1D). The size m arkers are 
derived from a M spl digest of pBR322, the fragments of which have been rendered blunt-ended 
with radio-labelled nucleotides.
RN A  preparations were made from galactose induced cultures as described in Chapter 
2.2.8 and 2.2.9.I. The numbers above the tracks indicate the durations of galactose induction 
(in hours) before R N A  was extracted from the cultures.
A. Prim er extension analysis of the M A T al-4 -lacZ  fusion transcript in the wild-type
strain, DBY745, incubated at 23 °C
B. Prim er extension analysis of the M A T al-4 -lacZ  fusion transcript in the wild-type
strain, DBY745, incubated at 36°C
C  Prim er extension analysis of the M A T al-4 -lacZ  fusion transcript in the prp2  strain,
DJY36, incubated at 23 °C
D. Prim er extension analysis o f the M A T al-4 -lacZ  fusion transcript in the prp2  strain,
DJY36, incubated at 36 °C
FIG. 4.1
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It. should be noted that the PG K  m R N A  shows a transient 6-7 fold accum ulation caused by the 
transient heat-shock effect (P iper et al., 1986). This effect lasts for 2 hours, then the R N A  level 
returns to the pre-heat- shock state and m ust be taken into account when referring to  R N A  
levels at the 1 hour tim e points a t 36°C  (see track 1, Fig. 4.1D).
4.1.2 Analysis o f Plasmid Encoded /?-galactosidase Activity
All experim ents utilised two independent transform ants for each plasmid (colony 
purified 3 tim es), which w ere both  assayed in duplicate. The results presented are an average 
of both  transform ants. In general the transform ants exhibited sim ilar activity profiles and the 
standard deviations for the results observed for pJBM-5 were usually w ithin 15% (results not 
presented). However individual pJB M -4-transform ants of the prp8 m utan t strain  did exhibit 
significant quantitative differences in /?-galactosidase activity, though qualitatively they were very 
similar; see below. For a detailed protocol intim ating the m ethod of galactose induction of the 
transform ants, please refer to  C hapter 2.2.9. In this section cultures o f transform ants will be 
described thus; the nam e of the  transform ed strain  e.g. DBY745, followed by the nam e of the 
plasmid, in brackets, residing in the strain e.g. (pJBM -5).
4.1.2.1 DBY745
(a) pJBM-5 (intron-less control)
Figure 4.2 com pares /3-galaetosidase activities m easured from cultures of DBY745 
(pJBM -5) incubated at 23 °C  and 36 °C. It is clear that no significant difference in 
/Tgalactosidase activity exists between cultures incubated at the two tem peratures until the  4 
hour tim e-point w here there is only a 1.25-fold decrease a t 23°C  relative to 36°C . This 
suggests that factors o ther than those involved in pre-m R N A  processing e.g. rates of 
transcrip tion/translation/R N A  stability/transport and protein  stability, rem ain sim ilar in the shift
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from 23 °C  to 36 °C. It also implies that DBY745 is an ideal strain  in which to recover rs prp 
m utants, as any substantial increase in /?-galactosidase activity exhibited by the m utants on 
incubation at 36 °C  would probably be due to pre-m R N A  processing defects.
(b) pJBM -4 (screening construct)
Figure 4.3 clearly indicates that cultures of DBY745 (pJBM -4) produce a m easureable 
am ount of /J-galactosidase activity. The activity produced is consistently greater from cultures 
incubated at 23 °C  (about 1.5-fold greater) and is in contrast to the activity profile exhibited by 
DBY745 (pJBM -5) incubated at the two tem peratures (see Fig. 4.2). This observation probably 
indicates a greater efficiency of pre-m R N A  splicing at 36 °C  which would produce relatively less 
pre-m RN A  and therefore less /?-galactosidase fusion-protein; this is supported  by densitom etric 
scanning of prim er-extended products generated from the fusion-transcript o f pJBM -4 (see 
above). The fact that /?-galactosidase was detected in DBY745 (pJBM -4) cultures means that 
pre-m R N A  "leaks" out of the nucleus into the cytoplasm, thus producing a background level of 
activity. It was found that pJBM -4 produced roughly 2.3% of the /J-galactosidase activity 
generated by pJBM-5 (values of 3-5 hour tim e-points added and averaged), and this was in good 
agreem ent with published results from sim ilar experim ents (Legrain and Rosbash, 1989; see the 
Appendix).
(c) pJBM-4/s (stop codon in intron)
In tim e-course induction experim ents only the 5 and 6 hour tim e-points at 23 °C  and 
36°C  were assayed (results not presented). It was not expected that pJBM-4/s would generate 
much activity; however at 23 °C  it produced roughly 44%  of that generated by pJBM-4, whereas 
at 36 °C  it produced 22%. pJBM-4/s did not produce such high percentage values of pJBM -4 
in any o ther strain tested at either tem peratu re  (see 4.1.2.2 to 4.1.2.5 and 4.2.3) and therefore 
this observation appeared to be strain-dependent phenom enon. T here are two possible
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FIGURE 4.2: /J-GALACTOSIDASE ACTIVITY PROFILE OF DBY745 (pJBM-5)
INCUBATED AT 23°C AND 36°C: A WILD-TYPE STRAIN ANALYSIS
Cultures were grown at 23 PC to an OD 600nm of 0.1-0.4 prior to galactose induction 
and heat-shock (see Chapter 2.2.9). Culture-sam ples (0.5ml) were retrieved at hourly intervals 
after galactose induction, and assayed for /J-galactosidase activity (see C hapter 22.9.2). The 
results presented represent the average values obtained from two transform ants, both  of which 
were assayed in duplicate. All activities were corrected for background activity present 
immediately after the addition of galactose, the so-called tim e-zero (see C hapter 2.2.9.1), and 
therefore 0 hours induction has an activity value of 0 (see Fig. 4.2). /5-galactosidase units were 
calculated as described in C hapter 2.2.9.2. .
FIGURE 4.3: ß-GALACTOSIDASE ACTIVITY PROFILE OF DBY745 (pJBM-4)
INCUBATED AT 23°C AND 36 °C; A  WILD-TYPE STRAIN ANALYSIS
All experim ental details were as described for DBY745 (pJBM -5) in Fig. 4.2, except
0.5-2ml culture-sam ples were taken.
FIG. 4.2
DBY745 (pJBM-5)
B-gal. un its/m in/m l 
1200  ¡--------------------------------------------
time (hrs)
23° C —  36°C
FIG. 4.3
DBY745 (pJBM-4)
B-gal. units /m in/m l
time (hrs)
23°C — '—  36°C
explanations that can account for the  ¡3-galactosidase activity profile exhibited by 
pJBM -4/s-containing cultures:
(i) splicing at alternative splice sites on the fusion-transcript generated from pJBM-4/s 
restores the reading-fram e of the M A T a l-la cZ  fusion. Results of prim er extension analysis (see 
Section 4.1.1) argue against this possibility because the use of these sites (with such high 
efficiency) was not detected on the fusion-transcript generated from pJBM-4.
(ii) translational read-through of the  stop codon present in the in tron of the  pJBM-4/s
fusion-transcript could generate /J-galactosidase activity. There is some evidence to  suggest that 
such translational read-through is possible in yeast (Brown, 1989).
4.1.2.2 D JY 36 (prp2)
(a) pJBM-5
Figure 4.4 com pares the activity m easured from cultures o f DJY36 (pJBM -5) incubated 
at 23 °C  and 36 °C. In contrast to DBY745 (results above), pJBM -5-generated activity in DJY36 
fell about 10-fold when the cultures were incubated at 36 °C  com pared to 23 °C. This is probably 
a reflection of the fact that essential in tron-containing genes (e.g. actin) are not being spliced 
at the non-perm issive tem perature resulting in cell stress and, eventually, cell death. This would 
lead to the decrease of /?-galactosidase activity, due to the cessation of those events required to 
produce a functional /?-galactosidase fusion-protein e.g. transcrip tion/R N A  processing/translation. 
However, it could be that DJY36 is rs for galactose induction and therefore cannot produce 
large am ounts of fusion-transcript at the high tem perature.
(b) pJBM -4
In Fig. 4.5 it can be seen that there  was 3-fold greater activity exhibited by cultures 
incubated at 3 6 °C  com pared to those incubated at 23 °C  The increase in activity may be a
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FIGURE 4.4: /J-GALACTOSIDASE ACTIVITY PROFILE OF DJY36 (pJBM-5)
INCUBATED AT 23°C AND 36°C: A prp2 STRAIN ANALYSIS
Cultures were grown at 23 °C  to O D  600nm o f 0.1-0.4 prior to galactose induction and 
heat-shock (see C hapter 2.2.9). Culture-sam ples (0.5ml) were taken at hourly intervals after 
galactose induction, and assayed for /J-galactosidase activity (see C hapter 2.2.9.2). The results 
presented represent the average values obtained from two transform ants, both  o f which were 
assayed in duplicate. All activities were corrected for background activity present im m ediately 
after the addition of galactose, the so-called tim e-zero (see C hapter 2.2.9.1), and therefore 0 
hours induction has an activity value of 0 (see Fig. 4.4). /Lgalactosidase units were calculated 
as described in C hapter 2.2.9.2.
FIGURE 4.5: /J-GALACTOSIDASE ACTIVITY PROFILE OF DJY36 (pJBM-4)
INCUBATED AT 23°C AND 36°C; A prp2 STRAIN ANALYSIS
All experim ental details were as described for DJY36 (pJBM -5) in Fig. 4.4-, except
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result of the accum ulation of pre-m R N A , which is a direct consequence of the prp2  defect. The 
initial peak in activity observed at 36 °C  (1 hour tim e-point) was reproducible, and m ust be 
related to  splicing as pJBM-5 did not dem onstrate  this effect (see Fig. 4.4). The reason for this 
sharp rise in /Tgalactosidase activity is no t known and is specific to DJY36, though o ther 
(unassayed) prp2  strains (M GL-1 and JBY27) do show a transient increase in viable cell num ber 
during the sam e period (results no t presented). It is possible that the phenom ena are 
associated. In DJY36 cultures incubated at 23 °C  (when splicing is functional), pJBM -4 generated 
roughly 3.5% of the activity originating from pJBM-5. This observation was close to that 
previuosly m easured by Legrain and R osbash though they only com pared values obtained from 
a wild-type strain.
(c) pJBM-4/s
(Tgalactosidase activities m easured from cultures o f D JY 36 (pJBM -4/s) incubated at 
23 °C  were 1.85% of those found in cultures o f DJY36 (pJBM -4) (averaging the 4 and 5 hour 
tim e-points; results not presented). This suggests that read-through and/or alternative splicing 
are significantly reduced in this strain , and represents a >  20-fold reduction com pared to 
DBY745 (pJBM -4/s) incubated at the sam e tem perature  (see Section 4.1.2.1). M ore significantly, 
no activity was detected at 3 6 ° C Both these observations suggest that the increase in 
/Tgalactosidase activity exhibited by cultures of DJY36 (pJBM -4) incubated at 3 6 °C  is due 
alm ost entirely to pre-m R N A  accum ulation.
4.1.2.3 SPJ8.31 (prp8)
(a) pJBM-5
Figure 4.6 com pares activities exhibited by cultures of SPJ8.31 (pJBM -5) when 
incubated at 23 °C  and 36°C. A lthough the absolute /Tgalactosidase levels were very much
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reduced, the overall activity profile generated  by SPJ8.31 (pJBM -5) was sim ilar to that seen for 
DJY36 (prp2)(pJBM -5). T here was an 8-fold reduction in activity m easured from cultures 
incubated a t 36 °C  com pared to 23 °C  and this is probably a consequence o f cell death (see 
Section 4.1.2.2).
(b) pJBM -4
Figure 4.7 com pares activities exhibited by cultures of SPJ8.31 (pJBM -4) when 
incubated at 23 °C  and 36°C . T here was a 10-fold increase in activity m easured at 36°C  relative 
to 23 °C, however the two transform ants of this strain  exhibited activities that were 
quantitatively, significantly different, though they were qualitatively sim ilar (results not 
presented). In sim ilar experim ents Legrain and Rosbash observed a 3-4 fold increase in the 
sam e strain. The increase in activity was probably due to  the accum ulation o f pre-m R N A  in this 
prp8  strain  incubated at the non-perm issive tem perature. Cultures of SPJ8.31 (pJBM -4) 
incubated at 23 °C  produced roughly 1% of the  /?-galactosidase activity m easured in cultures 
of SPJ8.31 (pJBM -5) under the sam e conditions. This is slightly less than that m easured from 
DJY36 and DBY745 (3.5% and 2.3% respectively).
(c) pJBM-4/s
No activity arising from this plasmid was detected under any conditions. This confirm ed 
that the activity m easured from pJBM -4 was due solely to the pre-m RN A , and that the increase 
in activity exhibited by cultures of SPJ8.31 (pJBM -4) incubated at 36°C  was a result of 
pre-m R N A  accum ulation caused by the splicing defect in this prp8  m utant.
Similar analyses to those described above using o ther prp  m utant strains proved to be 
impossible as the prp3, prp4, prp5, prp6  and p r p l l  strains in this laboratory were either ts for 
galactose induction (and therefore could no t generate the pJBM -4 fusion-transcript at 36 °C) or 
were not inducible at all.
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FIGURE 4.6: /7-GALACTOSIDASE ACTTVTTY PROFILE OF SPJ8.31 (pJBM-5)
INCUBATED AT 23°C AND 36°C; A prp8 STRAIN ANALYSIS
Cultures were grown at 23 °C  to an O D  600nm of 0.1-0.4 prior to galactose induction 
and heat-shock (see Chapter 2.2.9). Culture-sam ples (0.5ml) were taken at hourly intervals after 
galactose induction, and assayed for /3-galactosidase activity (see C hapter 2.2.9.2). The results 
presented represent the average values obtained from two transform ants, bo th  of which were 
assayed in duplicate. All activities were corrected for background activity present immediately 
after the addition of galactose, the so-called tim e-zero (C hapter 2.2.9.1), and therefore 0 hours 
induction has an activity value of 0 (see Fig. 4.6). /?-galactosidase units were calculated as 
described in C hapter 22.9.2.
FIGURE4.7: £f-GALACTOSIDASE ACTIVITY PROFILE OF SPJ8.31 (pJBM-4)
INCUBATED AT 23°C AND 36°C; A prp8 STRAIN ANALYSIS
All experim ental details were as described for SPJ8.31 (pJBM -5) in Fig. 4.6, except
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4.1.2.4 DJY72 (prpl)
Prpl m utant strains are not thought to be defective in pre-m R N A  splicing; however 
they are thought to  be defective in the transport of R N A  from the nucleus to the cytoplasm 
(for a fuller discussion see C hapter 5.6.3). It was decided to  investigate the /?-galactosidase 
profile o f each plasm id when present in the  ts p rp l strain  DJY72.
(a) pJBM-5
As with o ther strains a linear increase in activity was observed at 23 °C  (see Figure 
4.8). However no increase in /3-galactosidase was detected at 36 °C  i.e. there was no increase in 
background levels. This background m easurem ent (activity prior to  galactose induction) 
decreased with time, and was probably due to protein  degredation as a consequence of cell 
death. This was further supported  by the relatively quick arrest of cell division, as m easured by 
the cellular optical density at 600nm, com pared to  the o ther prp  strains at the non-perm issive 
tem perature (results not presented). This result could be in terpreted  as a com plete block in 
m R N A  transport at 3 6 °C; however it could be that this strain  was ts for galactose induction 
and/or that the p rp l defect acted alm ost instantaneously to kill the  cells. In both  cases these 
m utations would prevent the detection of any increase in /?-galactosidase activity. N one o f the 
strains which were ts for galactose induction had such a tight phenotype and they were only 
im paired in their ability to induce at the higher tem perature; in DBY746 and SPJ0.9 this was 
roughly a 16-fold reduction (results no t presented). These results suggest that at 36°C  a prpl-1  
m utant is defective in the transport of m R N A  from the nucleus to the cytoplasm. O ther 




To investigate the possibility that in a p rp l m utant pre-and m R N A  transport were 
separately controlled, the /Tgalactosidase activity profile o f DJY72 (pJBM -4) was examined. As 
can be seen from Figure 4.9, activity was only detected when the DJY72 (pJBM -4) cultures were 
incubated at 23 °C, and was com pletely absent from those incubated at 36 °C. Thus if the p rp l 
m utation affects R N A  transport it acts on both  pre-m R N A  and m RNA. C ultures of DJY72 
(pJBM -4) produced /?-galactosidase activity which was 2.7% of that m easured from those of 
DJY72 (pJBM -5) (incorporating the 3 to  5 hour tim e-points at 23 °C  and averaging their 
values), which was consistent with results from the o ther strains (see above).
(c) pJBM-4/s
In induction experim ents utilising cultures of DJY72 (pJBM -4/s), only one tim e-point 
was assayed (5 hours at 23 °C  and 36 °C  results not presented). pJBM-4/s accounted for roughly 
10% of the activity of pJBM -4 when the cu ltures.w ere incubated at 23 °C  which was higher 
than those observed for DJY36 and SPJ8.31 but still considerably less than that o f DBY745 (see 
Sections 4.1.2.1 to 4.1.2.3). Activity was not detected at 36°C , as would be expected of a defect 
in R N A  transport.
It m ust be made clear that because sub-cellular fractionation o f pre-m R N A  to m R N A  
was not perform ed, it was not possible to determ ine directly that the prp l m utation inhibited 
the transport of R N A  from the nucleus to  the  cytoplasm. However the results presented here
are consistent with such a proposal.
4.1.3 Summary of Results Indicating Screen Feasibility
The fusion-transcript pre-m R N A  generated from the screening construct, pJBM-4, is 
spliced correctly and accum ulates when splicing is inhibited. This accum ulation can be detected
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FIGURE 4.8: /?-GALACTOSIDASE ACTTVTTY PROFILE OF DJY72 (pJBM-5)
INCUBATED AT 23°C AND 36°C; A prp l STRAIN ANALYSIS
Cultures were grown at 23 °C  to an O D  600nm of 0.1-0.4 prior to galactose induction 
and heat-shock (see Chapter 2.2.9). Culture-sam ples (0.5ml) were taken at hourly intervals after 
galactose induction, and assayed for /3-galactosidase activity (see C hapter 2.2.9.2). The results 
presented represent the average values obtained from two transform ants, bo th  of which were 
assayed in duplicate. All activities were corrected for background activity present immediately 
prior to the addition of galactose, the so-called tim e-zero (see C hapter 2.2.9.1), and therefore 
0 hours induction has an activity value of 0 (see Fig. 4.8). /Tgalactosidase units were calculated 
as described in C hapter 2.2.9.2.
FIGURE. 4.9: /3-GALACTOSIDASE ACTTVTTY PROFILE OF DJY72 (pJBM-4)
INCUBATED AT 23°C AND 36°C; A prpl STRAIN ANALYSIS
All experim ental details were as described for DJY72 (pJBM -5) in Fig. 4.8, except. 





23“ C — 36° C
FIG. 4.9
DJY72 (pJBM-4)




as an increase in /?-galactosidase activity m easured in prp  strains incubated at the non-perm issive 
tem perature. Individual prp  strains may produce different relative increases which could be a 
consequence of the  stage in splicing at which they function. These results indicated that it was 
possible to set up a screening system using the rationale previously described (see C hapter 3.2).
4.2 DEVELOPMENT OF THE SCREENING PROCEDURE
From  section 4.1.3 it can be seen tha t prp  m utants harbouring the screening plasmid,
pJBM-4, exhibit elevated levels of /?-galactosidase activity when incubated at the non-perm issive
tem perature. Obviously screening individual Is m utants for splicing defects by liquid culture 
assay would have been tim e-consum ing and would therefore have defeated the point o f 
developing a new screening procedure. Thus the results gleaned from the experim ents described 
in sections 4.1.1 and 4.1.2 had to be transposed into a mass plate-screening procedure to 
accelerate detection of prp m utants. In the course of this transposition it becam e apparen t that 
certain criteria had to be fulfilled to enable the screen to function. These points will be dealt 
with individually in the following sections; however it m ust be noted that they were intrinsically 
linked and relied on each o ther for the screen to operate efficiently. Figure 4.10 describes the 
steps involved in the screening procedure, from the creation o f the ts m utant pool to  the 
detection o f potential prp  m utants.
4.2.1 Choice of W ild-Tvpe Strain
4.2.1.1 Strains Producing "Petite" M utants
O n exposure to ultraviolet light som e strains e.g. SI50-2B, produce a high percentage 
of "petite" m utants. This greatly hinders the isolation o f ts colonies from the m utagenised pool.
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4.2.1.2 G lucose repressibility
As a consequence of the screening procedure adopted, all strains harbouring plasmids 
with the G AL1  p rom oter had to be repressible for galactose induction when grown in the 
presence of glucose. It was also required that raffinose support growth of the chosen strain  
w ithout affecting the induction of the G AL1  p rom oter w ith galactose.
4.2.1.3 G alactose induction m utants
As previously stated in section 4.1.2.4, som e strains were rs for galactose induction. A t 
elevated tem peratures it was possible that insufficient fusion-transcript was generated to 
produce detectable /?-galactosidase activity. Indeed galactose induction was not possible in som e 
strains (results no t presented). A  partial ts phenotype (for galactose induction) did not appear 
to affect the screen (see C hapter 5.1); however the possibility exists that it determ ines the class 
o f m utants that is recovered i.e. only those that show a large decrease in splicing efficiency 
which causes a large accum ulation o f pre-m R N A  and consequently m ore /?-galactosidase activity. 
The use of strains which are rs for galactose induction may preclude the isolation of m utants 
with weak splicing defects because their small accum ulation of pre-m R N A  (splicing is relatively 
efficient) is further attenuated  by the ts galactose induction m utation which causes the 
production of less pre-m R N A  transcript. In this respect it is relevant to note that the plate 
assay was essentially crude, and therefore /3-galactosidase activity arising as a consequence of a 
prp  m utation may have been sufficiently reduced as to prohibit th e  differentiation of a wild-type 
strain from a weak prp  m utant.
There was no strain which fully satisfied all conditions; however both  DBY746 (which 
was partially ts for galactose induction) and DBY745 (which gave a high percentage of 
alternative splicing and/or translational read-through) were eventually utilised in the screening 
procedure.
I l l
4.2.2 G row th M edia
A  variety of growth media was examined in various com binations e.g. sucrose, 
raffinose, glucose and galactose (results no t presented). Some strains were not repressed when 
grown on  sucrose e.g. SI50-2B. G alactose induction of the G AL1  p rom oter was no t a problem  
for m ost strains; however they could not utilise galactose efficiently as a carbon source and 
therefore raffinose (which was a non-inducing and non-repressing carbon source) was included. 
The inclusion of raffinose alleviated m etabolic stress caused by carbon lim itation which may 
have affected the assay. In the final m ethod yeast cells were grown on glucose (YM G/Cas plates) 
and then transferred to galactose (Y M R/G al/Cas, see C hapter 2.1.2.2). This enabled full 
repression and induction of the yeast strains grown on these media.
4.2.3 D etection of ff-galactosidase Activity
Initially yeast cells were grown on plates containing X-gal which was used to detect 
any production of /?-galactosidase. These plates had to be buffered a t pH 7 to allow the 
jS-galactosidase to function. Y east cells require a pH  of 6.5 for optim al growth and as a 
consequence grow extremely slowly under these conditions (o ther differences in media 
constituents may also have contributed to im pair growth). The m ethod finally utilised was to 
spot the cells onto  nitrocellulose m em branes placed on top of the relevant media. The cells 
were assayed by fracturing them  in liquid nitrogen (while still on the m em brane) and then 
placing the m em brane into a petri-dish containing Z  buffer and X-gal. Incubation of the 
m em branes at 3 0 °C identified /J-galactosidase-producing colonies by virtue of their blue colour. 
For com parison of the  activities generated by pJBM -5, 4 and 4/s in SI50-2B using this assay, see 
Fig. 4.11. Please note the difference in colourm etric intensity between these plasmids, especially 
pJBM -4 and 4/s. W hen residing in DBY745, pJBM -4 and pJBM-4/s did not exhibit such a 
contrast under various sensitivity levels tested (results not presented). This observation is 
consistent with the results indicating that the background activity exhibited by cultures of
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DBY745 (pJBM -4/s) is greater than that of o ther strains (refer to  Section 4.1.2). Spotting the 
cells onto  nitrocellulose m em branes allowed greater flexibility in the design of the screening 
procedure by enabling easy transfer of colonies between different media w ithout changing the 
num ber of cells present in each colony (a problem  inheren t in replica plating). Because o f the 
background level of activity (see Section 4.1.2.1), it was im portan t that on individual plates the 
colonies grew at roughly the same rate  and therefore contained a sim ilar num ber of cells. This 
minimised the variation in background activity produced as larger colonies produced greater 
to tal am ounts o f background /?-galactosidase activity due to their increased cell num ber. Thus 
slow growing m utants were assayed separately. Fig. 4.12 shows an example of duplicate 
m em branes containing a num ber of rs m utants which were screened using the plate-assay. O ne 
o f the m utants in this screen clearly exhibits a blue colour when incubated at 36 °C  only 
(m arked by the arrows), while the wild-type control (pJBM -4-containing colony) is still 
colourless. T herefore this screen identified a possible prp  m utant. Cells containing pJBM-5 were 
used as a positive control to  detect efficient induction of the G AL1  prom oter.
W ild-type cells produce a background level of activity caused by the leakage of 
pre-m R N A  from the nucleus (see Section 4.1.2). In order to detect any increase in activity 
(taking into account the crude nature of the p late assay), the sensitvity of detection had to  be 
reduced below the leakage activity. Thus norm al wild-type (for splicing) cells would rem ain 
colourless even though pre-m R N A  could exit the nucleus and produce /?-galactosidase activity 
(this "leakage" activity was detected by increasing the sensitivity of the assay; results not 
presented). The sensitivity of the assay was regulated by including different am ounts of substrate 
(X-gal) in a constant volum e of Z  buffer (see Fig. 4.10). However o ther m ethods could have 
been utilised e.g. stoppage o f the assay reaction in a tim e-dependent m anner, lim iting the time 
of galactose induction and/or reducing the tim e of growth prior to induction. It was found that 
the most effective and convenient m ethod of prp  m utant detection was to grow the ts m utants 
at 23°C  on a G AL1  repressing medium, transfer them  to an inducing medium  and incubate 
duplicate samples of the cells at both 23 °C  and 36 °C, and then assay them  thereafter at hourly 
intervals. D ue to the increase in cell num ber the wild-type cells eventually produced enough
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/S-gaiactosidase activity to tu rn  blue. However this increase in /3-galactosidase activity could also 
be a consequence of the continual induction of the G AL1  prom oter, which may cause the 
titra tion  of factors necessary for the com m itm ent of pre-m R N A  transcripts to splicing, and 
therefore lead to  the exit o f m ore pre-m R N A  transcripts from the nucleus. The period before 
the wild-type cells w ent blue was a "window" in which increased /5-galactosidase activity (hence 
pre-m R N A ) could be detected, and the tim e-scale of this "window" depended on the sensitivity 
employed in the assay.
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FIGURE 4.10: THE SCREENING PROCEDURE
The screening procedure is given, from the creation of a bank of fs m utants to the 
final plate-assay m ethod utilised to identify possible prp  m utants.
FIG. 4.10 SCREENING PROCEDURE
W ild-type cells transform ed with pJBM-4
U ltraviolet light m utagenesis
Isolate rs m utants
Spot cells onto  nitrocellulose m em branes and grow on YM G /Cas plates 
for a pre-determ ined tim e (strain specific; if colony too large 
then it spreads over the m em brane when assayed)
Transfer m em brane to Y M R/G al/Cas plates 
(pre-incubated at 23 °C  and 3 6 °C) 
and incubate at the relevant tem perature
Assay (as described below) at hourly intervals until 
wild-type contro l is blue (strain specific)
Identify colonies that w ere blue before the wild-type control 
and save them  for further analysis
Assay Technique
Place m em brane on a float and lay on top of liquid nitrogen for
1-2 m inutes
I
Subm erge the m em brane in liquid nitrogen for 30 seconds
I
Place the m em brane into a petri-dish containing 350/xl of Z  buffer 
and a pre-determ ined am ount of X-gal (strain specific)
1
Incubate over-night at 30 °C  w ith the lids on the petri-dish
1
/Tgalactosidase producing colonies appear blue (see Fig. 4.12)
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FIGURE 4.11: COMPARISON OF /J-GALACTOSIDASE ACIWITIES ARISING FROM 
pJBM-5, -4 AND -4/s IN S150-2B, USING THE PLATE-ASSAY 
PROCEDURE
S150-2B transform ants containing the relevant plasmids were suspended in w ater and 
spotted onto a nitrocellulose m em brane placed on top of YM G/Cas medium  (see C hapter 
2.1.2.2). The plate was incubated at 23°C  for 21 hours and then the m em brane was transferred 
to YM R/Gal/Cas medium and incubated at 23 °C  for a further 5 hours. A fter placing on a float 
and leaving on liquid nitrogen for 1-2 m inutes, the  m em brane was subm erged for 30 seconds 
and then placed into a petri-dish containing 350/xl o f Z  buffer and 10/rl of 20mg/ml X-gal. It 
was then incubated at 30°C  overnight. The /Tgalactosidase activity arising from the plasmids 






FIGURE 4.12: IDENTIFICATION OF A POTENTIAL prp MUTANT USING THE 
PLATE-SCREEN ASSAY
A num ber of rs m utants were screened for a potential prp  phenotype. The rs m utants 
were suspended in water and spotted, in the sam e grid pattern , onto  two nitrocellulose 
mem branes which had been placed on top of two plates of YM G/Cas medium. Each plate was 
then incubated at 23 °C  for 21 hours. The two m em branes were then placed onto  Y M R/G al/Cas 
plates which had been pre-incubated at 23 °C  and 36 °C , and thereafter incubated at the relevant 
tem perature for five and a half hours. Thus identical rs colonies, placed on duplicate 
membranes, were induced at 23 °C  and 36 °C. O ne colony exhibited a blue colour (and hence 
increased levels of /3-galactosidase activity) after incubation at 36 °C  only (in fact it is 60h; see 
Chapter 5.3.1) and is thus identified as a potential prp  m utant (see the arrows).
The wild-type control transform ants on the m em branes presented in this figure clearly 
indicate that there is induction of the  G AL1  p rom oter at both  tem peratures (pJBM -5), and that 
the screening plasmid (pJBM -4) does not produce any detectable activity at any tem perature  
under these assay conditions. The relevant control transform ants have the nam e of the plasmids 





ISOLATION AND CHARACTERISATION OF POTENTIAL 
CONDITIONAL-LETHAL prp MUTANTS
5.1 GENERATION OF TEMPERATURE-SENSITIVE MUTANTS
As indicated in C hapter 1.9, the  existence of conditional-lethal m utants provides several 
advantages when studying m olecular processes. In order to isolate conditional-lethal prp  m utants 
a bank of ts m utants was created, using ultraviolet light (U V ) to  generate this pool (see 
C hapter 2.23.1). A part from being the m ethod in use in this laboratory U V  irradiation has 
several advantages over o ther procedures such as chemical mutagenesis; it is easily controllable 
and relatively safe. It might also be expected to produce m utations that differ from those 
previously detected by o ther screens in which chemical m utagens were used to  generate the ts 
pool (H artwell, 1967; Vijayraghavan et al., 1989). Two wild-type strains, DBY745 and DBY746, 
were chosen for mutagenesis. In generating rs m utants a balance m ust be obtained between the 
am ount of U V  energy expended (duration and intensity o f exposure), and the percentage of 
m utants recovered. Long exposure leads to the introduction of m ultiple rs m utations into the 
genetic background, and this can hinder the analysis o f the relevant ts gene and the isolation 
of is wild-type counterpart. Because of this, and also because each strain  has a distinct 
m utational repair response, a separate survival curve, in which the percentage o f cells tha t 
survive is plo tted  against the duration  of U V  exposure, is required for each strain (this also 
applies to  chemical mutagens; M iller, 1972; Haynes and Kunz, 1981). It was considered that the 
original prp  m utants had been over-exposed to  the chemical m utagen used to  generate them  
(chemical m utagenesis giving 99%-99.8%  killing) and this had often resulted in the presence of 
m ore than one rs m utation  in any given m utant strain  e.g. prp6, prp7  and prp9. A  value of
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80% -90%  killing is m ore likely to  produce a single rs m utation  per genom e (M addock, J., pers. 
comm.). In a recent screen 70% -90%  killing was the value utilised (Vijayraghavan et al., 1989).
Survival curves were generated for DBY745 and DBY746, and the appropriate  exposure 
time, calculated to produce 80% -90%  cell death (—1 m inute for DBY746 and ~1  m inute 15 
seconds for DBY745) was utilised to  create the  fs pool from each strain  (see Fig. 5.8 for the 
survival curves generated for each strain). In to tal 590 ts m utants representing  307 independent 
isolates, i.e. m utants isolated from different cell pools, were generated (296 rs m utants in total 
from DBY745, 129 of which were independent isolates, and 294 ts m utants from DBY746 of 
which 177 were independent isolates) and tested for pre-m R N A  processing defects in the 
screening procedure as described in C hapter 4.2. It should be noted that because the screening 
procedure is relatively fast the  discrim ination of a rs phenotype was not conclusive, thus not all 
590 m utants were in fact ts, although the vast m ajority were. This needs to  be taken into 
account when discussing the efficiency of the screen in com parison to others (see the Discussion 
at the end of this Chapter).
5.2 SCREENING FOR POTENTIAL pip  MUTANTS
All 590 rs m utants were screened for their ability to produce elevated levels of 
/J-galactosidase activity as detailed in C hapter 4.2.3, Fig. 4.10. However the strains used to 
generate the ts m utants respond differently to galactose induction and thus the conditions of 
assay are unique to  each one. In reference to  Fig. 4.10, DBY745 requires 21 hours growth on 
YM G/Cas and 10/xl o f 20mg/ml X-gal in the assay, com pared to 41 hours and 25/xl for DBY746. 
Because the screen was being tested for the  first time, colonies producing a relatively light blue 
phenotype were also isolated for fu rther analysis.
117
5.2.1 DBY746
O ut of 294 rs m utants 11 colonies were isolated for further analysis. The blue 
phenotype exhibited by the individual colonies at the two tem peratures is given in Table 5.1. 
Please no te  that the intensity of colour varied between colonies but is not indicated.
TABLE 5.1 DBY746 DERIVED t5 MUTANTS EXHIBITING A BLUE PHENOTYPE
Colony Blue Phenotype Colony Blue Phenotype
23 °C  36°C  23 °C  36 °C
82a + - 235f + -
193d + - 254 + -
196a* 9 9 275 - +
2 2 1 c + + 298 + -
234b Jr - 316b + -
196b* 9 9
( (+ )  or (-) indicates the presence or absence respectively o f a blue phenotype. (?) indicates that 
the tem perature  distinction in blue colour was no t noted. * indicates m utants isolated from the 
same aliquot).
5.2.2 DBY745
Thirty-five colonies were isolated for fu rther analysis ou t of the 296 f£ m utants 
originally generated from this strain. The blue phenotype exhibited by these colonies at the two 
tem peratures is given in Table 5.2. Please no te  that the intensity of colour varied between the 
colonies but is not indicated in this analysis.
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TABLE 5.2 DBY745 DERIVED t5 MUTANTS EXHIBITING A BLUE PHENOTYPE
Colony Blue Phenotype
23 °C  36°C
Colony Blue Phenotype










































































((+ )  and/or (-) indicates the presence or absence respectively of a blue phenotype : * indicates 
m utants isolated from the sam e plate; com pare the colony num bers to  identify relevant pairs).
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5 3 NORTHERN BLOT ANALYSIS OF POTENTIAL prp MUTANTS
R N A  preparations were m ade from  the 46 potential prp m utants after their incubation 
at 23°C  and 36°C  (see Sections 5.2.1 and 5.2.2 for the m utants used in this analysis). The 
heat-shock at 36°C  usually lasted 1.5-2 hours, in which tim e it was thought that any splicing 
defect would becom e apparent. This supposition  is based on the pre-m R N A  accum ulation 
profiles of prp2  to  p r p l l ; however this general tim e-scale of heat-shock and pre-m R N A  
accum ulation may no t allow detection o f all types of prp  m utants, o ther certain defects may only 
be detected on longer incubation at the elevated tem perature  (see the D iscussion at the end of 
this Chapter). T hree genes w ere utilised as probes to detect the  prp  phenotype in the N orthern  
blot experiments.
(a) Actin; the actin pre-m R N A  transcrip t is spliced efficiently and served as a com parison with 
the CYH2  pre-m RN A .
(b) CYH2\ this gene encodes the ribosom al protein  L29, and it’s transcript is spliced relatively 
inefficiently. This was used to  help distinguish those m utants which had a less pronounced effect 
on splicing, as it was presum ed that small decreases in splicing efficiency would produce a m ore 
noteable effect on pre-m R N A  to m R N A  ratios when an inefficiently spliced transcript was 
studied.
(c) G PM ; the phosphoglycerate m utase transcrip t has no in tron and served as an internal 
control of R N A  levels in each preparation. Thus it was possible to determ ine that any increase 
in pre-m R N A  at the non-perm issive tem pera tu re  was not due to  an increase in the general 
level o f RNA.
The criterion used to identify a possible defect in pre-m R N A  processing is that the 
ratio of m R N A  : pre-m R N A  decreases at 36 °C. This is based on a proposed steady-state kinetic
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model for the generation  of spliced m R N A  (Pikielny and Rosbash, 1985). Briefly, two possible 
scenarios are considered to explain the phenotype of m utations which affect splicing;
(a) there are  m utations that reduce the efficiency of splicing below the rate  of turnover of the 
pre-m R N A  and m RNA. Because splicing is drastically inhibited, m R N A  is not generated while 
the existing m R N A  is degraded in the cell. This results in rapid m R N A  depletion. A lthough 
degraded relatively quickly (com pared to  m R N A ), pre-m R N A  accum ulates in such m utants 
because it is not converted to m R N A  B oth RN A s can therefore reach a level which is 
dependent on the splicing efficiency of the pre-m R N A  and the turnover rates of the pre-m R N A  
and m RNA. This phenotype is characteristic o f the prp2 to  p r p l l  m utants.
(b) There are m utations which reduce the efficiency of splicing but not below the turnover 
rates of the RNAs. Because m R N A  is degraded relatively slowly (therefore relative to 
pre-m R N A  there  is m ore of it present at any one tim e) the small decrease in splicing efficiency 
does no t discernably affect the m R N A  pool size. In this way the m R N A  levels appear to rem ain 
constant. In contrast, the  pre-m R N A  is degraded relatively quickly (therefore at any one time 
there is less o f it about); thus small changes in splicing efficiency have a much m ore 
pronounced effect (relatively) on the pre-m R N A  pool size. It should be noted that m utants 
showing this phenotype could have a rs defect in a R N ase activity which results the  pre-m R N A  
accum ulation observed at the  non-perm issive tem perature.
The consequence of these two scenarios is that the pre-m R N A  level observed at 36 °C  
need not be greater than tha t m onitored at 23 °C  only that the  ratio  o f pre-m R N A  to m R N A  
increases. A no ther consequence is tha t in pre-m R N A  splicing m utants the m R N A  level need 
not change; however in these cases the pre-m R N A  level should increase.
Both scenarios can be described as a relative accum ulation of pre-m RN A . O n the 
basis of the results obtained from N orthern  blot analysis the  fs m utants isolated from the screen 
were placed into 4 groups.
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5.3.1 ts M utants Showing a prp N orthern  Phenotype
Prp 2 to  p r p l l  m utants accum ulate pre-m R N A  at the expense o f m R N A  when 
incubated at 36 °C. This pattern  is characteristic of such "classic" prp  m utants and several o f this 
type were identified in this screen. Fig. 5.1 A  shows the N orthern  phenotype exemplified by the 
two wild-type strains used in the screen (DBY745 and DBY746) and a prp8 strain  (SPJ8.31). 
Fig. 5.1B shows the N orthern  blot phenotype exhibited by the ts m utants 221c, 275, 298, 9c and 
104b, and Fig. 5.2 those of 105c, 109i, 60h, 61d and 124c. All m utants presented in Figs. 5.1B 
and 5.2 w ere isolated utilising the  screening procedure described in C hapter 4, Fig. 4.10. It 
should be noted that com pared to  the o thers 60h, 61d and 109i do not produce such a m arked 
increase in pre-m R N A  and indeed could also be included in section 5.3.2. In the  analysis of 
60h and 61d it is apparen t that the R N A  preparations made from these strains (incubated at 
23 C only) are defective (see tracks 5 and 7). The reason for this is unknown, however o ther 
R N A  preparations made from the sam e strains do not exhibit this defect (results not presented). 
The N orthern  blot of 124c (see Fig. 5.2, tracks 9 and 10) is over-exposed, however it is apparent 
that it accum ulates pre-m R N A  at the  expense of m R N A  when incubated at 36°C  though there 
is still a considerable level o f m R N A  present. Though it appears to  lose m ore m R N A  when 
incubated at 36 °C, 124c produces a N orthern  blot phenotype sim ilar to  121e and 196a (see 
Section 5.3.2) and could be included in tha t section. Thus 10 m utants dem onstrating a prp  
N orthern  phenotype have been identified.
5.3.2 M utants W hich May Have Been Defective in Splicing
There were 5 m utants in this class (20a, 36a, 109i, 121e and 196a), and each will be 
dealt with separately.
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RN A  was prepared from yeast strains which had been grown in Y PD A  at 23 °C  or 
shifted to 3 6 °C  for 1.5-2 hours (tem perature indicated above each track). R N A  (10-5Qug) was 
denatured with glyoxal, electrophoresed through a 1.2% or 1.5% agarose gel and blo tted  onto 
a GeneScreen m em brane (see C hapter 2.2.8). These were then hybridised with the uniformly 
labelled 1038bp BamHUBglW  fragm ent of pYA301 (actin transcript probe), the 2kb EcoR I 
fragment from pBRCYH-3 (CYH2  transcript probe) and the 1.3kb H indlll/Sa ll fragm ent of 
pUC-GPM  (phosphoglycerate m utase transcript probe) (see C hapter 2.1.5, Table 2.3). Only 
one probe was used at any one time, after which the m em brane was stripped of radioactivity 
and rehybridised with another. D N A  restriction size m arkers were usually run  with each 
experiment, however they are not shown because the transcripts analysed are  not presented in 
the order of size. The sizes of the relevant R N A  species (as indicated in the figure) are as 
follows;
Actin - pre-m R N A  - approx. 1700nts CYH2 - pre-m R N A  - 1082nts
m RN A  - approx. 1392nts m R N A  - 572nts
G PM  - m R N A  - approx. llOOnts
A, N orthern  blot analysis of DBY745, DBY746 and SPJ8.31! The results for these strains are
presented to enable a com parison with the potential prp  m utants. All of the newly isolated rs
m utants were derived from DBY745 and DBY746 (see Section 5.2).
FIGURE 5.1: NORTHERN BLOT HYBRIDISATION ANALYSIS OF POTENTIAL prp
MUTANTS
B. N orthern blot analysis of potential prp m utants.
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All experim ental details were as described for Fig. 5.1. The sizes of the relevant R N A  
species are as for Figure 5.1.
FIGURE 5.2: NORTHERN BLOT HYBRIDISATION ANALYSIS OF POTENTIAL prp
MUTANTS
FIG. 5.2
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5.3.2.1 20a
A  slight increase in the ratio o f pre-m R N A  to m R N A  of the actin and CYH2  
pre-m R N A  transcripts has been detected when this m utant is incubated at 36 °C  (see Fig. 5.3A 
and com pare tracks 1 and 2). R N A  preparations m ade at a later date (see below) did not show 
any accum ulation of actin pre-m R N A  whereas the CYH2  pre-m R N A  rem ained at a constant 
level even though its m R N A  level decreased, and this could be in terpreted  as indicating a 
splicing defect (see Fig. 5.3 A, tracks 3 and 4). To determ ine w hether efficient accum ulation of 
pre-m R N A  depended on a longer duration  of heat-shock, R N A  was prepared at hourly intervals 
up to  and including 4 hours from cells incubated at 36 °C  (see Fig. 5.3A, tracks 5 to 8; please 
no te  that the  culture was in the logarithm ic stage of growth when the heat-shock was applied, 
results not presented). However, actin and CYH2  pre-m R N A  increased in concert with their 
respective m RNAs at every time- point. The variation in the N orthern  phenotype was at first 
taken to m ean that the  m utan t was unstable, as the  prp phenotype appeared to  disappear with 
consecutive R N A  preparations (cells stored on plates and R N A  preparations m ade in the order 
given in Fig 5.3A, tracks 1-4). However, recent indications suggest that detection of a splicing 
defect may require longer heat-shock and there  is a possibility that it may be defective in 
snRN P assembly (see 36a below and the D iscussion at the end of this chapter). This m utant is 
by far the slowest growing rs m utan t isolated and grows better on Y PD A  than on YMG/Cas. 
Its genotype is as DBY745 i.e. Ieu2, ade2-100 and ura3-52 (results not presented), therefore the 
reason for its slow growth on YM G/Cas is no t due to  any auxotrophic m utation  and remains 
unknown.
5.3.2.2 36a
In the very first N orthern  blot perform ed using R N A  isolated from this m utant, 
accum ulation of the actin pre-m R N A  with a concom itant decrease in m R N A  was detected (see 
Fig. 5.3B, tracks 1 and 2); however this was the only gene transcript analysed. Subsequent
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analysis using different R N A  preparations revealed a sim ilar situation  to tha t encountered with 
20a i.e. the prp  phenotype disappeared w ith consecutive R N A  preparations. It is interesting to 
note that CYH2  R N A  is alm ost com pletely absent a t 3 6 °C  even though the GPM  control 
indicates that R N A  depletion is only 3-4-fold (see Fig. 5.3B, tracks 3 to 6). The reason for the 
depletion may be due to  the possibility tha t the R N A  was isolated from cells which had reached 
the late logarithm ic stage o f growth before the heat-shock was applied, as the optical density 
of the  culture used in this experim ent was not directly m onitored. To test this, and also to 
extend the duration  of heat-shock, a sim ilar tim e-course experim ent to that carried ou t with 20a 
was perform ed (see Fig. SAB, tracks 7 to  10). A liquots were removed at hourly tim e-points from 
a culture incubated at 36 °C. The O D  600nm m easurem ents each tim e-point were 0.217, 0.28, 
0.31 and 0.336 respectively; therefore the cells were in the logarithm ic phase of growth when 
the heat-shock was applied (please no te  that the same was true for all the tim e course 
experim ents i.e. 20a, 109i and 121e also, results not presented). Results clearly indicate that for 
both actin and CYH2  the R N A  level decreases up to 3 hours and then increases to roughly the 
1 hour level (this pattern  is m irrored by GPM ); however there  is a substantial increase in CYH2  
pre-m R N A  at the 4 hour tim e-point relative to the  1 hour (com pare tracks 7 and 10: a slight 
accum ulation of the  actin pre-m R N A  is also visible at the 4 hour tim e-point, see track 10). The 
reason for the increase in to tal R N A  after 4 hours is not known and needs to  be verified, 
though it could simply be the result of a m ore concentrated R N A  preparation. It is possible 
that the initial decrease in R N A  levels observed for 36a after incubation at 36° C is a general, 
transient heat-shock effect, however the wild-type strains, DBY745 and DBY746, do not exhibit 
a decrease in R N A  levels after two hours incubation at 36°C  (see Fig. 5.1). This suggests that 
the lose of R N A  is a consequence of the  ts m utation(s) (or o ther m utations) present in 36a. 
D etection o f a blue phenotype in the p late assay when 36a was incubated at 36 °C  required 6 
hours of galactose induction and heat-shock (results not presented) and could reflect this lag 
tim e in pre-m R N A  accum ulation (most m utants produced the blue colouration within 2-4 
hours). These results suggest that on longer incubation 36a accum ulates significant levels of 
pre-m RNA.
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FIGURE 5.3Aj NORTHERN BLOT HYBRIDISATION ANALYSIS OF MUTANT 20a
Tracks 1-4: R N A  was prepared from cultures of 20a grown in Y PD A  at 23°C  or shifted
to 36°C  for 1.5-2 hours (see C hapter 2.2.8). All o ther experim ental details and 
R N A  transcript sizes were as for Fig. 5.1. Tracks 1 and 2 represent one 
experiment and tracks 3 and 4 a repeat experim ent carried out at a later date.
Tracks 5-8: Tim e-course of N orthen blot phenotype exhibited by 20a on incubation at
36 °C. Cultures of 20a were initially grown in Y PD A  at 23 °C  to an O D  600nm 
of 0.1-0.4 and then shifted to 36 °C. Thereafter, R N A  was prepared at hourly 
intervals (1-4 hours, tracks 5-8 respectively).
FIGURE 53B: NORTHERN BLOT HYBRIDISATION ANALYSIS OF MUTANT 36a
Tracks 1-6: Experim ental details as described for Fig. 5.3A. The CYH2 or G PM  transcripts
were not analysed in the R N A  preparations used in tracks 1 and 2. Tracks 1 
and 2 represent one experiment and tracks 3 and 4, and tracks 5 and 6 represent 
two individual repeat experiments carried out at later dates.
Tracks 7-10: Tim e-course of N orthern  blot phenotype exhibited by 36a on incubation at
36 °C. Cultures of 36a were initially grown in Y PD A  at 23 °C  to  an O D  600n(n 
of 0.1-0.4 and then shifted to 36°C  T hereafter, R N A  was prepared at hourly 
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As indicated in 5.3.1, 109i shows a definite prp  phenotype. However in tim e-course 
experim ents (the same as those perform ed on 20a, 36a and 121e), pre-m R N A  increases relative 
to a m aintained m R N A  level. This effect lasts for 3 hours, after which both the pre-m R N A  
and m R N A  levels decrease (see Fig 5.4C). Such a result could indicate an increase in 
pre-m R N A  stability with no defect in splicing. If the rs m utation  is the cause of this observation 
then it must m ean that accum ulation of pre-m R N A  is detrim ental to the cell and/or that the 
m utation has pleio tropic effects because the cells cease to grow. The reason for the  difference 
between this observation and those utilising different R N A  preparations is not known, and 
indeed recent results repeat the prp  phenotype seen in Fig. 5.2 (results not presented).
5.3.2.4 121e
This m utan t appears to accum ulate pre-m R N A  when incubated at both the permissive 
and non-perm issive tem peratures; however there  appears to be relatively m ore pre-m R N A  
present at 3 6 °C  than  at 23 °C  (see Fig. 5.4A, tracks 1 and 2). W hen 121e was incubated at 3 6 °C  
the decrease in m R N A  level was not substantial and therefore it was considered that a longer 
heat-shock might be required to produce a significant contrast in the changes of pre-m R N A  and 
m R N A  levels. Fig. 5.4A, tracks 3 to 6 shows the results of a tim e-course experim ent sim ilar to 
those carried out for 20a and 36a (see above). M utant 121e produces a N orthern  phenotype 
sim ilar in ou tline to 109i (see Section 5.3.2.3) i.e. the  pre-m R N A  levels o f both  transcripts 
increase up to  three hours and then decrease. A t the  sam e tim e the m R N A  level appears to 
stay at a sim ilar level for the three hours and then also decreases. However in contrast to  109i 
the classic prp  phenotype has not been detected for 121e (com pare Fig. 5.2, tracks 3 and 4 with 
Fig. 5.4A, tracks 1 and 2). It should be noted  that com parison of 121e with 124c could mean 
that 124c should be included in this group (see Fig. 5.2), however 121e does not appear to  lose 
so much m R N A  at 36 °C  though the autoradiographs are over-exposed and caution must be
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observed when in terpreting  these data. M utan t 124c cannot com plem ent a prp24  m utant and is 
therefore likely to be allelic to prp24  (see Section 5.4), and indeed this is a reason for 
postulating that 121e is in fact a prp  m utant defective in splicing and also for placing 124c in 
Section 5.3.1.
5.3.2.5 196a
M utant 196a exhibits a N orthern  phenotype sim ilar to 121e (see Fig. 5.4B) though in 
196a there appears to be m ore pre-m R N A  accum ulation at 23 °C. M utant 196a is in fact a prp8  
allele (see Section 5.4), and the fact tha t its N orthern  phenotype is sim ilar to 121e supports the 
hypothesis that 121e is a splicing m utant. H owever it is difficult to in terp ret the observations 
m ade for 121e as the film is heavily over-exposed and therefore all com parisons m ade with 
o ther m utants (196a and 124c) m ust take this into account. It is interesting to com pare the 
N orthern  blot phenotypes exhibited by 196a and SPJ8.31 (see Figs. 5.4B and 5.1A, respectively). 
The results presented for these m utants suggest tha t different alleles can produce variable 
N orthern  phenotypes and this may indicate a m ultifunctional protein  in the  splicing process. 
Indeed the prpS .l allele also exhibits a N orthern  phenotype distinct from tha t produced by the 
o ther prp8  alleles (J. Brown, pers. comm.).
5.3.3 M utants in W hich T here A ppears to be a Small D ecrease in Splicing Efficiency
A  com parison of the  N orthern  phenotypes exhibited by the m utants identified in the 
screening procedure with those of DBY745 (all the m utants that could be placed in this group 
were derived from DBY745), 196a (prp8) and prp25, identified a set of m utants which appear 
to show a relatively small decrease in splicing efficiency (see Fig. 5.5). This analysis is based 
entirely on the N orthern  phenotype produced by m utants when probed with the CYH2  gene, 
and indeed possible splicing defects are undetected by analysing the actin transcript (see Fig. 
5.5). It can be seen that the  m utants may produce a relative accum ulation of pre-m RN A , as
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FIGURE 5.4A NORTHERN BLOT HYBRIDISATION ANALYSIS OF MUTANT 121e
Tracks 1-2: RN A  was prepeared from cultures of 121e grown in Y PD A  at 2 3 °C  or shifted
to 36°C  for 1.5-2 hours. All o ther experim ental details were as for Fig. 5.1.
Tracks 3-6: Tim e-course of N orthern  blot phenotype exhibited by 121e on incubation at
36°C. Cultures of 121e were initially grown in Y PD A  at 23°C  to an O D  600nm 
of 0.1-0.4 and then shifted to 36°C . Thereafter, R N A  was prepared a t hourly 
intervals (1-4 hours, tracks 3-6 respectively).
FIGURE 5.4B: NORTHERN BLOT HYBRIDISATION ANALYSIS OF MUTANT 196a
Tracks 1-4: R N A  was prepared from cultures of 196a grown in Y PD A  at 23°C  or shifted
to 36°C  for 1.5-2 hours. Tracks 1 and 2 and tracks 3 and 4 represent two 
independent experiments. A 1 o ther experim ental details were as for Fig. 5.1.
FIGURE 5.4C: NORTHERN BLOT HYBRIDISATION ANALYSIS OF MUTANT 109i
Tracks 1-4: Tim e-course of the N orthern  blot phenotype exhibited by 109i on incubation
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observed for 196a and prp25  at 36 °C  (see Fig. 5.4B and 5.7A respectively). O f those indicated 
in Figs. 5.5A and B, the m utants 6c, 24b, 34a, 51a, 63d, 70a, lO lg and lO lh  appear to exhibit 
the m ost pronounced contrast in pre-m R N A  and m R N A  ratios. F u rther experim ents analysing 
different transcripts are  required to  determ ine w hether these m utants are defective in splicing. 
Because of the  ambiguity in defining these m utants as prp strains they are no t considered in the 
com parative analysis with o ther screens discussed in Section 5.6.
5.3.4 M utants W ith A ltered Transcript Size
Three m utants, 7c, 31a and 43c fell in to  this class. W hen incubated at 36°C , 7c exhibits 
an increase in the size of pre-m R N A  (see Fig. 5.6A; indeed with shorter exposures the m R N A  
appears to  exhibit a sim ilar increase in size at 36°C , results not presented). 31a and 43c appear 
to show an increase in the size of the pre-m R N A  at 23 °C  relative to  3 6 °C, though the GPM  
control probably indicates that this effect is independent of the in tron (see Fig.5.6A). Prim er 
extension analysis of the CYH2 transcrip t using the JM C Y H 2A  oligodeoxynucleotide (see 
C hapter 2.1.6, Table 2.4) and R N A  preparations m ade from 7c and 31a indicate that the 
transcription initiation sites and the splice sites are identical in these m utants incubated at the 
two tem peratures (see Fig. 5.6B and no te  that CYH2  has at least th ree sites of transcription 
initiation), and this implies that the  reason for the increased transcrip t size is a defect in 
determ ining the 3 ' end of the transcript. This could be at the level o f transcriptional 
term ination  or polyadenylation. 43c was no t analysed. It has previously been noted that on 
incubation at 36°C , a prp l m utant accum ulates intron-less G A L 1 , 7 and 10  transcripts which 
are extended at their 3 '  ends (St. John and Davis, 1981) and this may be related to  the G A L  
prom oters as o ther genes do not exhibit such a phenom enon in p rp l m utants (Struhl and Davis, 
1981). In com plem entation analysis it is interesting to  no te  tha t 7c could com plem ent a prp l 
strain and thus was not defective in PRP1 (see below). However a sim ilar analysis has yet to 
be carried ou t with 31a and 43c. 31a appears to accum ulate pre-m R N A  at the expense of
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FIGURE 5.6A NORTHERN BLOT HYBRIDISATION ANALYSIS OF t5 MUTANTS 
7c, 43c AND 31a
A1 experim ental details were as for Fig. 5.1.
FIGURE 5.6B: PRIMER EXTENSION ANALYSIS OF MUTANTS 7c AND 31a
R N A  was prepared from cultures o f 7c and 31a which had been grown in Y PD A  at 
23 °C  or shifted to 36°C  for 1.5-2 hours. The oligodeoxynucleotide JM CY H 2A , which is 
complem entary to a region of exon two (see C hapter 2.1.6, Table 2.4), was hybridised to 
30-100^g total R N A  from each preparation  at 53 °C  for 15-30 m inutes, and the prim er 
extension reaction was then carried out as described in C hapter 2.2.8.5.
The m arkers are derived from a M spl digest of pBR322, the fragments of which were 
radioactively labelled by rendering the ends b lunt with radio-labelled nucleotides.
Tracks 1-2 and 5-6: 10/xl of each R N A  preparation (~30-50/ag) was used in the prim er
extension reactions. The tem perature  at which the yeast cultures had 
been grown is indicated above each track.
Tracks 3-4 and 7-8: 20/j.l of each R N A  preparation  (~60-100/ag) was used in the prim er
extension reactions.
The CYH2 gene has at least three transcription start sites, therefore the  sizes of the 
prim er extension products expected are,
pre-m R N A  - 616, 612 and 606nts (N.B. these th ree species have no t been resolved
at the top of the gel)
m RN A  - 106, 102 and 96nts
IVS-E2 - 66nts.
However the actual sizes of the pre-m R N A  and m R N A  species detected are roughly 
10 nucleotides smaller. Using the oligodeoxynucleotide JM CYH2B, which is com plem entary to 
a region of the intron, the sizes of pre-m RN A  species were also found to  be roughly 10 
nucleotides smaller than expected (results not presented). The reason for the discrepancy is 
unknown but may be due to differences in the transcription initiation sites of CYH2  in different 
yeast strains.
FIG. 5.6
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m R N A  when incubated at 36 °C  and thus may be a prp m utan t (see Fig. 5.6B, tracks 7 and 8).
The rem aining m utants that originally exhibited a blue phenotype in the screening 
procedure fail to show a discernable prp  phenotype on N orthern  blot analysis, and are not 
considered further.
5.4 COMPLEMENTATION ANALYSIS OF POTENTIAL prp MUTANTS
C om plem entation analysis (see C hapter 2.23.5) was perform ed using some of the 
possible prp  m utants isolated by the screening procedure and the results of this analysis are 
given in Table 5.3. All prp  strains (indicated in C hapter 2, Table 2.2) o f both mating-types were 
utilised in this analysis; each individual m utan t was crossed at least twice to the prp  strains to 
verify the results obtained. U nlinked m utations which fail to  com plem ent each o ther have been 
identified in yeast (M addock, J., pers. comm.) and therefore further genetic analyses are required 
to confirm the prp  genotype of the newly isolated m utants.
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M utant C om plem entation G roup M utant C om plem entation G roup
TABLE 5.3 COMPLEMENTATION ANALYSIS OF POSSIBLE prp MUTANTS
196a prp8  60h*
221c prp6  61d prp l
275 prp 5 104b prp 24
298 prp6  105c prp2
6c* - 109i
7c* - 121e
9c prp24  124c prp 24
36a - 20a
( (-) indicates that the m utant belongs to a new com plem entation group; * indicates that 
N orthern  analysis has not been perform ed using diploid strains o f this m utan t crossed to prp25  
and prp26).
5.4.1 N orthern  Analysis of Strains Crossed to  prp25  and prp26
Because pip25  and prp26  are  no t tem perature-sensitive (see C hapter 1.9), determ ining 
w hether the newly isolated m utants com plem ent the prp25 o r prp26  defects requires the
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generation of diploid strains from the relevant matings. R N A  was isolated from these diploids 
after their incubation at 23 °C  and 36 °C  and analysed for the  defects specific to the strains by 
N orthern  blotting. Fig. 5.7A shows the N orthern  phenotype exhibited by prp25 and prp26 and 
the results of crosses involving 36a, 109i and 121e with prp26. The accum ulation of the in tron 
dem onstrated by prp26  is clearly absent from these diploids (the result for the  actin in tron is 
no t presented for the cross involving 12 le  and prp26, however this diploid does not accum ulate 
the CYH2  in tron, see tracks 9 and 10). Therefore these new strains are unlikely to be prp26 
m utants. However it is noticeable that the diploid of 121e and prp26 appears to accum ulate 
CYH2 pre-m R N A  (but not actin) at 36 °C  even though it does not accum ulate the intron. A 
possible explanation for this could be that the relevant gene products of each strain  in teract to 
partially com plem ent the,121e-specific defect in pre-m R N A  accum ulation but com plem ent fully 
the defect in in tron metabolism . Indeed intragenic com plem entation is also a possibility.
The accum ulation of pre-m R N A  observed for 36a, 109i and 121e is absent from 
crosses involving prp25 , and it is likely that they represent a different com plem entation group(s) 
(see Fig. 5.7B). However in terp re ta tion  of the crosses involving prp25 is difficult as the 
individual defects are not so distinctive. Indeed for 36a and 109i crossed to prp25  there is a 
definite decrease in the total R N A  level a t 36 °C  though no accum ulation of pre-m R N A  is 
detected. In this respect it is im portant to  no te  that the pre-m R N A  accum ulation exhibited by 
prp25  is no t substantial (see Fig. 5.7, tracks 1 and 2) and therefore it cannot be certain that 36a 
and 109i are in a different com plem entation group to prp25.
It is therefore only possible to suggest that these three m utants represent a t least one 
newly identified com plem entation group(s). So far the  m utants have not been outcrossed and 
so it is not possible to determ ine the num ber of com plem entation groups they define. Analysis 
o f 6c, 20a and 60h has not been com pleted. They are probably no t prp25  or prp26 as they 
exhibit different N orthern  phenotypes, though the possibility exists that different m utations in 
the sam e gene exhibit different phenotypes. Indeed this is suggested by the isolation of 196a 
(prp8) and with current analysis of the  prp8.7  allele, which do no t display the "normal" prp8
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INVOLVING 36a, 109i AND 121e WITH prp25 AND prp26
FIGURE 5.7: NORTHERN BLOT HYBRIDISATION ANALYSIS OF CROSSES
RN A  was prepared from the relevant diploid strains grown at 23 °C  o r shifted to 36 °C  
for 1.5-2 hours. All experim ental details were as for Fig. 5.1, except that diploid strains of 36a 
and 109i crossed with prp25 and prp26 w ere grown in YM M  (see C hapter 2.1.2.2) plus the 
required supplem ents. In contrast diploid strains o f 121e crossed with prp25  and prp26  were 
grown in Y P D A  Thus the decrease in R N A  levels at 36 °C  evident for the form er diploid 
strains, may be a consequence o f the growth medium  used.
FIGURE 5.7A
Tracks 1-4: N orthern blot analysis of prp25  and prp26. The accum ulation of the in tron at
both  tem peratures is clearly evident in prp26. The sizes of the in tron species 
are;
actin - IVS - 308nts 
CYH2  - IVS - 510nts
Tracks 5-6 : prp26 crossed with 36a
Tracks 7-8 : prp26 crossed with 109i
Tracks 9-10: prp26 crossed with 121e
FIGURE 5.7B
Tracks 1-2 : prp25 crossed with 36a
Tracks 3-4 : prp25 crossed with 109i
Tracks 5-6 ; prp25 crossed with 121e
FIG. 5.7 
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F IG U R E  5.8: U V  M U TA G EN ESIS; SU R V IV A L C U R V E S O F  DBY756 A N D  DBY746
All mutagenesis procedures are described in C hapter 2.23.1  and 2.2.3.8. D uplicate 
samples of cells (for each tim e-point) were removed during exposure to  U V  light and spread 
on plates. The num ber of colonies arising from the U V  treated cell-pools, after 3-5 days 
incubation at 23 °C, was averaged and then com pared to the num ber of colonies present from 
untreated samples (duplicate samples also). This com parison is expressed as the percentage 
survival of cells after a specific U V  exposure time. The U V  dose was 10 ergs/mm2/sec, delivered 
from a height of 32cm.
UV M u t a g e n e s i s :  S u r v i v a l  C u r v e s
% colonv survival 
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N orthern  phenotype (Brown, J., pers. comm.). 124c may also be such a m utant, depending on 
the "normal" prp24 N orthern  blot phenotype. 6c, 20a and 60h are not allelic to  previously 
isolated prp  m utants (depending on the analysis with prp25  and prp26). 7c was analysed to 
determ ine if it could com plem ent a prp20  m utan t (Vijayraghavan et a!., 1989) or a prp l m utant 
(see above), but it proved to be a new com plem entation group (depending on analysis with 
prp25 and 26).
55  t5 PROFILE OF ISOLATED MUTANTS
All m utants which exhibited a blue phenotype, as assayed in the  screening procedure, 
(see C hapter 4, Fig. 4:10) were resuspended in w ater and spotted onto  YM G /Cas and Y PD A  
plates and incubated at 23 °C  for 4 days. The cells were then replica-plated onto  the same media 
used for its initial growth at 23 °C  and incubated at various tem peratures for 5 days. The results 
of the growth phenotypes at each tem pera tu re  are given in Table 5.4. Only those m utants which 
constitute the 4 groups in Section 5.3 are indicated.
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TABLE 5.4 t5 GROWTH PROFILE OF POSSIBLE prp MUTANTS
M utant 18°C  23 °C  3Q°C 34 °C  36°C
Y M G  Y PD A  Y M G  Y PD A  Y M G  Y PD A  Y M G  Y PD A  Y M G  Y PD A
9c + + + + + /- + /- - - - -
20a + - + + + + + + - -
36a + + + + + + + + /- - -
60h + + + + + + + +/- -/+ -
61d + + + + + + + - - -
104b + + + + + + + + - -
105c + + + + + + + + - -
109i + + + + + + + + - -
121e + + + + + + + - - -
124c + + + + + + + . + - -
196a + + + + + + +  /- +1- - -
221c + + + + - - - - - -
275 + + + + + 4- - - - -
298 - + + + + + /- + /- - - - -
6c + + + + + + + + - -
19a + + + + + +  /- - - - -
24a + + + + + + + + -/+ -/+
24b + + + + + + - - - -
34a + + + + + + + + -/+ -/+
51a + + + + + + + + -
70a + + + + + + + /- + /- - -
lO lh + + + + + + + + - -
102e +/- + /- +/■ + /- + + /- + + +/- -
110a + + + + + + + + - -
7c + + + + + + + + - -
31a + + + + + + + + - -
43c + + + + + +  /- + /- - - -
( (+ ) indicates growth; (-) indicates no growth; (+ /-) indicates partial growth which
a result o f a partial t s defect, reversion and/or contam ination of the original water-suspended
colony)
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R esults for the  all the  rs m utants isolated are no t presented. These growth profiles are 
tentative and need to be repeated. A t the tim e of writing a thorough investigation of the 
genotypes of all the m utants has not been perform ed, and it is therefore feasible that som e may 
be yeast contam inants e.g. 102e. The reason(s) for the discrepancy in growth occasionally 
observed between YM G/Cas and Y PD A  is unknown.
5.6 DISCUSSION
5.6.1 Com parison of the Efficiency of the Plate-Screening Procedure Using DBY745 and 
DBY746
O ut o f 296 rs m utants derived from DBY745, five were new isolates of pre-existing prp 
m utants (9c, 61d, 104b, 105c and 124c) and five exhibited properties that suggested that they 
were newly defined prp  com plem entation groups (20a, 36a, 60h, 109i and 121e). Thus the prp 
m utants accounted for 3.38% of the total rs pool (see Section 5.6.2 for a com parison with o ther 
screens). However it has not been shown that 20a and 36a can consistently exhibit a N orthern 
blot phenotype that would indicate that they were prp  m utants. Thirty-five rs m utants produced 
a blue phenotype in the plate-screening procedure and ten of these m utants exhibited a possible 
prp phenotype when investigated by N orthern  blot analysis. Thus 28.6% of the m utants 
screened by N orthern  blot analysis were possible prp  m utants.
O ut o f 294 rs m utants derived from DBY746, four were allelic m utants of pre-existing 
prp com plem entation groups (196a, 221c, 275 and 298). Thus the prp  m utants accounted for 
1.36% of the total t s pool (it is possible that 196b is also in the sam e com plem entation group 
as prp8 because it was derived from the same m utagenised cell-pool as 196a; however 
com plem entation analysis has not been perform ed using this m utant). Eleven m utants produced 
a blue phenotype in the plate-screening m ethod and on N orthern  blot analysis 36.36%  of these 
w ere prp  m utants.
It would appear from these observations that it is easier to specifically identify prp 
m utants when DBY746 is the strain utilised in the plate-screening procedure (a 36.36% success 
rate com pared to one o f 28.6%, at best, for DBY745). A  possible explanation for this difference 
is the fact tha t DBY745 produces a considerable am ount o f background 0-galactosidase activity 
(see C hapter 4.1.2). Using the crude p late assay this makes it difficult to  distinguish the 
relatively small increase in activity produced by the weak prp  m utants from the background 
activity exhibited by m ost of the  o ther colonies, and this results in the "positive" blue phenotype
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of many m ore colonies. It should be noted tha t colonies that w ere slightly blue were isolated 
and screened by N orthern  blot analysis. However it is also clear that m utants that show a weak 
prp phenotype, as investigated by N orthern  blot analysis (e.g. 61d, 60h and 109i), are  clearly 
under-represented in the screen utilising DBY746. Indeed if 60h, 61d, 109i, 20a and 36a are 
excluded from the final tally of possible prp  m utants isolated using DBY745, then the 
percentage of prp  m utants isolated using both  strains is very sim ilar (1.36%  for DBY746 to 
1.69% for DBY745). DBY746 is ts for galactose induction and it is possible tha t this restricts 
the types of prp  m utants tha t can be isolated using this strain (see C hapter 4.2.1.3 for a fuller 
explanation). It seems likely tha t the screen would function with increased efficiency if a suitable 
strain  was utilised that was not ts for galactose induction and which did not produce high 
background levels ofactivity.
5.6.2 Com parison of the Plate-Screening M ethod W ith O ther Screening Procedures
Two o ther large-scale screening procedures have identified conditional-lethal prp  
m utants (see C hapter 1.9). The first screen defined m utants defective in R N A  m etabolism  on 
the basis that they exhibited a pro tein :R N A  ratio > 4  (P/R  >4; henceforth called the P/R 
screen) when incubated at the non- permissive tem perature  (Hartwell, 1967) and the second
identified prp  m utants by N orthern  blot analysis as described in Section 5.3 and in C hapter 1.9
(Vijayraghavan et a!., 1989). prp  m utants isolated by each screen accounted for roughly 5%  and 
3.7% respectively of the ts pools generated.
5.6.2.1 Advantages of the Plate-Screening Procedure
The plate-screening m ethod is significantly faster than either the  P/R  or N orthern  blot 
screens. It reduces the num ber o f rs m utants that have to  be analysed by N orthern  blotting 
procedures alm ost 13-fold (the average of DBY745 and DBY746) and indeed this may be 
further reduced depending on the strain  utilised in the screen (see 5.6.1), e.g. if DBY746 is 
considered on its own then there is a 30-fold reduction in the num ber of m utants that were 
analysed using N orthern  blotting techniques. In practise the rate-lim iting step in the whole 
procedure (from  the generation of ts m utants to the N orthern  blot analysis of potential prp  
m utants) is the creation of a ts m utant pool.
The sensitivity of the plate-assay can be m odulated by simply changing the
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concentration of X-gal in the reaction (see C hapter 4.2.3). Thus the m utants can be induced on 
Y M R/G al/Cas medium  for relatively short o r long incubations at the appropriate  tem peratures. 
In this way it should be possible to  differentiate those m utants which take longer to  exhibit an 
effect on splicing e.g. snR N P assembly m utants, from the norm al wild-type background activity. 
The approaches taken using the o ther two screening procedures may not have identified such 
m utants as the ts m utants were analysed after only 2-3 hours incubation at the non-perm issive 
tem perature  (H artwell, 1967; Vijayraghavan et al., 1989). SnRN P particles are metabolically 
stable and therefore it is probable that m utations in snRN P assembly would take longer to 
produce an effect on splicing. It would not be unreasonable to expect that such m utants would 
take longer to  exhibit any t s effect on their ra te  of growth. Indeed 196a only starts to show a 
tem perature effect on its ra te  of growth (as m easured by the OD 600nm) after 10 hours 
incubation at 36°C  (results no t presented). Experim ents are underway to examine the ts growth 
profile o f all the m utants isolated by this screen. In this respect it is interesting to no te  that 
20a and 36a have yet to  exhibit a reproducible accum ulation of pre-m RN A , and it may be that 
they require extended lengths o f incubation at 36 °C  i.e. > 4  hours; indeed 36a accum ulates 
pre-m R N A  after 4 hours incubation at 3 6 °C  (see 5.3.2.2).
5.6.2.2 Disadvantages of the Plate-Screening Procedure
The plate-screening procedure relies on the accum ulation of pre-m R N A  that can 
encode an active /5-galactosidase fusion protein. Consequently it may not be able to detect 
m utants that accum ulate either the splicing interm ediates and/or products only (see 
Vijayraghavan et al., 1989). Indeed no such m utants were detected in this particular screen. 
However it is possible that m utations which cause accum ulation o f the interm ediates and/or 
products of splicing may feedback inhibit earlier steps in the splicing reaction by titrating out 
snRN Ps and o ther factors required for the initial stages in splicing. This would result in an 
accum ulation of pre-m R N A  which should be detectable using the plate-assay. This postulated 
titra tion  of snRN Ps and other factors may take a relatively long tim e to  produce an effect on 
pre-m R N A  accum ulation, and therefore it is of benefit that the  plate-screening procedure can 
be prolonged by regulating the sensitivity of the assay. It is therefore possible tha t such m utants 
were not detected using this plate-screening assay because a relatively small pool o f ts m utants 
was analysed. However it m ust be noted tha t in the  N orthern  b lo t screen of Vijayraghavan et 
al., (1989), nine out of the thirty-seven prp  m utants isolated accum ulated the interm ediates or 
products of splicing. It would be expected that a similar p roportion  would have been detected 
using the plate-assay screen. These differences could be a result o f the screen employed (i.e this
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screen relies on the accum ulation of pre-m R N A , see above) or a consequence of the different 
forms of m utagenesis utilised (i.e. U V  m utagenesis versus chemical mutagenesis).
The num ber of prp  m utants isolated by the plate-screening procedure, expressed as a 
percentage of the num ber o f m utants in the  rs pool, may be lower than those identified by the 
o ther two m ethods e.g. 3.38%  when DBY745 is used in the  plate- screen com pared to ~ 5 %  
and 3.7% for the P/R  and N orthern  screens respectively. It is interesting to no te  that in the 
N orthern  screen if the m utants that accum ulate interm ediates or products only are  excluded 
from this analysis then the percentage recovery of prp  m utants falls to —2.8%. Thus the 
differences in the percentage recovery o f prp  m utants may be due to the possibility that the 
plate-screen cannot detect m utants which accum ulate the interm ediates or products of splicing 
(see above). However the figures for each screening procedure are relatively close. It should be 
noted that a m inority o f the  m utants originally placed in  the rs pool created in this study were 
not infact tem perature- sensitive and therefore  this may reflect the slight decrease in the 
percentage recovery o f m utants observed for the plate-screen when DBY745 was used. The 
reason for the relatively low recovery of prp  m utants using DBY746 may be a consequence of 
its tem perature-sensitive galactose induction phenotype (see above).
5.6.3 New Isolates o f Pre-Existing prp M utants Isolated by the Plate-Assav Screening 
Procedure
Using the plate-assay, alleles o f p rp l  (one isolate), prp2  (one isolate), prp5  (one 
isolate), prp6  (two isolates), prp8  (one isolate) and prp24 (three isolates) were identified. It has 
been proposed that m utations at the com m itm ent stage in splicing may allow the escape of 
relatively m ore pre-m R N A  from the nucleus (Legrain and Rosbash, 1989). The plate-assay 
screen would therefore readily identify "commitment" m utants by their increased /?-galactosidase 
activities. PR P6 may be involved in the  com m itm ent stage of splicing (see Legrain and Rosbash, 
1989) and it is interesting to note tha t two independent prp6  alleles were isolated using the 
plate-assay screen. It has also been suggested that PRP24 is involved in the early stages of 
spliceosom e assembly (Arenas et ah, 1989) and indeed th ree independent prp24 alleles were 
identified in this screen. The plate-assay screen may therefore enhance the detection of m utants 
defective in the early stages o f splicing.
The new prp8  allele (196a) exhibits a N orthern  blot phenotype unlike the o ther prp8 
alleles (except prp8. 7 which does not readily accum ulate pre-m R N A  unless extended incubation, 
> 8  hours at 36°C , is undertaken). Consistent w ith the observation that the  m R N A  level is not
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significantly depleted on incubation at 3 6 °C  for 2 hours, 196a continues to  grow for up to 10 
hours at the non-perm issive tem perature  (see Section 5.6.2.1). The fact that the growth of 196a 
is tem perature-sensitive suggests that the effect of the m utation is m ore pronounced at the 
higher tem perature. A fter only two hours incubation 196a accum ulates pre-m R N A  at both  23 °C  
and 3 6 °C. The early accum ulation o f pre-m R N A  may not be consistent with 196a being 
defective in snR N P assembly. However it could be that snR N P assembly is affected at both 
tem peratures producing partially active snRN Ps which can function in splicing. In this case the 
defect would be greater at the higher tem perature. These observations may suggest that 196a 
is defective in the splicing process directly, ra ther than in snRN P assembly.
Isolation o f a p rp l allele which accum ulated pre-m R N A  was unexpected. Based on the 
results presented in C hapter 4.1.2.4 it was expected that p rp l m utants would not be isolated 
using the plate-assay screen. PRP1 has been im plicated in a variety of R N A  processing events. 
Early experim ents suggested that p rp l m utants were defective in the transport of R N A  from 
the nucleus (H utchison et al., 1969; Shiokawa and Pogo, 1974). It was subsequently observed 
that the prpl-1  m utant was also defective in the  processing of som e pre-tR N A s and pre-rR N A s 
when incubated at the restrictive tem pera tu re  (H opper et al., 1978; K napp et al., 1978). It was 
also found that the  levels o f in tron-containing and intron-less transcripts were reduced in a 
similar m anner when a p rp l-1  m utan t was incubated at 36°C  (Rosbash et al., 1981). This 
suggested that PRP1 was not directly involved in pre-m R N A  processing. The PRP1 gene has 
been cloned and sequenced and deletion analysis has indicated that a specific region of the 
PRP1 protein is required to  produce an effect on pre-tR N A  or pre-rR N A  processing (A tkinson 
et al., 1985; Traglia et al., 1989). The new prp  allele isolated in the  plate-assay screen constitutes 
the first evidence im plicating PRP1 in pre-m R N A  processing. However it is possible that this 
p rp l m utan t also contains ano ther prp m utation which is reponsible for the accum ulation of 
pre-m R N A  observed in this m utant. If the introduction of the PRP1 gene (on a yeast expression 
vector) into this m utant restores the ability of the cells to  splice pre-m R N A  then this will 
indicate that the accum ulation of pre-m R N A  is due to  the p ip l  m utation. This experim ent is 
currently underway.
5.6.4 O ther Types of M utants that Could be Isolated Using the Plate-Assav Screen
M utations that caused an aberran t 5 ' o r 3 ' splice site cleavage event could lead to  the 
splicing o f the pJBM -4 fusion- transcript back into frame with the lacZ  gene. This m RN A
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transcrip t would then be able to encode an active /3-galactosidase fusion protein. The plate-assay 
would, in theory, detect this novel class of splicing m utants.
M utants which exhibited altered rates of translation  or could change translational 
reading frames could possibly be isolated using this screen.
M utants which w ere defective in R N ase activity would produce relatively m ore 
pre-m R N A  than those which were not, thus becom ing detectable using this screen.
5.6.5 F u tu re  W ork
The isolation of potential prp  m utants which may represent new com plem entation 
groups was achieved using a novel screening procedure. It is now im portan t to design 
experim ents that can determ ine w hether these m utants are defective in the process of 
pre-m R N A  splicing. Y east provides a powerful system in which various com plem entary 
approaches can be taken to study the function of gene products.
Initially these m utants will be out-crossed into the appropria te  wild-type genetic 
background. T etrad analysis will be perform ed to establish a 2:2 segregation pattern  of the fs 
m utation. It will also be ascertained w hether the R N A  splicing defect co-segregates with the ts 
phenotype. Following this the m utants will be crossed with each o ther to identify the num ber 
of new com plem entation groups isolated. A n intensive study of the / s growth profile and 
pre-m R N A  accum ulation pattern  of these m utants will then be initiated (see Section 5.6.2.1). 
C om plem entation of the rs defect in these m utants should enable the isolation of the wild-type 
gene of interest. The cloning of the wild-type genes should allow the generation of antibodies 
directed against their protein  products (if indeed they are protein-encoding genes) and thus 
facilitate a num ber of experim ents which could determ ine the ro le of these proteins in splicing 
(e.g. see Lossky et al., 1987). O ther approaches designed to  determ ine the role of the prp
products in splicing include making heat-sensitive splicing extracts (Lustig et al., 1986) and
m utational analysis o f the genes themselves.
5.6.6 O ther Possible Screens
Using yeast strains harbouring the  plasmid pJBM-4/s it should be possible to  use the 
same plate-assay procedure as described in C hapter 4, Fig. 4.10, to detect conditional-lethal 
m utants that are defective in the choice of the  correct 5 ' and 3 ' splice sites when incubated 
at the restrictive tem perature. Using an appropria te  strain the background activity arising from 
pJBM-4/s could be considerably reduced (see C hapter 4.1.2.1). Trans- o r c/s-acting m utations
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could conceivably cause an alternative splicing event generating m R N A  transcripts (derived 
from pJBM -4/s) that are  able to encode an active /?-galactosidase fusion protein. Because the 
turnover ra te  of a m R N A  transcrip t is considerably less than that o f the pre-m R N A  and 
because in general pre-m R N A  may be retained in the nucleus whereas m R N A  is transported 
out, it is likely that the detection of these splice site m utants would be enhanced in a screen 
w here it is the m R N A  that encodes the /?-galactosidase activity ra ther than the pre-m RN A , as 
for pJBM-4. Thus the detection of conditional-lethal 5 ' and 3 ' splice site  m utants may be 
relatively straightforward.
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APPENDIX
COMMITMENT OF A PRE-mRNA TRANSCRIPT TO SPLICING 
INTRODUCTION
Previous in vitro studies have dem onstrated that pre-m R N A  is com m itted to splicing 
prior to  the form ation of the  U2 snR N P-containing prespliceosom e (Seraphin et al., 1988; 
Legrain et a /., 1988; Seraphin and Rosbash, 1989b). A  "commitment" complex has been 
identified and its form ation (which requires little or no ATP) relies upon the presence on the 
transcript o f the conserved 5 ' splice-site and branch-point sequences (Seraphin and Rosbash, 
1989b). This complex contains the U1 snRN P. A  ra ther subtle in vivo approach was used to 
identify cis- and trans-acting factors which might interfere with this com m itm ent stage (Legrain 
and Rosbash, 1989). Based on the observations made by this approach, the  authors proposed 
a model for the com m itm ent of pre-m R N A  to splicing. This A ppendix presents experim ents 
designed to com plem ent and extend such an approach. Please refer to  Legrain and Rosbash
(1989) for a full description of the  experim ents undertaken. A  brief account of the pre-m R N A  
com m itm ent model is given below.
Newly transcribed pre-m R N A  is bound by a com m itm ent factor(s) (at least one of 
which is the U1 snR N P) which determ ines that the transcript enters the splicing pathway. The 
binding of this com m itm ent factor(s) inhibits the transport o f pre-m R N A  to the cytoplasm, 
retaining it in the nucleus until the in tron  has been removed. In this model intron-less 
transcripts are not retained in the nucleus because they lack the conserved 5 ' splice site and 
branchpoint sequences which are required for the form ation of the com m itm ent complex.
The rationale for the experim ents used to establish the com m itm ent model is that 
intron-containing transcripts may be retarded in the  nucleus by the splicing m achinery in 
contrast to their intron-less counterparts. If these respective transcripts encode /?-galactosidase 
fusion-proteins, then m ore activity should be m easureable from the intron-less transcripts 
because at any one tim e m ore of them  are  present in the cytoplasm (even though the rate of 
transcription is the same for intron-less and intron-containing). Therefore pJBM-5 should
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produce m ore /?-galactosidase activity than pJBM-1 (see Table below). The difference in 
activities arising from pJBM-1 and pJB M -l/s (if any) should be due to pre-m R N A  transcripts 
(generated from pJBM -1) which leave the nucleus before being com m itted to  splicing, and this 
should be equivalent to the  activity produced by pJBM-4.
ANALYSIS OF PRE-mRNA COMMITMENT UTILISING pJBM-1 TO -5
In an attem pt to repeat part of the analyses carried out by Legrain and Rosbash (1989), 
DBY745 (the sam e strain  as used by these authors) was transform ed with pJBM-1 to pJBM-5 
(see C hapter 3.4) and assayed for /?-galactosidase activity as described in C hapter 2.2.9. As 
previously indicated the pJBM -4 fusion-transcript containing the M A T a l  in tron is spliced with 
roughly 80%  efficiency (see C hapter 4.1.1). This contrasts with the transcript utilised in the 
study of Legrain and Rosbash which is spliced with 20%. efficiency. It was considered that a 
repeat of the experim ents of Legrain and Rosbash, incorporating a "normal" yeast in tron, would 
indicate w hether the results observed were general for yeast intron-contain ing transcripts. In the 
following sections cultures of transform ed strains are described thus; the nam e of the strain  e.g. 
DBY745, followed by the nam e of the plasmid residing in it, in brackets, e.g. (pJBM -5). A 
table indicating the equivalent plasmids (in term s of their /?-galactosidase producing ability) used 
in the  study of Legrain and Rosbash and in this study, is presented below.
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Plasmid Name Plasm id Name jS-galactosidase
(Leerain and Rosbashl (This Study) Pre-m R N A  m RN A
pLGSD5 pJBM-5 +
PLint pJBM-1 +  +
Acc° pJB M -l/s +
N de°A cc° pJBM -4 +
Sty0 pJBM-4/s -
Com parison of pJBM-1, -1/s and -5
Figs. 6.1 and 6.2 com pares the /?-galactosidase activities exhibited by DBY745 
(pJBM -1), (pJB M -l/s) and (pJBM -5) when incubated at 23°C  and 36°C  respectively. In all 
experim ents for each plasmid, two independent transform ants (colony purified 3 times) were 
tested and each was assayed in duplicate. The results presented are  the average values for each 
plasmid i.e. the results of the two transform ants (of a specific plasmid) were com bined and 
averaged.
O n incubation at 23 °C  and 36°C , DBY745 (pJBM -1) produces greater activity when 
com pared to  DBY745 (pJBM -5). Such results are in com plete contrast to those obtained by 
Legrain and Rosbash. A t 23 °C, cultures of DBY745 (pJB M -l/s) showed a sim ilar level of 
activity to those of DBY745 (pJBM -5) (at least for the first 4 hours). However activity arising 
from pJB M -l/s is greater than that arising from pJBM-5 when the cultures are incubated 3 6 °C. 
Com parison of DBY745 (pJBM -1) and (pJB M -l/s) reveals that the activity of each is greater 
a t 36 °C  relative to 23 °C. In contrast DBY745 (pJBM -5) showed sim ilar /S-galactosidase activities 
at both tem peratures (see Figs. 4.2, 6.1 and 6.2). It appears that splicing may be m ore efficient 
when cultures are incubated at 36°C  (see C hapter 4.1 and 4.2). Thus increased levels o f m R N A  
caused by this increase in splicing efficiency may explain the increase in /Tgalactosidase activity 
of DBY745 (pJBM -1) and DBY745 (pJB M -l/s) at 36°C  (see Table above).
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C ultures of DBY745 (pJB M -l/s) incubated at 23 °C  or 3 6 °C  exhibit roughly 66% of 
the activity of DBY745 (pJBM -1). A ccording to the observations of Legrain and Rosbash the 
difference in activities arising from pJBM-1 and -1/s should equal the pre-m RN A -encoded 
activity arising from pJBM -4 (see the difference between PLint and A c c ')  which therefore 
should produce 34% of the activity of DBY745 (pJBM -1). However activity exhibited by 
DBY745 (pJBM -4), on incubation at 2 3 °C, is only 1.57% (all tim e-points averaged) of the 
activity of DBY745 (pJBM -1) (com pare Figs. 4.3, 6.4 and 6.1). This may m ean that a large 
proportion  of the /Tgalactosidase activity generated from pJBM-1 is not encoded by the 
pre-m RN A . However o ther in terpretations are feasible e.g. the pJB M -l/s M A T a l-la cZ  fusion 
transcript may be poorly spliced, and/or the gene otherw ise poorly expressed resulting in its 
decreased expression relative to pJBM-1 (also see below).
V ariations in /Tgalactosidase activities could be a result o f differences in the stability 
of the pre-m R N A  and/or (3-galactosidase fusion proteins encoded by pJBM-1 to pJBM-5. 
Instability could be a consequence of the specific m utations introduced into the plasmid 
constructs and/or the removal of the in tron sequences due to splicing (see C hapter 3 and 
Discussion). A lthough such differences were not detected in the study o f Legrain and Rosbash 
(it should be noted that reference is m ade only to  those RN A s that could encode 
/Tgalactosidase, presumably others would be unstable in the  cytoplasm due to  the absence of 
"protecting" ribosom es), the possibility of differential instability o f R N A  and/or protein cannot 
be ruled out.
A nother possible reason for the anom alous jS-galactosidase activities is the presence 
of internal A U G  codons on the fusion-transcripts generated from pJBM-1 and -1/s (see C hapter 
3.3.3.2). Initiation of translation at these codons on a transcript not normally able to encode 
a /Tgalactosidase fusion protein, could theoretically lead to the production of /?-galactosidase 
activity. The plasmid pJBM-2 encodes a M A T a l-la cZ  fusion-transcript that contains three 
internal A U G  codons which could be possible sites of in itiation (NB. it differed from the 
fusion-transcript generated from pJBM -4 only in this respect). It was hypothesised that the 
activity exhibited by DBY745 (pJBM -2) could possibly produce the 34% difference in activities
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F IG U R E  6.1: C O M PA RISO N  O F  /J-G A LA CTO SID A SE A C IT V T nE S  P R O D U C E D  BY
pJBM -5, -1 and -1/s IN DBY745 IN C U B A TED  A T  2 3 °C
Cultures were grown at 23 °C  to an O D  600ntn of 0.1-0.4 prior to dilution and galactose 
induction, after which incubation was continued at 23 °C  (see C hapter 2.2.9). Culture-sam ples 
(0.5ml) were taken at hourly intervals after galactose induction and assayed for /3-galactosidase 
activity (see C hapter 2.2.9.2). The results presented represent the average values obtained from 
two transform ants, both  of which were assayed in duplicate. All activities were corrected for 
background activity present immediately after the  addition of galactose, the so-called tim e-zero 
(see C hapter 2.2.9.1) and therefore 0 hours induction has an activity value o f 0 (see Fig. 6.1). 
/Tgalactosidase units were calculated as described in C hapter 2.2.92.
FIGURE 6.2: COMPARISON OF ^-GALACTOSEDASE ACITVTnES PRODUCED BY
pJBM-5, -1 AND -1/s IN DBY745 INCUBATED AT 36°C
All experim ental details were as for Fig. 6.1 except that the cultures were initially 
grown at 23°C  to an OD 600nm of 0.1-0.4 then heat-shocked and incubated at 36°C . Fifteen 
minutes after the heat-shock at 36 °C  galactose was added to a final concentration o f 2%  and 
this is time-zero (see Chapter 2.2.9.1).
FIG. 6.1
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observed between DBY745 (pJBM -1) and (pJB M -l/s) (see above). Figs. 6.3 and 6.4 com pare 
the activities of DBY745 (pJBM -2) and (pJBM -4) when incubated at 23 °C  and 3 6 °C  
respectively. The activities of DBY745 (pJBM -2) incubated at both tem peratures are roughly 3 
times those of DBY745 (pJBM -4) (4 hour tim e-point onwards). This suggests that there is a 
substantial level of in ternal in itiation of translation, however the activity exhibited by DBY745 
(pJBM -2) is only approxim ately 4%  of that produced by DBY745 (pJBM -1) and not the 34% 
difference in activity observed between DBY745 (pJBM -1) and (pJB M -l/s). It m ust be 
rem em bered that pJBM -2 and 4 differ only in the presence of these three AUGs.
To determ ine if this effect was a strain  dependent phenom enon a sim ilar analysis was 
carried out in the yeast strain SI50-2B. Fig. 6.5 com pares the activities generated in cultures of 
SI50-2B (pJBM -2) incubated at 30°C  with cultures of SI50-2B (pJBM -4). Internal initiation of 
translation  may have been a consequence o f incubating the cultures a t sub-optim al tem peratures 
i.e. 23 °C  and 36 °C, therefore in this experim ent the cultures were incubated at the optim al 
tem perature  for yeast growth. Activity arising from pJBM -2 is roughly 3-5 times greater than 
that generated by pJBM -4 (2-4 hour tim e-points), suggesting that this effect is not strain 
dependent.
It was considered that there  had to be ano ther contributing factor(s) to  account for the 
34% increase in activity arising from pJBM-1 com pared to pJBM -l/s. The only difference 
between pJBM-1 and -1/s (apart from the stop  codon in the in tron) is the absence in pJB M -l/s 
of an A U G  at the 5 ' end of the lacZ  gene (see C hapter 3.3.1.3) i.e. pJB M -l/s has only two 
of the in ternal in itiation codons. Thus the greater activity observed for cultures of DBY745 
(pJBM -1) i.e above what would be predicted according to  the observations of Legrain and 
Rosbash, could be a result o f initiation at this A U G . Indeed the two internal A U G  codons 
present in pJB M -l/s may explain the relative increase in activity of that construct com pared to 
pJBM-5, when a com parison between the results o f Legrain and Rosbash and those presented 
here is made (pJBM -5 does not contain the three internal A U G  codons). Because of this 
possible phenom enon of internal initiation of translation no conclusions regarding the process 
of pre-m R N A  com m itm ent can be drawn from  the com parative analysis o f pJBM-1, -1/s and -5.
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F IG U R E  6 3 : C O M PA RISO N  O F  /J-G A LA CTO SID A SE ACTTVITIES P R O D U C E D  BY
pJBM -4 A N D  pJBM -2 IN DBY745 IN C U B A TED  A T  2 3 °C
All experimental details were as for Fig. 6.1 except that 0.5-2ml culture-sam ples were
taken.
FIGURE 6.4: COMPARISON OF /J-GALACTOSIDASE ACTTVTTTES PRODUCED BY
pJBM-4 AND pJBM-2 IN DBY745 INCUBATED AT 36°C
All experim ental details were as for Fig. 6.2 except that 0.5-2ml culture-sam ples were
taken.
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F IG U R E  63 : C O M PA RISO N  O F  /3-GALACTOSIDASE A CTIV ITIES P R O D U C E D  BY
pJBM -4 A N D  pJBM -2 IN S150-2B IN C U B A TED  A T 30 °C
Cultures were grown at 30 °C  to an O D  600nm of 0.1-0'4 prio r to galactose induction, 
after which incubation was continued at 3 0 °C  (see Chapter 2.2.9). Culture-sam ples (0.5-2ml) 
were taken at hourly intervals after galactose induction, and assayed for /3-galactosidase activity 
(see Chapter 2.2.9.2). The results presented represent the  average values obtained from two 
transform ants, both of which were assayed in duplicate. A ll activities were corrected for 
background activity present immediately after the addition of galactose, the so-called tim e-zero 
(see C hapter 2.2.9.1) and therefore 0 hour induction has an activity value of 0 (see Fig. 6.5). 
/3-galactosidase units were calculated as described in C hapter 2.2.9.2.
FIG. 6.5
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Com parison of pJBM -4 with pJBM-5; Relevance to C om m itm ent
Cultures of DBY745 (pJBM -4) incubated at 23 °C  exhibit roughly 2.3% o f the activity 
of DBY745 (pJBM -5) (see C hapter 4, Figs. 4.2 and 4.3). N either plasmid contains the three 
internal A U G s described above (see C hapter 3.3.1.3 and 3.3.3.2). This result is in close 
agreem ent with that observed for cultures o f DBY745 (N de°A cc°) and (pLGSD5). However 
the introns used in either study are spliced from their respective transcripts with different 
efficiencies (see above and C hapter 4). This means that although at any one tim e cells 
transform ed with N de°A cc° contain vastly m ore unspliced pre-m RN A , roughly the sam e am ount 
of pre-m R N A  leaves the nucleus as that observed for cells transform ed with pJBM -4 (N.B. that 
both analyses were perform ed in DBY745). These results suggest that transcripts with completely 
contrasting splicing efficiencies are com m ited to splicing with a sim ilar efficiency.
O ne problem  with this analysis is that the activity of DBY745 (pJBM -4/s) at 23°C  
accounts for roughly 45% of the activity of DBY745 (pJBM -4). This is not the case with 
DBY745 (S ty0) and (N de°A cc°). If the activity arising from pJBM-4/s results from 
read-through of the stop-codon in the pre-m R N A  (as suspected), this means that the pre-m RN A  
generated from pJBM -4 has still exited the nucleus and that the  percentage activity m easured 
is indeed 2.3% of that arising from pJBM-5. However if it is due to alternative splicing and/or 
fram eshifting then it is an activity encoded by m R N A  and therefore has to  be subtracted from 
pJBM-4, leaving roughly 1.27% com pared to the 2.3% m easured (see Chapter 4.1.2.1 for details 
of the pJBM-4/s percentage activity of pJBM -4). If the la tter scenario is correct then there may 
be a possible explanation for the slight com parative difference in activity exhibited by DBY745 
(pJBM -4) and (N de°A cc°) (1.27% com pared to roughly 3% ). The higher ratio  of activity 
observed for DBY745 (N de°A cc°) in com parison to DBY745 (pJBM -4) may be a consequence 
of the fact that the intron present on the N de° Acc° generated fusion-transcript (the transcript 
which encodes the /?-galactosidase fusion pro tein) is spliced inefficiently and thus may produce 
a m odest titra tion  o f com m itm ent factors. This would lead to  an exit o f m ore pre-m R N A  from 
the nucleus and thus effect the difference in ratios between pJBM -4 and N de° A cc° in 
com parison to their respective controls.
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DISCUSSION
In an a ttem pt to repeat part of the analyses carried ou t by Legrain and Rosbash, the 
/S-galactosidase activity profiles exhibited by cultures o f DBY745 (pJBM -1) to  (pJBM -5) were 
obtained. In terp retation  of the results was com plicated by the dem onstration  that there appeared 
to be in ternal initiation of translation occurring from at least one of three internal A U G  codons 
present on the transcripts generated by som e o f the plasmids. However anom alous results could 
also have been a consequence of R N A  and/or protein  instability.
In contrast to  the  situation in higher eukaryotes, initiation of translation in yeast is 
largely independent of sequence context surrounding the initiating A U G  (Cigan and D onahue, 
1987; Kozak, 1989a, 1989c). R ecent reports suggest that nuleotides at positions (-1) and (-3), 
with respect to  the A U G , are im portant in yeast in determ ining the efficiency of initiation; with 
an A  preferred at (-3) (Bairn and Sherm an, 1988). However although a consensus sequence 
round the A U G  can be derived for yeast, it appears that context effects are  not extensive. In 
fact som e yeast genes have initiating A U G s situated in regions that clearly differ from the 
consensus sequence e.g. PPR1 and PET3  (Brown, 1989 and see below). In a study of initiation 
sites of yeast gene transcripts it was concluded that 95%  initiate translation at the first AUG. 
M A T a l was included in this analysis and is thought to initiate at the first A U G  on the 
transcript (Cigan and D onahue, 1987). The sequence context of the in ternal A U G s (which could 
give rise to  /Tgalactosidase activity) present on the transcripts encoding the M A T al-lacZ  fusion 
proteins, are all different and thus may affect the relative choice of initiation sites. Initiation 
at non-A U G  codons has been detected in yeast transcripts but appears to be relatively 
inefficient (Brown, 1989). Initiation of this kind (if any) would probably be sim ilar on 
fusion-transcripts generated by the constructs pJBM-1 to pJBM-5, unless sequence differences 
which led to  secondary structure variations had an effect on their use. T herefore this would not 
be expected to  present a problem  for this study.
Initiation of translation in yeast as in higher eukaryotes can be influenced by the 
presence of secondary structure in the vicinity of the first A U G  (Baim and Sherm an, 1988;
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Kozak, 1989b). This regulation is dependent on the position of R N A  hairpins that appear to 
inhibit translation when upstream  of the A U G , yet enhance it when further downstream, 
presum ably by slowing up the 40S ribosom al in itiation complex (Kozak, 1989b). The presence 
of R N A  secondary structures may be a possible explanation for the use o f alternative AUGs. 
The norm al size of the  M A T a l transcript leader sequence is 11 nucleotides but pJBM-1 to  -5 
transcripts contain the G AL1  transcript leader which is roughly 60 nucleotides long. This R N A  
extension at the 5 ' end of the M A T a l-la cZ  transcrip t may contribute secondary structures which 
may exclude the initiating A U G ; however the  "scanning" model of translation  initiation would 
predict that in this case downstream  A U G s would not be utilised (Kozak, 1989b). It is not 
known w hether the ribosom al in itiation complex can by-pass secondary structure  which shields 
the first A U G  to initiate a t an in ternal A U G , w ithout firstly unwinding the R N A  and 
presum ably recognising the first A U G , as predicted by the "scanning" model (Kozak, 1989b). 
This situation  is further com plicated by the fact that splicing produces different sequences with 
potentially different secondary structures; indeed the introduction of single m utations may 
induce sim ilar effects. These changes may produce subtle or drastic effects on the initiation 
process which may enable the use o f m ore than one site on a given transcript. In this respect 
it has been dem onstrated that changes in the secondary structure  at the 5 ' end of the E.coli 
lacZ  transcript leader sequence can produce different (Tgalactosidase activities by either aiding 
o r obstructing in itiation of translation (Schulz and Reznikoff, 1990). It is not unreasonable to 
speculate that secondary structures arising in the  G AL1  and M A T a l  sequences (spliced and/or 
unspliced) may thus affect translation  of the M A T al-lacZ  fusion transcript.
In higher eukaryotic systems it has been shown that ribosom es can scan past upstream  
A U G s to initiate translation  at downstream  A U G  codons (Kozak, 1989c). This process is known 
as "leaky" scanning and is dependent on the upstream  A U G s being situated in a poor sequence 
context for initiation. Also o f im portance is the observation that ribosom es can reinitiate 
translation at a downstream  site on the sam e transcript as long as the previous translational 
event has been term inated (Peabody et a /., 1986; Peabody and Berg, 1986). Efficient reinitiation 
relies on the site o f term ination being relatively close (roughly lOOnts) to the rein itiation  site
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and indeed term ination  can be either side of the rein itiation  codon, suggesting that a ribosom e 
can scan the transcript in both directions. A no ther interesting possibility is that eukaryotic 
ribosom es can bind directly to  internal sites on the transcript ra ther than scan along to  them  
from the 5 ' end. Such a phenom enon has been reported  for a few anim al viruses (H erm an, 
1989; Sonenberg and Pelletier, 1989), however a need for caution in the in terp reta tion  of these 
results has been argued vigorously (Kozak, 1989c).
T here are several examples o f yeast transcripts that contain A U G  codons in the leader 
sequence upstream  of the main initiating A U G , e.g. CPA1, GCN4, PET3, PPR1, SUC2 etc. 
(Brown, 1989). In some of these cases e.g. CPA1 and G C N 4 , it is postulated that frww-acting 
factors may regulate the relative use of these codons. The mechanism by which the initiating 
complex recognises the downstream  A U G  is unknown. Indeed it may be a com bination of 
several considerations i.e. sequence contexts, secondary structure  and Trans-acting factors. The 
upstream  A U G s can be in variable sequence contexts, at different positions relative to the 
initiating A U G , be in or ou t of frame with the main A U G  and with o r w ithout downstream  
term ination  signals. It is obvious that regulation of gene expression at the  level o f translation 
is complex and may be transcript dependent.
A nother possibility which may lead to production of /?-galactosidase activity from the 
m R N A  encoded by pJBM -2 and not pJBM -4, is that translational frame-shifting on transcripts 
generated from pJBM -2 is greater than on those generated from pJBM-4. If this happened on 
the pre-m R N A  M A T a l -lacZ  fusion transcripts generated by these constructs then no activity 
would be encoded (pre-m R N A  is already in-frame). However it could occur on the m RN A  
which is out of frame and lead to  increased /?-galactosidase activity. Sequence differences 
between the M A T a l-la cZ  fusion transcripts generated from pJBM -2 and 4 (albeit very m inor) 
could account for different rates of frame-shifting. This would also apply to  the o ther constructs. 
O nce again different sequence contexts may produce variations in the relative efficiencies of 
frame-shifting and result in different /?-galactosidase activities. Yeast does in fact appear to 
exhibit translational frame-shifting at a level o f 5-10%  of norm al translation (W ilson et al., 
1988). However this relied on the presence of six U  nucleotides on the transcript immediately
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upstream  of the fram e-shift site and it was suggested that the ribosom es fail to  translocate 
properly due to the uniformity of this sequence. Indeed m utations in this sequence which 
replaced certain U nucleotides inhibited the frame-shift. Secondary structures in the R N A  may 
also affect frame-shifting, though this was excluded in the study of W ilson et al. (Brown, 1989; 
W ilson, et al., 1988 and references therein). There does not appear to be anything analogous 
to the U  rich sequence described, in the G AL1  o r M A T a l  regions of pJBM-1 to -5 and thus 
frame-shifting may not occur. However the m echanism (s) responsible for this process has not 
been elucidated and therefore o ther unidentified factors present on these M A T a l-la cZ  fusion 
transcripts may perm it frame-shifting to occur.
It is apparent that any sequence changes and R N A  processing steps (including R N A  
editing, changes in term ination  and/or polyadenylation) which could affect secondary structure 
and/or consensus sequences required for translation initiation, have the potential to influence 
both translational initiation and possibly the rates of translation  between different transcripts. 
Thus the in terpreta tion  of results based on translation  which are extrapolated to accom m odate 
changes in the R N A  itself m ust take account o f these possible problems.
Future  work on the com m itm ent of pre-m R N A  to splicing will involve the construction 
of plasmids with the coding capacity of pJBM-1 and -1/s but w ithout the in ternal AUGs. These 
will be derived from pJBM -4 and 4/s respectively. In this way it is hoped to  generate transcripts 
that are m ore com parable w ith each o ther and to  possibly control for the  potential problems 
indicated above (it should be noted that pJBM-5 is derived from pJBM-4). However because 
the analysis relies on splicing, the  potential secondary structure  differences due to intron 
removal are impossible to  control for.
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